CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: formamides
Accession: CHEBI:24079
browse the term
Definition: Amides with the general formula R(1)R(2)NCHO (R(1) and R(2) can be H).
G
Neil1
nei-like DNA glycosylase 1
affects metabolic processing
ISO
NEIL1 protein affects the metabolism of 2,6-diamino-4-hydroxy-5-formamidopyrimidine
CTD
PMID:17389588 PMID:20067321
NCBI chr 8:57,550,142...57,556,884
Ensembl chr 8:57,550,147...57,556,258
G
Ogg1
8-oxoguanine DNA glycosylase
affects metabolic processing
ISO
OGG1 protein affects the metabolism of 2,6-diamino-4-hydroxy-5-formamidopyrimidine
CTD
PMID:20067321
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Neil1
nei-like DNA glycosylase 1
affects metabolic processing
ISO
NEIL1 protein affects the metabolism of 4,6-diamino-5-N-formamidopyrimidine
CTD
PMID:17389588
NCBI chr 8:57,550,142...57,556,884
Ensembl chr 8:57,550,147...57,556,258
G
Nat2
N-acetyltransferase 2
multiple interactions
ISO
[NAT2 protein results in increased metabolism of 1,7-dimethylxanthine] which results in increased chemical synthesis of 5-acetylamino-6-formylamino-3-methyluracil
CTD
PMID:19215233
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
4933427D14Rikl
RIKEN cDNA 4933427D14 gene like
decreases expression
ISO
Antimycin A results in decreased expression of KIAA0753 mRNA
CTD
PMID:33512557
NCBI chr10:56,783,869...56,832,668
Ensembl chr10:56,783,775...56,832,968
G
Abcb6
ATP binding cassette subfamily B member 6
increases expression
ISO
Antimycin A results in increased expression of ABCB6 mRNA
CTD
PMID:33512557
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
G
Abhd6
abhydrolase domain containing 6, acylglycerol lipase
decreases expression
ISO
Antimycin A results in decreased expression of ABHD6 mRNA
CTD
PMID:33512557
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
G
Acadvl
acyl-CoA dehydrogenase, very long chain
decreases expression
ISO
Antimycin A results in decreased expression of ACADVL mRNA
CTD
PMID:33512557
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
G
Acox2
acyl-CoA oxidase 2
increases expression
ISO
Antimycin A results in increased expression of ACOX2 mRNA
CTD
PMID:19304788
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
G
Adam10
ADAM metallopeptidase domain 10
decreases expression
ISO
Antimycin A results in decreased expression of ADAM10 mRNA
CTD
PMID:33512557
NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889
G
Adm
adrenomedullin
increases expression
ISO
Antimycin A results in increased expression of ADM mRNA
CTD
PMID:33512557
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
Antimycin A results in increased expression of AEN mRNA
CTD
PMID:33512557
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
ISO
Antimycin A results in increased expression of AHSA1 mRNA
CTD
PMID:33512557
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Akr1b1
aldo-keto reductase family 1 member B1
decreases expression
ISO
Antimycin A results in decreased expression of AKR1B1 mRNA
CTD
PMID:33512557
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b7
aldo-keto reductase family 1, member B7
increases expression
ISO
Antimycin A results in increased expression of AKR1B7 mRNA
CTD
PMID:19304788
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
G
Akr7a2
aldo-keto reductase family 7, member A2
decreases expression
ISO
Antimycin A results in decreased expression of AKR7A2 mRNA
CTD
PMID:33512557
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases expression decreases activity
ISO
Luteolin inhibits the reaction [Antimycin A results in decreased activity of AKT1 protein] Antimycin A results in decreased expression of AKT1 mRNA
CTD
PMID:21466842 PMID:21782929 PMID:33512557
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alas1
5'-aminolevulinate synthase 1
decreases expression
ISO
Antimycin A results in decreased expression of ALAS1 mRNA
CTD
PMID:33512557
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
increases expression
ISO
Antimycin A results in increased expression of ALDH1L2 mRNA
CTD
PMID:19304788
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Aldh2
aldehyde dehydrogenase 2 family member
decreases expression
ISO
Antimycin A results in decreased expression of ALDH2 mRNA
CTD
PMID:33512557
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
decreases expression
ISO
Antimycin A results in decreased expression of ALDH7A1 mRNA
CTD
PMID:33512557
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
ISO
Antimycin A results in increased expression of ALDOA mRNA
CTD
PMID:33512557
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Amer1
APC membrane recruitment protein 1
decreases expression
ISO
Antimycin A results in decreased expression of AMER1 mRNA
CTD
PMID:33512557
NCBI chr X:60,300,595...60,316,480
Ensembl chr X:60,295,751...60,316,440
G
Angptl6
angiopoietin-like 6
increases expression
ISO
Antimycin A results in increased expression of ANGPTL6 mRNA
CTD
PMID:19304788
NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
G
Anln
anillin, actin binding protein
increases expression
ISO
Antimycin A results in increased expression of ANLN mRNA
CTD
PMID:33512557
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Anp32e
acidic nuclear phosphoprotein 32 family member E
increases expression
ISO
Antimycin A results in increased expression of ANP32E mRNA
CTD
PMID:33512557
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
G
Anxa2
annexin A2
increases expression
ISO
Antimycin A results in increased expression of ANXA2 mRNA
CTD
PMID:33512557
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Ap3m1
adaptor related protein complex 3 subunit mu 1
decreases expression
ISO
Antimycin A results in decreased expression of AP3M1 mRNA
CTD
PMID:33512557
NCBI chr15:3,246,616...3,264,846
Ensembl chr15:3,246,926...3,264,844
G
Aplp1
amyloid beta precursor like protein 1
decreases expression
ISO
Antimycin A results in decreased expression of APLP1 mRNA
CTD
PMID:33512557
NCBI chr 1:85,696,880...85,707,215
Ensembl chr 1:85,696,882...85,707,155
G
Arhgap8
Rho GTPase activating protein 8
increases expression
ISO
Antimycin A results in increased expression of ARHGAP8 mRNA
CTD
PMID:33512557
NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093
G
Arl4d
ADP-ribosylation factor like GTPase 4D
increases expression
ISO
Antimycin A results in increased expression of ARL4D mRNA
CTD
PMID:33512557
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
G
Arrdc4
arrestin domain containing 4
decreases expression
ISO
Antimycin A results in decreased expression of ARRDC4 mRNA
CTD
PMID:33512557
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Ascc3
activating signal cointegrator 1 complex subunit 3
increases expression
ISO
Antimycin A results in increased expression of ASCC3 mRNA
CTD
PMID:33512557
NCBI chr20:53,510,137...53,795,446
Ensembl chr20:53,510,184...53,790,165
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Antimycin A results in increased expression of ASNS mRNA
CTD
PMID:33512557
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Ass1
argininosuccinate synthase 1
increases expression
ISO
Antimycin A results in increased expression of ASS1 mRNA
CTD
PMID:33512557
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atf3
activating transcription factor 3
increases expression
ISO
Antimycin A results in increased expression of ATF3 mRNA
CTD
PMID:19304788
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases expression
ISO
Antimycin A results in increased expression of ATF4 mRNA
CTD
PMID:33512557
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
increases expression
ISO
Antimycin A results in increased expression of ATF5 mRNA
CTD
PMID:33512557
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atg13
autophagy related 13
multiple interactions
ISO
Antimycin A promotes the reaction [ATG13 protein results in increased expression of ULK1 protein]; ATG13 protein promotes the reaction [Antimycin A results in increased expression of ULK1 protein]
CTD
PMID:27629431
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
G
Atm
ATM serine/threonine kinase
decreases expression
ISO
Antimycin A results in decreased expression of ATM mRNA
CTD
PMID:33512557
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atmin
ATM interactor
decreases expression
ISO
Antimycin A results in decreased expression of ATMIN mRNA
CTD
PMID:33512557
NCBI chr19:44,996,506...45,013,606
Ensembl chr19:44,996,356...45,013,605
G
Atp11b
ATPase phospholipid transporting 11B (putative)
decreases expression
ISO
Antimycin A results in decreased expression of ATP11B mRNA
CTD
PMID:33512557
NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
ISO
Antimycin A results in decreased expression of ATP11C mRNA
CTD
PMID:33512557
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp5f1c
ATP synthase F1 subunit gamma
decreases expression
ISO
Antimycin A results in decreased expression of ATP5F1C mRNA
CTD
PMID:33512557
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
decreases expression
ISO
Antimycin A results in decreased expression of ATP6V0E1 mRNA
CTD
PMID:33512557
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
G
Atp6v1b2
ATPase H+ transporting V1 subunit B2
decreases expression
ISO
Antimycin A results in decreased expression of ATP6V1B2 mRNA
CTD
PMID:33512557
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
G
Atp6v1h
ATPase H+ transporting V1 subunit H
multiple interactions
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA
CTD
PMID:28366621
NCBI chr 5:14,379,029...14,484,703
Ensembl chr 5:14,378,257...14,537,962
G
Atrx
ATRX, chromatin remodeler
increases expression
ISO
Antimycin A results in increased expression of ATRX mRNA
CTD
PMID:33512557
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
G
Aurkb
aurora kinase B
increases expression
ISO
Antimycin A results in increased expression of AURKB mRNA
CTD
PMID:33512557
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
B2m
beta-2 microglobulin
increases expression
ISO
Antimycin A results in increased expression of B2M mRNA
CTD
PMID:33512557
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
B3galt6
Beta-1,3-galactosyltransferase 6
decreases expression
ISO
Antimycin A results in decreased expression of B3GALT6 mRNA
CTD
PMID:33512557
NCBI chr 5:166,584,202...166,586,338
Ensembl chr 5:166,584,202...166,586,338
G
Bag3
BAG cochaperone 3
increases expression
ISO
Antimycin A results in increased expression of BAG3 mRNA
CTD
PMID:33512557
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
Antimycin A results in increased expression of BAMBI mRNA
CTD
PMID:33512557
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Banf1
BAF nuclear assembly factor 1
increases expression
ISO
Antimycin A results in increased expression of BANF1 mRNA
CTD
PMID:33512557
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
[FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein] Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of BAX mRNA]
CTD
PMID:24040102 PMID:33512557 PMID:35430258
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases response to substance multiple interactions
ISO
BCL2 protein results in decreased susceptibility to Antimycin A PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A]
CTD
PMID:12730627
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l13
Bcl2-like 13
decreases expression
ISO
Antimycin A results in decreased expression of BCL2L13 mRNA
CTD
PMID:33512557
NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:154,056,127...154,108,985
G
Bcl7b
BAF chromatin remodeling complex subunit BCL7B
decreases expression
ISO
Antimycin A results in decreased expression of BCL7B mRNA
CTD
PMID:33512557
NCBI chr12:21,496,860...21,510,079
Ensembl chr12:21,496,856...21,510,202
G
Bglap
bone gamma-carboxyglutamate protein
increases expression multiple interactions
ISO
Antimycin A results in increased expression of BGLAP protein sciadopitysin inhibits the reaction [Antimycin A results in increased expression of BGLAP protein]
CTD
PMID:23624148
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
Antimycin A results in decreased expression of BID mRNA
CTD
PMID:33512557
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
Antimycin A results in increased expression of BIRC5 mRNA
CTD
PMID:33512557
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bmf
Bcl2 modifying factor
decreases expression
ISO
Antimycin A results in decreased expression of BMF mRNA
CTD
PMID:33512557
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
G
Bnip1
BCL2 interacting protein 1
increases expression
ISO
Antimycin A results in increased expression of BNIP1 mRNA
CTD
PMID:33770205
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
G
Bnip3
BCL2 interacting protein 3
increases expression
ISO
Antimycin A results in increased expression of BNIP3 mRNA
CTD
PMID:19304788
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bphl
biphenyl hydrolase like
decreases expression
ISO
Antimycin A results in decreased expression of BPHL mRNA
CTD
PMID:33512557
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
G
Brd3
bromodomain containing 3
decreases expression
ISO
Antimycin A results in decreased expression of BRD3 mRNA
CTD
PMID:33512557
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
decreases expression
ISO
Antimycin A results in decreased expression of BSCL2 mRNA
CTD
PMID:33512557
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Antimycin A results in increased expression of BTG2 mRNA
CTD
PMID:33512557
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg3
BTG anti-proliferation factor 3
increases expression
ISO
Antimycin A results in increased expression of BTG3 mRNA
CTD
PMID:33512557
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
increases expression
ISO
Antimycin A results in increased expression of BUB1 mRNA
CTD
PMID:33512557
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bzw2
basic leucine zipper and W2 domains 2
increases expression
ISO
Antimycin A results in increased expression of BZW2 mRNA
CTD
PMID:33512557
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
G
C1d
C1D nuclear receptor corepressor
increases expression
ISO
Antimycin A results in increased expression of C1D mRNA
CTD
PMID:33512557
NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852
G
C2cd5
C2 calcium-dependent domain containing 5
decreases expression
ISO
Antimycin A results in decreased expression of C2CD5 mRNA
CTD
PMID:33512557
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
G
Calm1
calmodulin 1
decreases expression
ISO
Antimycin A results in decreased expression of CALM1 mRNA
CTD
PMID:33512557
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
decreases expression
ISO
Antimycin A results in decreased expression of CAMK2B mRNA
CTD
PMID:33512557
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Caps
calcyphosine
decreases expression
ISO
Antimycin A results in decreased expression of CAPS mRNA
CTD
PMID:33512557
NCBI chr 9:1,544,597...1,545,631
Ensembl chr 9:1,544,719...1,545,647
G
Car6
carbonic anhydrase 6
increases expression
ISO
Antimycin A results in increased expression of CAR6 mRNA
CTD
PMID:19304788
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
Antimycin A results in increased expression of CARS1 mRNA
CTD
PMID:33512557
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Casp1
caspase 1
increases activity
ISO
Antimycin A results in increased activity of CASP1 protein
CTD
PMID:30582969
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases cleavage increases activity increases expression multiple interactions
ISO EXP
Antimycin A results in increased cleavage of CASP3 protein Antimycin A results in increased activity of CASP3 protein Antimycin A results in increased expression of CASP3 mRNA [chromium hexavalent ion co-treated with Antimycin A] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of CASP3 mRNA]; Ascorbic Acid inhibits the reaction [[chromium hexavalent ion co-treated with Antimycin A] results in increased activity of CASP3 protein]; Ascorbic Acid inhibits the reaction [Antimycin A results in increased activity of CASP3 protein] NAD inhibits the reaction [Antimycin A results in increased cleavage of CASP3 protein]; Niacinamide promotes the reaction [Antimycin A results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Antimycin A results in increased cleavage of CASP3 protein]; splitomicin promotes the reaction [Antimycin A results in increased cleavage of CASP3 protein]
CTD
PMID:11078377 PMID:24040102 PMID:24732427 PMID:32662599 PMID:35430258
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases cleavage
ISO
Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP8 protein]
CTD
PMID:32662599
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage decreases expression multiple interactions
ISO
Antimycin A results in increased cleavage of CASP9 protein Antimycin A results in decreased expression of CASP9 mRNA Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP9 protein]
CTD
PMID:32662599 PMID:33512557
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
decreases expression
ISO
Antimycin A results in decreased expression of CAST mRNA
CTD
PMID:33512557
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
increases expression multiple interactions
ISO
Antimycin A results in increased expression of CAT mRNA Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of CAT mRNA]
CTD
PMID:35430258
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbr1
carbonyl reductase 1
decreases expression
ISO
Antimycin A results in decreased expression of CBR1 mRNA
CTD
PMID:33512557
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cbx4
chromobox 4
increases expression
ISO
Antimycin A results in increased expression of CBX4 mRNA
CTD
PMID:33512557
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
Antimycin A results in decreased expression of CCL2 protein
CTD
PMID:20116850
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
ISO
Antimycin A results in decreased expression of CCL3 protein
CTD
PMID:20116850
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
Antimycin A results in decreased expression of CCL4 protein
CTD
PMID:20116850
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
decreases expression
ISO
Antimycin A results in decreased expression of CCL5 protein
CTD
PMID:20116850
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl9
C-C motif chemokine ligand 9
decreases expression
ISO
Antimycin A results in decreased expression of CCL15 mRNA
CTD
PMID:33512557
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccn1
cellular communication network factor 1
increases expression
ISO
Antimycin A results in increased expression of CCN1 mRNA
CTD
PMID:33512557
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
increases expression
ISO
Antimycin A results in increased expression of CCN2 mRNA
CTD
PMID:33512557
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
decreases expression increases expression multiple interactions
ISO
Antimycin A results in decreased expression of CCNA2 mRNA; Antimycin A results in decreased expression of CCNA2 protein Antimycin A results in increased expression of CCNA2 mRNA Antimycin A inhibits the reaction [ELAVL1 protein binds to CCNA2 3' UTR]
CTD
PMID:12730239 PMID:33512557
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
multiple interactions increases expression decreases expression
ISO
Antimycin A inhibits the reaction [ELAVL1 protein binds to CCNB1 3' UTR] Antimycin A results in increased expression of CCNB1 mRNA Antimycin A results in decreased expression of CCNB1 mRNA; Antimycin A results in decreased expression of CCNB1 protein
CTD
PMID:12730239 PMID:33512557
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
increases expression
ISO
Antimycin A results in increased expression of CCNB2 mRNA
CTD
PMID:33512557
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd2
cyclin D2
increases expression
ISO
Antimycin A results in increased expression of CCND2 mRNA
CTD
PMID:33512557
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccng1
cyclin G1
increases expression
ISO
Antimycin A results in increased expression of CCNG1 mRNA
CTD
PMID:33512557
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccnh
cyclin H
increases expression
ISO
Antimycin A results in increased expression of CCNH mRNA
CTD
PMID:33512557
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
G
Cd14
CD14 molecule
increases expression
ISO
Antimycin A results in increased expression of CD14 mRNA
CTD
PMID:10491287
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd24
CD24 molecule
decreases expression
ISO
Antimycin A results in decreased expression of CD24 mRNA
CTD
PMID:33512557
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd34
CD34 molecule
decreases expression
ISO
Antimycin A results in decreased expression of CD34 mRNA
CTD
PMID:19304788
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
G
Cd38
CD38 molecule
increases expression
ISO
Antimycin A results in increased expression of CD38 mRNA
CTD
PMID:10491287
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
G
Cd55
CD55 molecule (Cromer blood group)
decreases expression
ISO
Antimycin A results in decreased expression of CD55 mRNA
CTD
PMID:33512557
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd68
Cd68 molecule
increases expression
ISO
Antimycin A results in increased expression of CD68 mRNA
CTD
PMID:19304788
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cdc6
cell division cycle 6
increases expression decreases expression
ISO
Antimycin A results in increased expression of CDC6 mRNA Antimycin A results in decreased expression of CDC6 mRNA
CTD
PMID:33512557 PMID:34642769
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdca3
cell division cycle associated 3
increases expression
ISO
Antimycin A results in increased expression of CDCA3 mRNA
CTD
PMID:33512557
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca5
cell division cycle associated 5
increases expression
ISO
Antimycin A results in increased expression of CDCA5 mRNA
CTD
PMID:33512557
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
G
Cdca8
cell division cycle associated 8
increases expression
ISO
Antimycin A results in increased expression of CDCA8 mRNA
CTD
PMID:33512557
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdh10
cadherin 10
decreases expression
ISO
Antimycin A results in decreased expression of CDH10 mRNA
CTD
PMID:33512557
NCBI chr 2:68,628,623...68,850,995
Ensembl chr 2:68,628,780...68,850,995
G
Cdh2
cadherin 2
decreases expression
ISO
Antimycin A results in decreased expression of CDH2 mRNA
CTD
PMID:33512557
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
Antimycin A results in increased expression of CDK1 mRNA
CTD
PMID:33512557
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk5
cyclin-dependent kinase 5
decreases expression
ISO
Antimycin A results in decreased expression of CDK5 mRNA
CTD
PMID:33512557
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
decreases expression
ISO
Antimycin A results in decreased expression of CDK5R1 mRNA
CTD
PMID:33512557
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
ISO
Antimycin A results in increased expression of CDKN3 mRNA
CTD
PMID:33512557
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cdt1
chromatin licensing and DNA replication factor 1
increases expression
ISO
Antimycin A results in increased expression of CDT1 mRNA
CTD
PMID:33512557
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
Antimycin A results in increased expression of CEBPA mRNA
CTD
PMID:33512557
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Antimycin A results in increased expression of CEBPB mRNA
CTD
PMID:33512557
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cel
carboxyl ester lipase
decreases expression
ISO
Antimycin A results in decreased expression of CEL mRNA
CTD
PMID:33512557
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
G
Cemip2
cell migration inducing hyaluronidase 2
decreases expression
ISO
Antimycin A results in decreased expression of CEMIP2 mRNA
CTD
PMID:33512557
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
G
Cenpf
centromere protein F
increases expression
ISO
Antimycin A results in increased expression of CENPF mRNA
CTD
PMID:33512557
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpu
centromere protein U
increases expression
ISO
Antimycin A results in increased expression of CENPU mRNA
CTD
PMID:33512557
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cenpw
centromere protein W
increases expression
ISO
Antimycin A results in increased expression of CENPW mRNA
CTD
PMID:33512557
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
G
Cep55
centrosomal protein 55
increases expression
ISO
Antimycin A results in increased expression of CEP55 mRNA
CTD
PMID:33512557
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
G
Cep57
centrosomal protein 57
decreases expression
ISO
Antimycin A results in decreased expression of CEP57 mRNA
CTD
PMID:33512557
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
G
Cetn3
centrin 3
decreases expression
ISO
Antimycin A results in decreased expression of CETN3 mRNA
CTD
PMID:33512557
NCBI chr 2:12,089,025...12,101,828
Ensembl chr 2:12,089,226...12,101,828
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
increases expression
ISO
Antimycin A results in increased expression of CHAC1 mRNA
CTD
PMID:33512557
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Chchd10
coiled-coil-helix-coiled-coil-helix domain containing 10
increases expression
ISO
Antimycin A results in increased expression of CHCHD10 mRNA
CTD
PMID:19304788
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
G
Chek1
checkpoint kinase 1
increases expression
ISO
Antimycin A results in increased expression of CHEK1 mRNA
CTD
PMID:33512557
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chmp6
charged multivesicular body protein 6
decreases expression
ISO
Antimycin A results in decreased expression of CHMP6 mRNA
CTD
PMID:33512557
NCBI chr10:105,191,972...105,197,642
Ensembl chr10:105,191,950...105,197,640
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
decreases expression
ISO
Antimycin A results in decreased expression of CHRNB2 mRNA
CTD
PMID:33512557
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Ciao2a
cytosolic iron-sulfur assembly component 2A
decreases expression
ISO
Antimycin A results in decreased expression of CIAO2A mRNA
CTD
PMID:33512557
NCBI chr 8:66,670,533...66,682,455
Ensembl chr 8:66,670,483...66,682,455
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
increases expression
ISO
Antimycin A results in increased expression of CKS1B mRNA
CTD
PMID:33512557
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
G
Cks2
CDC28 protein kinase regulatory subunit 2
increases expression
ISO
Antimycin A results in increased expression of CKS2 mRNA
CTD
PMID:33512557
NCBI chr17:13,570,611...13,575,770
G
Clic4
chloride intracellular channel 4
increases expression
ISO
Antimycin A results in increased expression of CLIC4 mRNA
CTD
PMID:33512557
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
G
Cnn3
calponin 3
increases expression
ISO
Antimycin A results in increased expression of CNN3 mRNA
CTD
PMID:33512557
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
G
Cntn1
contactin 1
increases expression
ISO
Antimycin A results in increased expression of CNTN1 mRNA
CTD
PMID:33512557
NCBI chr 7:123,263,146...123,560,896
Ensembl chr 7:123,372,792...123,558,541
G
Coa6
cytochrome c oxidase assembly factor 6
increases expression
ISO
Antimycin A results in increased expression of COA6 mRNA
CTD
PMID:33512557
NCBI chr19:54,395,746...54,398,348
Ensembl chr19:54,395,742...54,399,407
G
Cog2
component of oligomeric golgi complex 2
decreases expression
ISO
Antimycin A results in decreased expression of COG2 mRNA
CTD
PMID:33512557
NCBI chr19:52,493,901...52,532,667
Ensembl chr19:52,493,932...52,526,874
G
Col16a1
collagen type XVI alpha 1 chain
decreases expression increases expression
ISO
Antimycin A results in decreased expression of COL16A1 mRNA Antimycin A results in increased expression of COL16A1 mRNA
CTD
PMID:19304788 PMID:33512557
NCBI chr 5:142,388,376...142,442,825
Ensembl chr 5:142,388,426...142,442,825
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Antimycin A results in increased expression of COL1A1 mRNA
CTD
PMID:33512557
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col4a1
collagen type IV alpha 1 chain
increases expression
ISO
Antimycin A results in increased expression of COL4A1 mRNA
CTD
PMID:33512557
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Col4a2
collagen type IV alpha 2 chain
increases expression
ISO
Antimycin A results in increased expression of COL4A2 mRNA
CTD
PMID:33512557
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Cops5
COP9 signalosome subunit 5
decreases expression
ISO
Antimycin A results in decreased expression of COPS5 mRNA
CTD
PMID:33512557
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
G
Cox6a2
cytochrome c oxidase subunit 6A2
increases expression
ISO
Antimycin A results in increased expression of COX6A2 mRNA
CTD
PMID:19304788
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cp
ceruloplasmin
increases degradation decreases expression
ISO
Antimycin A results in increased degradation of CP mRNA Antimycin A results in decreased expression of CP mRNA; Antimycin A results in decreased expression of CP protein
CTD
PMID:19019832
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpne3
copine 3
decreases expression
ISO
Antimycin A results in decreased expression of CPNE3 mRNA
CTD
PMID:33512557
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Cramp1
cramped chromatin regulator homolog 1
decreases expression
ISO
Antimycin A results in decreased expression of CRAMP1 mRNA
CTD
PMID:33512557
NCBI chr10:13,983,781...14,032,409
Ensembl chr10:13,983,866...14,032,392
G
Creb1
cAMP responsive element binding protein 1
multiple interactions decreases phosphorylation
ISO
23-epi-26-deoxyactein inhibits the reaction [Antimycin A results in decreased phosphorylation of CREB1 protein]; acetovanillone inhibits the reaction [Antimycin A results in decreased phosphorylation of CREB1 protein]
CTD
PMID:21538410 PMID:22180388
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
Antimycin A results in increased expression of CREBRF mRNA
CTD
PMID:33512557
NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999
G
Creg1
cellular repressor of E1A-stimulated genes 1
increases expression
ISO
Antimycin A results in increased expression of CREG1 mRNA
CTD
PMID:33512557
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
G
Crk
CRK proto-oncogene, adaptor protein
decreases expression
ISO
Antimycin A results in decreased expression of CRK mRNA
CTD
PMID:33512557
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
Antimycin A results in decreased expression of CSNK1D mRNA
CTD
PMID:33512557
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression
ISO
Antimycin A results in increased expression of CSRNP1 mRNA
CTD
PMID:33512557
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Cth
cystathionine gamma-lyase
increases expression
ISO
Antimycin A results in increased expression of CTH mRNA
CTD
PMID:19304788
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnnal1
catenin alpha-like 1
increases expression
ISO
Antimycin A results in increased expression of CTNNAL1 mRNA
CTD
PMID:33512557
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
G
Ctps1
CTP synthase 1
decreases expression
ISO
Antimycin A results in decreased expression of CTPS1 mRNA
CTD
PMID:33512557
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctsl
cathepsin L
increases expression
ISO
Antimycin A results in increased expression of CTSL mRNA
CTD
PMID:33512557
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cttn
cortactin
decreases expression
ISO
Antimycin A results in decreased expression of CTTN mRNA
CTD
PMID:33512557
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
Antimycin A inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]
CTD
PMID:24316229
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases expression
ISO
Antimycin A results in decreased expression of CXCR4 mRNA
CTD
PMID:33512557
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cycs
cytochrome c, somatic
multiple interactions affects localization
ISO
glabridin inhibits the reaction [Antimycin A affects the localization of CYCS protein]
CTD
PMID:21621525
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
ISO
Antimycin A results in increased expression of CYP3A5 mRNA
CTD
PMID:34642769
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
ISO
Antimycin A results in decreased expression of DAAM1 mRNA
CTD
PMID:33512557
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
G
Dag1
dystroglycan 1
decreases expression
ISO
Antimycin A results in decreased expression of DAG1 mRNA
CTD
PMID:33512557
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
G
Daxx
death-domain associated protein
decreases expression
ISO
Antimycin A results in decreased expression of DAXX mRNA
CTD
PMID:33512557
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dctd
dCMP deaminase
decreases expression
ISO
Antimycin A results in decreased expression of DCTD mRNA
CTD
PMID:33512557
NCBI chr16:44,066,952...44,098,654
Ensembl chr16:44,055,128...44,098,446
G
Dcx
doublecortin
decreases expression
ISO
Antimycin A results in decreased expression of DCX mRNA
CTD
PMID:33512557
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
G
Ddc
dopa decarboxylase
decreases expression
ISO
Antimycin A results in decreased expression of DDC mRNA
CTD
PMID:34642769
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit3
DNA-damage inducible transcript 3
increases expression
EXP ISO
Antimycin A results in increased expression of DDIT3 protein Antimycin A results in increased expression of DDIT3 mRNA
CTD
PMID:19304788 PMID:21337367 PMID:33512557
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
Antimycin A results in increased expression of DDIT4 mRNA
CTD
PMID:33512557
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddx60
DEXD/H-box helicase 60
decreases expression
ISO
Antimycin A results in decreased expression of DDX60 mRNA
CTD
PMID:33512557
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dek
DEK proto-oncogene
increases expression
ISO
Antimycin A results in increased expression of DEK mRNA
CTD
PMID:33512557
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
G
Depdc1b
DEP domain containing 1B
increases expression
ISO
Antimycin A results in increased expression of DEPDC1B mRNA
CTD
PMID:33512557
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
G
Dffb
DNA fragmentation factor subunit beta
decreases expression
ISO
Antimycin A results in decreased expression of DFFB mRNA
CTD
PMID:33512557
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dlgap5
DLG associated protein 5
increases expression
ISO
Antimycin A results in increased expression of DLGAP5 mRNA
CTD
PMID:33512557
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dll1
delta like canonical Notch ligand 1
increases expression
ISO
Antimycin A results in increased expression of DLL1 mRNA
CTD
PMID:33512557
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
G
Dnajb6
DnaJ heat shock protein family (Hsp40) member B6
increases expression
ISO
Antimycin A results in increased expression of DNAJB6 mRNA
CTD
PMID:33512557
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
G
Drd2
dopamine receptor D2
decreases expression
ISO
Antimycin A results in decreased expression of DRD2 mRNA
CTD
PMID:33512557
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Antimycin A results in increased expression of DUSP1 mRNA
CTD
PMID:33512557
NCBI chr10:16,680,478...16,683,275
G
Dusp14
dual specificity phosphatase 14
increases expression
ISO
Antimycin A results in increased expression of DUSP14 mRNA
CTD
PMID:33512557
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
Antimycin A results in increased expression of DUSP4 mRNA
CTD
PMID:33512557
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dynlt3
dynein light chain Tctex-type 3
decreases expression
ISO
Antimycin A results in decreased expression of DYNLT3 mRNA
CTD
PMID:33512557
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
G
E2f7
E2F transcription factor 7
decreases expression
ISO
Antimycin A results in decreased expression of E2F7 mRNA
CTD
PMID:19304788
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
Eaf2
ELL associated factor 2
decreases expression
ISO
Antimycin A results in decreased expression of EAF2 mRNA
CTD
PMID:33770205
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
G
Ebna1bp2
EBNA1 binding protein 2
decreases expression
ISO
Antimycin A results in decreased expression of EBNA1BP2 mRNA
CTD
PMID:33512557
NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267
G
Eci1
enoyl-CoA delta isomerase 1
decreases expression
ISO
Antimycin A results in decreased expression of ECI1 mRNA
CTD
PMID:33512557
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
G
Egr1
early growth response 1
increases expression
ISO
Antimycin A results in increased expression of EGR1 mRNA
CTD
PMID:33512557
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif1ax
eukaryotic translation initiation factor 1A, X-linked
increases expression
ISO
Antimycin A results in increased expression of EIF1AX mRNA
CTD
PMID:33512557
NCBI chr X:35,498,698...35,513,402
Ensembl chr X:35,498,517...35,513,335
G
Eif3e
eukaryotic translation initiation factor 3 subunit E
decreases expression
ISO
Antimycin A results in decreased expression of EIF3E mRNA
CTD
PMID:33512557
NCBI chr 7:74,339,848...74,372,483
Ensembl chr 7:74,339,828...74,373,096
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
increases expression
ISO
Antimycin A results in increased expression of EIF4EBP1 mRNA
CTD
PMID:33512557
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Eif6
eukaryotic translation initiation factor 6
increases expression
ISO
Antimycin A results in increased expression of EIF6 mRNA
CTD
PMID:33512557
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Elavl1
ELAV like RNA binding protein 1
multiple interactions decreases expression decreases localization
ISO
Antimycin A inhibits the reaction [ELAVL1 protein binds to CCNA2 3' UTR]; Antimycin A inhibits the reaction [ELAVL1 protein binds to CCNB1 3' UTR] Antimycin A results in decreased expression of ELAVL1 mRNA Antimycin A results in decreased localization of ELAVL1 protein
CTD
PMID:12730239 PMID:33512557
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
G
Elavl3
ELAV like RNA binding protein 3
decreases expression
ISO
Antimycin A results in decreased expression of ELAVL3 mRNA
CTD
PMID:33512557
NCBI chr 8:20,547,108...20,583,369
Ensembl chr 8:20,550,201...20,583,641
G
Elmod1
ELMO domain containing 1
decreases expression
ISO
Antimycin A results in decreased expression of ELMOD1 mRNA
CTD
PMID:33512557
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
G
Emg1
EMG1 N1-specific pseudouridine methyltransferase
increases expression
ISO
Antimycin A results in increased expression of EMG1 mRNA
CTD
PMID:33512557
NCBI chr 4:157,509,258...157,517,540
Ensembl chr 4:157,509,277...157,517,540
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
increases expression
ISO
Antimycin A results in increased expression of ENTPD2 mRNA
CTD
PMID:19304788
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
G
Ep300
E1A binding protein p300
decreases expression
ISO
Antimycin A results in decreased expression of EP300 mRNA
CTD
PMID:33512557
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epas1
endothelial PAS domain protein 1
multiple interactions
EXP
Antimycin A inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]
CTD
PMID:18353899
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Epha3
Eph receptor A3
decreases expression
ISO
Antimycin A results in decreased expression of EPHA3 mRNA
CTD
PMID:33512557
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
G
Ephb2
Eph receptor B2
decreases expression
ISO
Antimycin A results in decreased expression of EPHB2 mRNA
CTD
PMID:33512557
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Erbb3
erb-b2 receptor tyrosine kinase 3
increases expression
ISO
Antimycin A results in increased expression of ERBB3 mRNA
CTD
PMID:33512557
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
ISO
Antimycin A results in increased expression of ERO1A mRNA
CTD
PMID:19304788
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Ets1
ETS proto-oncogene 1, transcription factor
increases expression
ISO
Antimycin A results in increased expression of ETS1 mRNA
CTD
PMID:33512557
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Etv1
ETS variant transcription factor 1
decreases expression
ISO
Antimycin A results in decreased expression of ETV1 mRNA
CTD
PMID:33512557
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
G
Evl
Enah/Vasp-like
decreases expression
ISO
Antimycin A results in decreased expression of EVL mRNA
CTD
PMID:33512557
NCBI chr 6:127,473,119...127,594,342
Ensembl chr 6:127,474,543...127,594,344
G
Exosc8
exosome component 8
increases expression
ISO
Antimycin A results in increased expression of EXOSC8 mRNA
CTD
PMID:33512557
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
G
Fam174a
family with sequence similarity 174, member A
decreases expression
ISO
Antimycin A results in decreased expression of FAM174A mRNA
CTD
PMID:33512557
NCBI chr 9:95,742,815...95,761,083
Ensembl chr 9:95,742,927...95,761,081
G
Fam217b
family with sequence similarity 217, member B
increases expression
ISO
Antimycin A results in increased expression of FAM217B mRNA
CTD
PMID:33770205
NCBI chr 3:165,505,574...165,515,273
Ensembl chr 3:165,501,532...165,513,377
G
Fam72a
family with sequence similarity 72, member A
increases expression
ISO
Antimycin A results in increased expression of FAM72A mRNA
CTD
PMID:33512557
NCBI chr13:42,967,701...42,979,083
Ensembl chr13:42,967,578...42,984,208
G
Fam83d
family with sequence similarity 83, member D
increases expression
ISO
Antimycin A results in increased expression of FAM83D mRNA
CTD
PMID:33512557
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fas
Fas cell surface death receptor
decreases expression increases expression
ISO
Antimycin A results in decreased expression of FAS mRNA Antimycin A results in increased expression of FAS mRNA
CTD
PMID:8902626 PMID:33512557
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
decreases expression
ISO
Antimycin A results in decreased expression of FASN mRNA
CTD
PMID:33512557
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fez2
fasciculation and elongation protein zeta 2
decreases expression
ISO
Antimycin A results in decreased expression of FEZ2 mRNA
CTD
PMID:33512557
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
G
Fgf1
fibroblast growth factor 1
decreases expression
ISO
Antimycin A results in decreased expression of FGF1 mRNA
CTD
PMID:19304788
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
increases expression
ISO
Antimycin A results in increased expression of FGF2 mRNA
CTD
PMID:33512557
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fig4
FIG4 phosphoinositide 5-phosphatase
decreases expression
ISO
Antimycin A results in decreased expression of FIG4 mRNA
CTD
PMID:33512557
NCBI chr20:44,600,603...44,724,047
Ensembl chr20:44,600,603...44,723,844
G
Fkbp4
FKBP prolyl isomerase 4
increases expression
ISO
Antimycin A results in increased expression of FKBP4 mRNA
CTD
PMID:33512557
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
ISO
Antimycin A results in increased expression of FKBP5 mRNA
CTD
PMID:33512557
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Flna
filamin A
increases expression
ISO
Antimycin A results in increased expression of FLNA mRNA
CTD
PMID:33512557
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
G
Flrt3
fibronectin leucine rich transmembrane protein 3
increases expression
ISO
Antimycin A results in increased expression of FLRT3 mRNA
CTD
PMID:33512557
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Antimycin A results in increased expression of FOS mRNA
CTD
PMID:33512557
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Antimycin A results in increased expression of FOSB mRNA
CTD
PMID:33512557
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
Antimycin A results in increased expression of FOSL1 mRNA
CTD
PMID:33512557
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Foxo1
forkhead box O1
multiple interactions decreases expression
ISO
[Antimycin A co-treated with Resveratrol] results in decreased acetylation of FOXO1 protein; [FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; FOXO1 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO1 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein] Antimycin A results in decreased expression of FOXO1 protein
CTD
PMID:24040102
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Foxo3
forkhead box O3
decreases expression multiple interactions
ISO
Antimycin A results in decreased expression of FOXO3 protein [FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; FOXO3 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO3 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein]
CTD
PMID:24040102
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Foxo4
forkhead box O4
multiple interactions decreases expression
ISO
[FOXO1 protein co-treated with FOXO4 protein co-treated with FOXO3 protein] affects the reaction [Resveratrol inhibits the reaction [Antimycin A results in increased expression of BAX protein]]; FOXO4 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO4 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein] Antimycin A results in decreased expression of FOXO4 protein
CTD
PMID:24040102
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
G
Fpgs
folylpolyglutamate synthase
decreases expression
ISO
Antimycin A results in decreased expression of FPGS mRNA
CTD
PMID:33512557
NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563
G
Fth1
ferritin heavy chain 1
increases expression
ISO
Antimycin A results in increased expression of FTH1 mRNA
CTD
PMID:33512557
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Ftl1
ferritin light chain 1
increases expression
ISO
Antimycin A results in increased expression of FTL mRNA
CTD
PMID:33512557
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Fut1
fucosyltransferase 1
increases expression
ISO
Antimycin A results in increased expression of FUT1 mRNA
CTD
PMID:33512557
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Antimycin A results in decreased expression of FYN mRNA
CTD
PMID:33512557
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
Fzd1
frizzled class receptor 1
decreases expression
ISO
Antimycin A results in decreased expression of FZD1 mRNA
CTD
PMID:33512557
NCBI chr 4:29,310,303...29,314,701
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Fzd2
frizzled class receptor 2
decreases expression
ISO
Antimycin A results in decreased expression of FZD2 mRNA
CTD
PMID:33512557
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression
ISO
Antimycin A results in decreased expression of G6PD mRNA
CTD
PMID:33512557
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gabpb1
GA binding protein transcription factor subunit beta 1
increases expression
ISO
Antimycin A results in increased expression of GABPB1 mRNA
CTD
PMID:33512557
NCBI chr 3:113,879,972...113,924,742
Ensembl chr 3:113,879,973...113,923,696
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Antimycin A results in increased expression of GADD45A mRNA
CTD
PMID:19304788 PMID:33512557
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
Antimycin A results in increased expression of GADD45B mRNA
CTD
PMID:33512557
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
decreases expression
ISO
Antimycin A results in decreased expression of GALNT3 mRNA
CTD
PMID:33512557
NCBI chr 3:50,742,500...50,779,266
Ensembl chr 3:50,742,512...50,766,268
G
Gap43
growth associated protein 43
decreases expression
ISO
Antimycin A results in decreased expression of GAP43 mRNA
CTD
PMID:33512557
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gata2
GATA binding protein 2
increases expression
ISO
Antimycin A results in increased expression of GATA2 mRNA
CTD
PMID:33512557
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
G
Gch1
GTP cyclohydrolase 1
increases expression
ISO
Antimycin A results in increased expression of GCH1 mRNA
CTD
PMID:19304788
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Antimycin A results in increased expression of GCLM mRNA
CTD
PMID:33512557
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Antimycin A results in increased expression of GDF15 mRNA
CTD
PMID:33512557
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gemin5
gem (nuclear organelle) associated protein 5
decreases expression
ISO
Antimycin A results in decreased expression of GEMIN5 mRNA
CTD
PMID:33512557
NCBI chr10:42,295,729...42,342,902
Ensembl chr10:42,297,515...42,342,892
G
Gfod1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
increases expression
ISO
Antimycin A results in increased expression of GFOD1 mRNA
CTD
PMID:33512557
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
G
Gins2
GINS complex subunit 2
increases expression
ISO
Antimycin A results in increased expression of GINS2 mRNA
CTD
PMID:33512557
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gja1
gap junction protein, alpha 1
increases expression
ISO
Antimycin A results in increased expression of GJA1 mRNA
CTD
PMID:33512557
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gldc
glycine decarboxylase
decreases expression
ISO
Antimycin A results in decreased expression of GLDC mRNA
CTD
PMID:33512557
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Gli3
GLI family zinc finger 3
decreases expression
ISO
Antimycin A results in decreased expression of GLI3 mRNA
CTD
PMID:33512557
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
G
Gmnn
geminin, DNA replication inhibitor
increases expression
ISO
Antimycin A results in increased expression of GMNN mRNA
CTD
PMID:33512557
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
G
Gnai2
G protein subunit alpha i2
decreases expression
ISO
Antimycin A results in decreased expression of GNAI2 mRNA
CTD
PMID:33512557
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnpda1
glucosamine-6-phosphate deaminase 1
decreases expression
ISO
Antimycin A results in decreased expression of GNPDA1 mRNA
CTD
PMID:33512557
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,165,427...30,177,486
G
Gpc1
glypican 1
decreases expression
ISO
Antimycin A results in decreased expression of GPC1 mRNA
CTD
PMID:33512557
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
Antimycin A results in increased expression of GRB10 mRNA
CTD
PMID:33512557
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
decreases expression
ISO
Antimycin A results in decreased expression of GRIA2 mRNA
CTD
PMID:33512557
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
G
Grm4
glutamate metabotropic receptor 4
decreases expression
ISO
Antimycin A results in decreased expression of GRM4 mRNA
CTD
PMID:33512557
NCBI chr20:5,484,172...5,572,821
Ensembl chr20:5,481,124...5,572,821
G
Gsta2
glutathione S-transferase alpha 2
increases expression
ISO
Antimycin A results in increased expression of GSTA2 mRNA
CTD
PMID:19304788
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta5
glutathione S-transferase alpha 5
increases expression
ISO
Antimycin A results in increased expression of GSTA1 mRNA
CTD
PMID:19304788
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm2
glutathione S-transferase mu 2
decreases expression
ISO
Antimycin A results in decreased expression of GSTM2 mRNA
CTD
PMID:33512557
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
Antimycin A results in increased expression of H1-2 mRNA
CTD
PMID:33512557
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
Hba-a3
hemoglobin alpha, adult chain 3
increases expression
ISO
Antimycin A results in increased expression of HBA2 mRNA
CTD
PMID:33512557
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
G
Hdac2
histone deacetylase 2
decreases expression
ISO
Antimycin A results in decreased expression of HDAC2 mRNA
CTD
PMID:33512557
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Antimycin A results in increased expression of HERPUD1 mRNA
CTD
PMID:33512557
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
Antimycin A results in increased expression of HES1 mRNA
CTD
PMID:33512557
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hes5
hes family bHLH transcription factor 5
increases expression
ISO
Antimycin A results in increased expression of HES5 mRNA
CTD
PMID:33512557
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
G
Hif1a
hypoxia inducible factor 1 subunit alpha
affects expression multiple interactions increases expression
EXP ISO
Antimycin A affects the expression of HIF1A protein Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of HIF1A mRNA]
CTD
PMID:16034640 PMID:35430258
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hist1h2ah
histone cluster 1 H2A family member H
increases expression
ISO
Antimycin A results in increased expression of H2AC11 mRNA
CTD
PMID:33512557
NCBI chr17:41,384,521...41,385,018
G
Hist1h2al1
histone cluster 1 H2A family like 1
increases expression
ISO
Antimycin A results in increased expression of H2AC6 mRNA
CTD
PMID:33512557
NCBI chr17:42,707,954...42,708,420
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
Antimycin A results in increased expression of H2BC5 mRNA
CTD
PMID:33512557
NCBI chr17:42,792,887...42,793,268
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
Antimycin A results in increased expression of HMGA2 mRNA
CTD
PMID:33512557
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmmr
hyaluronan-mediated motility receptor
increases expression
ISO
Antimycin A results in increased expression of HMMR mRNA
CTD
PMID:33512557
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
increases expression
ISO
Antimycin A results in increased expression of HMOX1 mRNA
CTD
PMID:33512557
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
Antimycin A results in increased expression of HSP90AA1 mRNA
CTD
PMID:33512557
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
ISO
Antimycin A results in increased expression of HSP90AB1 mRNA
CTD
PMID:33512557
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Antimycin A results in increased expression of HSPA1A mRNA
CTD
PMID:33512557
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
Antimycin A results in increased expression of HSPA1B mRNA
CTD
PMID:33512557
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa2
heat shock protein family A (Hsp70) member 2
increases expression
ISO
Antimycin A results in increased expression of HSPA2 mRNA
CTD
PMID:33512557
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
EXP ISO
Antimycin A results in increased expression of HSPA5 protein Antimycin A results in increased expression of HSPA5 mRNA
CTD
PMID:21337367 PMID:33512557
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Antimycin A results in increased expression of HSPA6 mRNA
CTD
PMID:33512557
NCBI chr13:83,273,176...83,274,317
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
Antimycin A results in increased expression of HSPB1 mRNA
CTD
PMID:33512557
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
Antimycin A results in increased expression of HSPB8 mRNA
CTD
PMID:33512557
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
ISO
Antimycin A results in increased expression of HSPD1 mRNA
CTD
PMID:33512557
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hspe1
heat shock protein family E (Hsp10) member 1
increases expression
ISO
Antimycin A results in increased expression of HSPE1 mRNA
CTD
PMID:33512557
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
G
Htra1
HtrA serine peptidase 1
increases expression
ISO
Antimycin A results in increased expression of HTRA1 mRNA
CTD
PMID:19304788
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
decreases expression multiple interactions
ISO
Antimycin A results in decreased expression of ICAM1 mRNA Antimycin A inhibits the reaction [N-caproylsphingosine results in increased expression of ICAM1 mRNA]
CTD
PMID:12952965 PMID:19304788
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
Antimycin A results in increased expression of ID2 mRNA
CTD
PMID:33512557
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
Antimycin A results in decreased expression of IDI1 mRNA
CTD
PMID:33770205
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ier3
immediate early response 3
increases expression
ISO
Antimycin A results in increased expression of IER3 mRNA
CTD
PMID:33512557
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
Antimycin A results in increased expression of IFI44L mRNA
CTD
PMID:33512557
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifitm1
interferon induced transmembrane protein 1
increases expression
ISO
Antimycin A results in increased expression of IFITM1 mRNA
CTD
PMID:33512557
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm3
interferon induced transmembrane protein 3
decreases expression
ISO
Antimycin A results in decreased expression of IFITM3 mRNA
CTD
PMID:33512557
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifrd1
interferon-related developmental regulator 1
increases expression
ISO
Antimycin A results in increased expression of IFRD1 mRNA
CTD
PMID:33512557
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ifrd2
interferon-related developmental regulator 2
increases expression
ISO
Antimycin A results in increased expression of IFRD2 mRNA
CTD
PMID:33512557
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
Antimycin A results in decreased expression of IGFBP2 mRNA
CTD
PMID:33512557
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Ikbip
IKBKB interacting protein
increases expression
ISO
Antimycin A results in increased expression of IKBIP mRNA
CTD
PMID:33512557
NCBI chr 7:25,579,865...25,598,548
Ensembl chr 7:25,579,832...25,605,162
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Acetylcysteine inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]; Antimycin A promotes the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; Antimycin A promotes the reaction [IL1B protein results in increased expression of CXCL8 protein]; Antimycin A promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]; BAY 11-7085 inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]; IL1B protein promotes the reaction [Antimycin A results in increased expression of PTGS2 protein]; Resveratrol inhibits the reaction [[Antimycin A co-treated with IL1B protein] results in increased expression of CXCL8 protein]
CTD
PMID:22549761 PMID:24609059
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il3ra
interleukin 3 receptor subunit alpha
decreases expression
ISO
Antimycin A results in decreased expression of IL3RA mRNA
CTD
PMID:33770205
NCBI chr12:16,318,081...16,323,781
Ensembl chr12:16,318,081...16,323,484
G
Il6
interleukin 6
multiple interactions increases expression
ISO
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Antimycin A results in increased expression of and results in increased secretion of IL6 protein]; 23-epi-26-deoxyactein inhibits the reaction [Antimycin A results in increased expression of IL6 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Antimycin A results in increased expression of and results in increased secretion of IL6 protein]; Antimycin A results in increased expression of and results in increased secretion of IL6 protein; Cyclosporine inhibits the reaction [Antimycin A results in increased expression of and results in increased secretion of IL6 protein]
CTD
PMID:21381053 PMID:21910134
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
decreases expression
ISO
Antimycin A results in decreased expression of IL6R protein modified form
CTD
PMID:20116850
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Ina
internexin neuronal intermediate filament protein, alpha
decreases expression
ISO
Antimycin A results in decreased expression of INA mRNA
CTD
PMID:33512557
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Inpp1
inositol polyphosphate-1-phosphatase
increases expression
ISO
Antimycin A results in increased expression of INPP1 mRNA
CTD
PMID:33512557
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
G
Inpp5f
inositol polyphosphate-5-phosphatase F
decreases expression
ISO
Antimycin A results in decreased expression of INPP5F mRNA
CTD
PMID:33770205
NCBI chr 1:183,190,480...183,270,276
Ensembl chr 1:183,190,480...183,270,276
G
Insig1
insulin induced gene 1
increases expression
ISO
Antimycin A results in increased expression of INSIG1 mRNA
CTD
PMID:33512557
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insm1
INSM transcriptional repressor 1
decreases expression
ISO
Antimycin A results in decreased expression of INSM1 mRNA
CTD
PMID:33512557
NCBI chr 3:133,640,030...133,642,963
Ensembl chr 3:133,639,580...133,643,003
G
Ipo5
importin 5
increases expression
ISO
Antimycin A results in increased expression of IPO5 mRNA
CTD
PMID:33512557
NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
G
Irf1
interferon regulatory factor 1
increases expression
ISO
Antimycin A results in increased expression of IRF1 mRNA
CTD
PMID:33512557
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Isl1
ISL LIM homeobox 1
decreases expression
ISO
Antimycin A results in decreased expression of ISL1 mRNA
CTD
PMID:33512557
NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584
G
Itgb7
integrin subunit beta 7
increases expression
ISO
Antimycin A results in increased expression of ITGB7 mRNA
CTD
PMID:19304788
NCBI chr 7:133,347,927...133,364,955
Ensembl chr 7:133,347,960...133,364,876
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
decreases expression
ISO
Antimycin A results in decreased expression of ITPR2 mRNA
CTD
PMID:33512557
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression
ISO
Antimycin A results in increased expression of JMJD6 mRNA
CTD
PMID:33512557
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
[Antimycin A co-treated with Paraquat] results in increased expression of JUN protein Antimycin A results in increased expression of JUN protein
CTD
PMID:16237197
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kdm3a
lysine demethylase 3A
decreases expression
ISO
Antimycin A results in decreased expression of KDM3A mRNA
CTD
PMID:33512557
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
G
Kdm5b
lysine demethylase 5B
decreases expression
ISO
Antimycin A results in decreased expression of KDM5B mRNA
CTD
PMID:33512557
NCBI chr13:46,001,589...46,073,868
Ensembl chr13:46,002,542...46,073,872
G
Kif14
kinesin family member 14
increases expression
ISO
Antimycin A results in increased expression of KIF14 mRNA
CTD
PMID:33512557
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
G
Kif15
kinesin family member 15
increases expression
ISO
Antimycin A results in increased expression of KIF15 mRNA
CTD
PMID:33512557
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif20a
kinesin family member 20A
increases expression
ISO
Antimycin A results in increased expression of KIF20A mRNA
CTD
PMID:33512557
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif23
kinesin family member 23
increases expression
ISO
Antimycin A results in increased expression of KIF23 mRNA
CTD
PMID:33512557
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif2c
kinesin family member 2C
increases expression
ISO
Antimycin A results in increased expression of KIF2C mRNA
CTD
PMID:33512557
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kif5c
kinesin family member 5C
decreases expression
ISO
Antimycin A results in decreased expression of KIF5C mRNA
CTD
PMID:33512557
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
G
Klf5
KLF transcription factor 5
increases expression
ISO
Antimycin A results in increased expression of KLF5 mRNA
CTD
PMID:33512557
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Klf6
KLF transcription factor 6
increases expression
ISO
Antimycin A results in increased expression of KLF6 mRNA
CTD
PMID:33512557
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klhl24
kelch-like family member 24
increases expression
ISO
Antimycin A results in increased expression of KLHL24 mRNA
CTD
PMID:34642769
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
G
Klhl9
kelch-like family member 9
decreases expression
ISO
Antimycin A results in decreased expression of KLHL9 mRNA
CTD
PMID:33512557
NCBI chr 5:103,333,747...103,337,931
G
Krt17
keratin 17
increases expression
ISO
Antimycin A results in increased expression of KRT17 mRNA
CTD
PMID:33512557
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
G
Krt19
keratin 19
decreases expression
ISO
Antimycin A results in decreased expression of KRT19 mRNA
CTD
PMID:33512557
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Kyat3
kynurenine aminotransferase 3
decreases expression
ISO
Antimycin A results in decreased expression of KYAT3 mRNA
CTD
PMID:33512557
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
G
L1cam
L1 cell adhesion molecule
decreases expression
ISO
Antimycin A results in decreased expression of L1CAM mRNA
CTD
PMID:33512557
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
G
Lamp1
lysosomal-associated membrane protein 1
multiple interactions decreases expression
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA Antimycin A results in decreased expression of LAMP1 mRNA
CTD
PMID:28366621 PMID:33512557
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
G
Lmod1
leiomodin 1
decreases expression
ISO
Antimycin A results in decreased expression of LMOD1 mRNA
CTD
PMID:33512557
NCBI chr13:46,754,048...46,796,186
Ensembl chr13:46,754,033...46,794,900
G
LOC102549061
histone H2B type 1-N-like
increases expression
ISO
Antimycin A results in increased expression of H2BC3 mRNA
CTD
PMID:33512557
NCBI chr17:41,380,056...41,380,686
G
Loxl1
lysyl oxidase-like 1
decreases expression
ISO
Antimycin A results in decreased expression of LOXL1 mRNA
CTD
PMID:33512557
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lrp4
LDL receptor related protein 4
decreases expression
ISO
Antimycin A results in decreased expression of LRP4 mRNA
CTD
PMID:33512557
NCBI chr 3:77,429,600...77,483,593
Ensembl chr 3:77,429,798...77,483,593
G
Lrrc41
leucine rich repeat containing 41
decreases expression
ISO
Antimycin A results in decreased expression of LRRC41 mRNA
CTD
PMID:33512557
NCBI chr 5:129,554,547...129,575,450
Ensembl chr 5:129,554,547...129,575,449
G
Lsm6
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
Antimycin A results in decreased expression of LSM6 mRNA
CTD
PMID:19304788
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
G
Lum
lumican
increases expression
ISO
Antimycin A results in increased expression of LUM mRNA
CTD
PMID:33512557
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Macf1
microtubule-actin crosslinking factor 1
decreases expression
ISO
Antimycin A results in decreased expression of MACF1 mRNA
CTD
PMID:33512557
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Antimycin A results in increased expression of MAFF mRNA
CTD
PMID:33512557
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Map1b
microtubule-associated protein 1B
decreases expression
ISO
Antimycin A results in decreased expression of MAP1B mRNA
CTD
PMID:33512557
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
Antimycin A results in increased expression of MAP1LC3B mRNA
CTD
PMID:33512557
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2
microtubule-associated protein 2
decreases expression
ISO
Antimycin A results in decreased expression of MAP2 mRNA
CTD
PMID:33512557
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Map2k4
mitogen activated protein kinase kinase 4
decreases expression
ISO
Antimycin A results in decreased expression of MAP2K4 mRNA
CTD
PMID:33512557
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Map6
microtubule-associated protein 6
decreases expression
ISO
Antimycin A results in decreased expression of MAP6 mRNA
CTD
PMID:33512557
NCBI chr 1:153,568,020...153,634,415
Ensembl chr 1:153,568,368...153,634,414
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO
Antimycin A inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK14 protein]
CTD
PMID:15650392
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
decreases expression
ISO
Antimycin A results in decreased expression of MAPK3 mRNA
CTD
PMID:33512557
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
decreases expression
ISO
Antimycin A results in decreased expression of MAPRE3 mRNA
CTD
PMID:33512557
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
Antimycin A results in decreased expression of MAPT mRNA
CTD
PMID:33512557
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mbnl2
muscleblind-like splicing regulator 2
increases expression
ISO
Antimycin A results in increased expression of MBNL2 mRNA
CTD
PMID:33512557
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
increases expression
ISO
Antimycin A results in increased expression of MCL1 mRNA
CTD
PMID:33512557
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm7
minichromosome maintenance complex component 7
increases expression
ISO
Antimycin A results in increased expression of MCM7 mRNA
CTD
PMID:33512557
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mdk
midkine
increases expression
ISO
Antimycin A results in increased expression of MDK mRNA
CTD
PMID:33512557
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
Antimycin A results in increased expression of MDM2 mRNA
CTD
PMID:33512557
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
increases expression
ISO
Antimycin A results in increased expression of ME1 mRNA
CTD
PMID:33512557
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Med21
mediator complex subunit 21
increases expression
ISO
Antimycin A results in increased expression of MED21 mRNA
CTD
PMID:33512557
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
G
Mefv
MEFV innate immunity regulator, pyrin
increases expression
ISO
Antimycin A results in increased expression of MEFV mRNA
CTD
PMID:33512557
NCBI chr10:11,786,948...11,796,977
Ensembl chr10:11,787,422...11,796,973
G
Metrn
meteorin, glial cell differentiation regulator
decreases expression
ISO
Antimycin A results in decreased expression of METRN mRNA
CTD
PMID:33512557
NCBI chr10:14,816,684...14,818,702
Ensembl chr10:14,816,572...14,818,701
G
Mki67
marker of proliferation Ki-67
increases expression
ISO
Antimycin A results in increased expression of MKI67 mRNA
CTD
PMID:33512557
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mllt11
MLLT11, transcription factor 7 cofactor
decreases expression
ISO
Antimycin A results in decreased expression of MLLT11 mRNA
CTD
PMID:33512557
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
G
Mmp13
matrix metallopeptidase 13
increases expression
ISO
Antimycin A results in increased expression of MMP13 mRNA
CTD
PMID:19304788
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
multiple interactions increases activity
ISO
[Antimycin A results in increased abundance of Reactive Oxygen Species] which results in increased activity of MMP2 protein Antimycin A results in increased activity of MMP2 protein
CTD
PMID:11929863
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mnat1
MNAT1 component of CDK activating kinase
decreases expression
ISO
Antimycin A results in decreased expression of MNAT1 mRNA
CTD
PMID:33512557
NCBI chr 6:91,814,703...91,971,945
Ensembl chr 6:91,814,749...91,970,744
G
Morn2
MORN repeat containing 2
decreases expression
ISO
Antimycin A results in decreased expression of MORN2 mRNA
CTD
PMID:33512557
NCBI chr 6:14,718,799...14,725,281
G
Mre11
MRE11 homolog, double strand break repair nuclease
decreases expression
ISO
Antimycin A results in decreased expression of MRE11 mRNA
CTD
PMID:33512557
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
G
Msi2
musashi RNA-binding protein 2
decreases expression
ISO
Antimycin A results in decreased expression of MSI2 mRNA
CTD
PMID:33512557
NCBI chr10:73,143,760...73,510,566
Ensembl chr10:73,147,380...73,510,157
G
Msl1
MSL complex subunit 1
increases expression
ISO
Antimycin A results in increased expression of MSL1 mRNA
CTD
PMID:33770205
NCBI chr10:83,755,380...83,767,147
Ensembl chr10:83,755,720...83,765,726
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression
ISO
Antimycin A results in decreased expression of ND6 mRNA
CTD
PMID:33512557
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mta1
metastasis associated 1
decreases expression
ISO
Antimycin A results in decreased expression of MTA1 mRNA
CTD
PMID:33512557
NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
ISO
Antimycin A results in increased expression of MTHFD2 mRNA
CTD
PMID:33512557
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of MTOR mRNA]
CTD
PMID:35430258
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mybl2
MYB proto-oncogene like 2
increases expression
ISO
Antimycin A results in increased expression of MYBL2 mRNA
CTD
PMID:33512557
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
Antimycin A results in increased expression of MYC mRNA
CTD
PMID:33512557
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycbp2
MYC binding protein 2
decreases expression
ISO
Antimycin A results in decreased expression of MYCBP2 mRNA
CTD
PMID:33512557
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
G
Myod1
myogenic differentiation 1
decreases expression
ISO
Antimycin A results in decreased expression of MYOD1 mRNA
CTD
PMID:34302933
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
G
Myog
myogenin
decreases expression
ISO
Antimycin A results in decreased expression of MYOG mRNA
CTD
PMID:34302933
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Nav1
neuron navigator 1
decreases expression
ISO
Antimycin A results in decreased expression of NAV1 mRNA
CTD
PMID:33512557
NCBI chr13:46,866,972...47,119,368
Ensembl chr13:46,873,689...47,126,449
G
Ncam1
neural cell adhesion molecule 1
decreases expression
ISO
Antimycin A results in decreased expression of NCAM1 mRNA
CTD
PMID:33512557
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Ncan
neurocan
decreases expression
ISO
Antimycin A results in decreased expression of NCAN mRNA
CTD
PMID:33512557
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
G
Ncaph
non-SMC condensin I complex, subunit H
increases expression
ISO
Antimycin A results in increased expression of NCAPH mRNA
CTD
PMID:33512557
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
Antimycin A results in increased expression of NDRG1 mRNA
CTD
PMID:19304788
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Nefl
neurofilament light chain
decreases expression
ISO
Antimycin A results in decreased expression of NEFL mRNA
CTD
PMID:33512557
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nek2
NIMA-related kinase 2
increases expression
ISO
Antimycin A results in increased expression of NEK2 mRNA
CTD
PMID:33512557
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
G
Nfatc3
nuclear factor of activated T-cells 3
decreases expression
ISO
Antimycin A results in decreased expression of NFATC3 mRNA
CTD
PMID:33512557
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
G
Nfe2l1
NFE2 like bZIP transcription factor 1
increases expression
ISO
Antimycin A results in increased expression of NFE2L1 mRNA
CTD
PMID:33512557
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NFE2L2 mRNA]
CTD
PMID:35430258
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
Antimycin A inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]
CTD
PMID:24316229
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nhlh1
nescient helix loop helix 1
decreases expression
ISO
Antimycin A results in decreased expression of NHLH1 mRNA
CTD
PMID:33512557
NCBI chr13:84,517,347...84,522,548
Ensembl chr13:84,517,289...84,525,094
G
Nit1
nitrilase 1
decreases expression
ISO
Antimycin A results in decreased expression of NIT1 mRNA
CTD
PMID:33512557
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
Antimycin A results in decreased expression of NNT mRNA
CTD
PMID:33512557
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Nol3
nucleolar protein 3
decreases expression
ISO
Antimycin A results in decreased expression of NOL3 mRNA
CTD
PMID:33512557
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
G
Nop58
NOP58 ribonucleoprotein
increases expression
ISO
Antimycin A results in increased expression of NOP58 mRNA
CTD
PMID:33512557
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
G
Notch3
notch receptor 3
decreases expression
ISO
Antimycin A results in decreased expression of NOTCH3 mRNA
CTD
PMID:33512557
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
G
Npc1
NPC intracellular cholesterol transporter 1
decreases expression
ISO
Antimycin A results in decreased expression of NPC1 mRNA
CTD
PMID:33512557
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
G
Nptx1
neuronal pentraxin 1
increases expression
ISO
Antimycin A results in increased expression of NPTX1 mRNA
CTD
PMID:33512557
NCBI chr10:104,811,107...104,820,358
Ensembl chr10:104,811,403...104,820,367
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
Antimycin A results in increased expression of NQO1 mRNA Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NQO1 mRNA]
CTD
PMID:33512557 PMID:35430258
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr2f1
nuclear receptor subfamily 2, group F, member 1
decreases expression
ISO
Antimycin A results in decreased expression of NR2F1 mRNA
CTD
PMID:33512557
NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases expression
ISO
Antimycin A results in increased expression of NR3C1 mRNA
CTD
PMID:33512557
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Antimycin A results in increased expression of NR4A2 mRNA
CTD
PMID:33512557
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nr5a1
nuclear receptor subfamily 5, group A, member 1
decreases expression
ISO
Antimycin A results in decreased expression of NR5A1 mRNA
CTD
PMID:33512557
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
G
Nras
NRAS proto-oncogene, GTPase
decreases expression
ISO
Antimycin A results in decreased expression of NRAS mRNA
CTD
PMID:33512557
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Nrcam
neuronal cell adhesion molecule
decreases expression
ISO
Antimycin A results in decreased expression of NRCAM mRNA
CTD
PMID:33512557
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
G
Nrg1
neuregulin 1
decreases expression
ISO
Antimycin A results in decreased expression of NRG1 mRNA
CTD
PMID:33512557
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nrp1
neuropilin 1
decreases expression
ISO
Antimycin A results in decreased expression of NRP1 mRNA
CTD
PMID:19304788
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrxn1
neurexin 1
decreases expression
ISO
Antimycin A results in decreased expression of NRXN1 mRNA
CTD
PMID:33512557
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
Antimycin A results in increased expression of NT5E mRNA
CTD
PMID:19304788
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Nup50
nucleoporin 50
increases expression
ISO
Antimycin A results in increased expression of NUP50 mRNA
CTD
PMID:33512557
NCBI chr 7:116,047,960...116,065,231
Ensembl chr 7:116,048,021...116,066,905
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Antimycin A results in increased expression of NUPR1 mRNA
CTD
PMID:19304788
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Oip5
Opa interacting protein 5
increases expression
ISO
Antimycin A results in increased expression of OIP5 mRNA
CTD
PMID:33512557
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Onecut1
one cut homeobox 1
decreases expression
ISO
Antimycin A results in decreased expression of ONECUT1 mRNA
CTD
PMID:33512557
NCBI chr 8:75,599,432...75,633,598
Ensembl chr 8:75,599,740...75,627,277
G
Ophn1
oligophrenin 1
decreases expression
ISO
Antimycin A results in decreased expression of OPHN1 mRNA
CTD
PMID:33512557
NCBI chr X:63,599,746...63,976,678
Ensembl chr X:63,603,042...63,976,633
G
P2rx3
purinergic receptor P2X 3
decreases expression
ISO
Antimycin A results in decreased expression of P2RX3 mRNA
CTD
PMID:33512557
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
Pafah1b3
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
decreases expression
ISO
Antimycin A results in decreased expression of PAFAH1B3 mRNA
CTD
PMID:33512557
NCBI chr 1:80,881,263...80,883,789
Ensembl chr 1:80,881,309...80,883,893
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Antimycin A results in increased cleavage of PARP1 protein [Antimycin A co-treated with Paraquat] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of PARP1 protein]
CTD
PMID:16237197 PMID:32662599
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp2
poly (ADP-ribose) polymerase 2
increases expression
ISO
Antimycin A results in increased expression of PARP2 mRNA
CTD
PMID:33512557
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
G
Pbk
PDZ binding kinase
increases expression
ISO
Antimycin A results in increased expression of PBK mRNA
CTD
PMID:33512557
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pcdh8
protocadherin 8
increases expression
ISO
Antimycin A results in increased expression of PCDH8 mRNA
CTD
PMID:33512557
NCBI chr15:55,198,470...55,203,039
Ensembl chr15:55,198,459...55,205,872
G
Pcdha9
protocadherin alpha 9
decreases expression
ISO
Antimycin A results in decreased expression of PCDHA9 mRNA
CTD
PMID:33512557
G
Pck1
phosphoenolpyruvate carboxykinase 1
increases expression
ISO
Antimycin A results in increased expression of PCK1 mRNA
CTD
PMID:33512557
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pdcd6ip
programmed cell death 6 interacting protein
decreases expression
ISO
Antimycin A results in decreased expression of PDCD6IP mRNA
CTD
PMID:33512557
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
G
Pdia5
protein disulfide isomerase family A, member 5
increases expression
ISO
Antimycin A results in increased expression of PDIA5 mRNA
CTD
PMID:33512557
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdia6
protein disulfide isomerase family A, member 6
increases expression
ISO
Antimycin A results in increased expression of PDIA6 mRNA
CTD
PMID:33512557
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pdk4
pyruvate dehydrogenase kinase 4
increases expression
ISO
Antimycin A results in increased expression of PDK4 mRNA
CTD
PMID:33512557
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pebp1
phosphatidylethanolamine binding protein 1
decreases expression
ISO
Antimycin A results in decreased expression of PEBP1 mRNA
CTD
PMID:33512557
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
G
Peg10
paternally expressed 10
decreases expression
ISO
Antimycin A results in decreased expression of PEG10 mRNA
CTD
PMID:33512557
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Pex3
peroxisomal biogenesis factor 3
decreases expression
ISO
Antimycin A results in decreased expression of PEX3 mRNA
CTD
PMID:33512557
NCBI chr 1:7,912,508...7,954,474
Ensembl chr 1:7,912,506...7,954,518
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
Antimycin A results in increased expression of PFKP mRNA
CTD
PMID:34642769
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pga5
pepsinogen A5
increases expression
ISO
Antimycin A results in increased expression of PGA5 mRNA
CTD
PMID:33512557
NCBI chr 1:207,317,021...207,327,156
Ensembl chr 1:207,317,021...207,327,156
G
Pgk1
phosphoglycerate kinase 1
decreases expression
ISO
Antimycin A results in decreased expression of PGK1 mRNA
CTD
PMID:33512557
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgm3
phosphoglucomutase 3
increases expression
ISO
Antimycin A results in increased expression of PGM3 mRNA
CTD
PMID:33512557
NCBI chr 8:87,518,317...87,536,021
Ensembl chr 8:87,517,701...87,536,022
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
ISO
Antimycin A results in increased expression of PHGDH mRNA
CTD
PMID:33512557
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
Antimycin A results in decreased expression of PHKB mRNA
CTD
PMID:33512557
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Phlda1
pleckstrin homology-like domain, family A, member 1
decreases expression
ISO
Antimycin A results in decreased expression of PHLDA1 mRNA
CTD
PMID:33512557
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pink1
PTEN induced kinase 1
multiple interactions decreases expression
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA]; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]] Antimycin A results in decreased expression of PINK1 mRNA
CTD
PMID:28366621 PMID:33512557
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pip4k2b
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
decreases expression
ISO
Antimycin A results in decreased expression of PIP4K2B mRNA
CTD
PMID:33512557
NCBI chr10:82,706,016...82,734,938
Ensembl chr10:82,701,098...82,734,938
G
Pitpna
phosphatidylinositol transfer protein, alpha
decreases expression
ISO
Antimycin A results in decreased expression of PITPNA mRNA
CTD
PMID:33512557
NCBI chr10:60,430,712...60,473,564
Ensembl chr10:60,430,748...60,471,342
G
Plscr3
phospholipid scramblase 3
decreases expression
ISO
Antimycin A results in decreased expression of PLSCR3 mRNA
CTD
PMID:33512557
NCBI chr10:54,566,556...54,573,240
Ensembl chr10:54,566,873...54,578,709
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
Antimycin A results in increased expression of PMAIP1 mRNA
CTD
PMID:33512557
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pole3
DNA polymerase epsilon 3, accessory subunit
increases expression
ISO
Antimycin A results in increased expression of POLE3 mRNA
CTD
PMID:33512557
NCBI chr 5:75,973,941...75,977,175
Ensembl chr 5:75,974,717...75,977,231 Ensembl chr 7:75,974,717...75,977,231
G
Polr1c
RNA polymerase I and III subunit C
increases expression
ISO
Antimycin A results in increased expression of POLR1C mRNA
CTD
PMID:33512557
NCBI chr 9:14,735,740...14,739,852
Ensembl chr 9:14,735,714...14,739,852
G
Polr2h
RNA polymerase II, I and III subunit H
increases expression
ISO
Antimycin A results in increased expression of POLR2H mRNA
CTD
PMID:33512557
NCBI chr11:80,192,017...80,197,468
Ensembl chr11:80,192,032...80,197,515 Ensembl chr10:80,192,032...80,197,515
G
Potem
POTE ankyrin domain family member M
decreases expression
ISO
Antimycin A results in decreased expression of POTEM mRNA
CTD
PMID:33770205
NCBI chr16:20,193,646...20,311,924
Ensembl chr16:19,949,230...19,976,541
G
Pou4f1
POU class 4 homeobox 1
decreases expression
ISO
Antimycin A results in decreased expression of POU4F1 mRNA
CTD
PMID:33512557
NCBI chr15:81,253,714...81,260,057
Ensembl chr15:81,257,781...81,259,728
G
Pou4f2
POU class 4 homeobox 2
decreases expression
ISO
Antimycin A results in decreased expression of POU4F2 mRNA
CTD
PMID:33512557
NCBI chr19:29,486,686...29,490,327
Ensembl chr19:29,486,686...29,490,327
G
Ppard
peroxisome proliferator-activated receptor delta
decreases expression
ISO
Antimycin A results in decreased expression of PPARD mRNA
CTD
PMID:33512557
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Ppargc1a
PPARG coactivator 1 alpha
decreases expression
ISO
Antimycin A results in decreased expression of PPARGC1A protein
CTD
PMID:34302933
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppie
peptidylprolyl isomerase E
increases expression
ISO
Antimycin A results in increased expression of PPIE mRNA
CTD
PMID:33512557
NCBI chr 5:135,406,172...135,419,332
Ensembl chr 5:135,406,176...135,419,235
G
Ppl
periplakin
decreases expression
ISO
Antimycin A results in decreased expression of PPL mRNA
CTD
PMID:19304788
NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
Antimycin A results in increased expression of PPM1D mRNA
CTD
PMID:33512557
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
increases expression
ISO
Antimycin A results in increased expression of PPP1CC mRNA
CTD
PMID:33512557
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
Antimycin A results in increased expression of PPP1R15A mRNA
CTD
PMID:19304788 PMID:33512557
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r17
protein phosphatase 1, regulatory subunit 17
decreases expression
ISO
Antimycin A results in decreased expression of PPP1R17 mRNA
CTD
PMID:33512557
NCBI chr 4:85,213,595...85,230,607
Ensembl chr 4:85,213,887...85,230,603
G
Praf2
PRA1 domain family, member 2
decreases expression
ISO
Antimycin A results in decreased expression of PRAF2 mRNA
CTD
PMID:33512557
NCBI chr X:14,773,398...14,776,035
Ensembl chr X:14,773,420...14,775,909
G
Prdx3
peroxiredoxin 3
decreases expression
ISO
Antimycin A results in decreased expression of PRDX3 mRNA
CTD
PMID:33512557
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
ISO
Antimycin A results in decreased expression of PRKACA mRNA
CTD
PMID:33512557
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prkag1
protein kinase AMP-activated non-catalytic subunit gamma 1
decreases expression
ISO
Antimycin A results in decreased expression of PRKAG1 mRNA
CTD
PMID:33512557
NCBI chr 7:129,963,105...129,980,532
Ensembl chr 7:129,963,105...129,980,561
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
ISO
Antimycin A results in decreased expression of PRKAR1A mRNA
CTD
PMID:33512557
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Prkcb
protein kinase C, beta
decreases expression
ISO
Antimycin A results in decreased expression of PRKCB mRNA
CTD
PMID:33512557
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions decreases expression
ISO
[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein; [Oligomycins co-treated with Antimycin A] affects the localization of PRKN protein; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein] Antimycin A results in decreased expression of PRKN mRNA
CTD
PMID:28366621 PMID:28673964 PMID:33512557
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Prr11
proline rich 11
increases expression
ISO
Antimycin A results in increased expression of PRR11 mRNA
CTD
PMID:33512557
NCBI chr10:71,898,858...71,943,325
Ensembl chr10:71,901,202...71,921,012
G
Psat1
phosphoserine aminotransferase 1
increases expression
ISO
Antimycin A results in increased expression of PSAT1 mRNA
CTD
PMID:33512557
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Pten
phosphatase and tensin homolog
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of PTEN mRNA]
CTD
PMID:35430258
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
ISO
Antimycin A results in increased expression of PTGS2 protein Antimycin A results in increased expression of PTGS2 mRNA Antimycin A promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]; IL1B protein promotes the reaction [Antimycin A results in increased expression of PTGS2 protein]
CTD
PMID:19304788 PMID:24609059
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
ISO
Antimycin A results in decreased expression of PTPRF mRNA
CTD
PMID:33512557
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
Antimycin A results in increased expression of PTTG1 mRNA
CTD
PMID:33512557
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Rab31
RAB31, member RAS oncogene family
decreases expression
ISO
Antimycin A results in decreased expression of RAB31 mRNA
CTD
PMID:33512557
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
G
Rad54l
RAD54 like
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of RAD54L mRNA]
CTD
PMID:35430258
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Ralgds
ral guanine nucleotide dissociation stimulator
decreases expression
ISO
Antimycin A results in decreased expression of RALGDS mRNA
CTD
PMID:33512557
NCBI chr 3:11,839,686...11,880,059
Ensembl chr 3:11,839,416...11,880,059
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
Antimycin A results in decreased expression of RBL1 mRNA
CTD
PMID:19304788
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbm6
RNA binding motif protein 6
increases expression
ISO
Antimycin A results in increased expression of RBM6 mRNA
CTD
PMID:33512557
NCBI chr 8:108,452,687...108,552,783
Ensembl chr 8:108,452,687...108,552,771
G
Rbx1
ring-box 1
decreases expression
ISO
Antimycin A results in decreased expression of RBX1 mRNA
CTD
PMID:33512557
NCBI chr 7:112,976,863...113,001,051
Ensembl chr 7:112,990,835...113,001,051
G
Rel
REL proto-oncogene, NF-kB subunit
increases expression
ISO
Antimycin A results in increased expression of REL mRNA
CTD
PMID:33512557
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization multiple interactions
ISO
Antimycin A affects the localization of RELA protein Antimycin A inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]
CTD
PMID:24316229 PMID:24609059
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Reln
reelin
decreases expression
ISO
Antimycin A results in decreased expression of RELN mRNA
CTD
PMID:33512557
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
Antimycin A results in increased expression of RGS2 mRNA
CTD
PMID:33512557
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rnd1
Rho family GTPase 1
increases expression
ISO
Antimycin A results in increased expression of RND1 mRNA
CTD
PMID:19304788
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf167
ring finger protein 167
decreases expression
ISO
Antimycin A results in decreased expression of RNF167 mRNA
CTD
PMID:33512557
NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927
G
Rpap3
RNA polymerase II associated protein 3
decreases expression
ISO
Antimycin A results in decreased expression of RPAP3 mRNA
CTD
PMID:33512557
NCBI chr 7:128,810,820...128,840,006
Ensembl chr 7:128,810,827...128,839,950
G
Rpl11
ribosomal protein L11
increases expression
ISO
Antimycin A results in increased expression of RPL11 mRNA
CTD
PMID:33512557
NCBI chr 5:148,274,060...148,277,708
Ensembl chr 5:148,274,069...148,277,599
G
Rpl17
ribosomal protein L17
increases expression
ISO
Antimycin A results in increased expression of RPL17 mRNA
CTD
PMID:33512557
NCBI chr18:68,581,141...68,584,253
Ensembl chr18:68,581,098...68,584,253
G
Rpl35
ribosomal protein L35
increases expression
ISO
Antimycin A results in increased expression of RPL35 mRNA
CTD
PMID:33512557
NCBI chr 3:22,753,255...22,756,217
Ensembl chr 3:22,753,253...22,756,243
G
Rpl36
ribosomal protein L36
increases expression
ISO
Antimycin A results in increased expression of RPL36 mRNA
CTD
PMID:33512557
NCBI chr 9:1,441,986...1,447,397
Ensembl chr 6:98,809,534...98,809,897
G
Rpl7a
ribosomal protein L7A
increases expression
ISO
Antimycin A results in increased expression of RPL7A mRNA
CTD
PMID:33512557
NCBI chr 3:10,239,026...10,241,703
Ensembl chr 3:10,239,001...10,241,716
G
Rps10
ribosomal protein S10
decreases expression
ISO
Antimycin A results in decreased expression of RPS10 mRNA
CTD
PMID:33512557
NCBI chr20:5,694,313...5,698,922
Ensembl chr20:5,694,313...5,699,044 Ensembl chr 6:5,694,313...5,699,044
G
Rps18
ribosomal protein S18
increases expression
ISO
Antimycin A results in increased expression of RPS18 mRNA
CTD
PMID:33512557
NCBI chr20:4,931,427...4,935,538
Ensembl chr10:101,204,500...101,205,146 Ensembl chr20:101,204,500...101,205,146
G
Rps2
ribosomal protein S2
increases expression
ISO
Antimycin A results in increased expression of RPS2 mRNA
CTD
PMID:33512557
NCBI chr10:13,747,316...13,749,165
Ensembl chr10:13,747,301...13,749,163
G
Rps25
ribosomal protein s25
increases expression
ISO
Antimycin A results in increased expression of RPS25 mRNA
CTD
PMID:33512557
NCBI chr 8:44,733,623...44,735,999
Ensembl chr 8:44,733,029...44,737,271
G
Rps3
ribosomal protein S3
increases expression
ISO
Antimycin A results in increased expression of RPS3 mRNA
CTD
PMID:33512557
NCBI chr 1:153,778,363...153,783,663
Ensembl chr 1:153,777,472...153,783,680
G
Rps5
ribosomal protein S5
increases expression
ISO
Antimycin A results in increased expression of RPS5 mRNA
CTD
PMID:33512557
NCBI chr 1:73,538,776...73,543,073
Ensembl chr 1:73,538,776...73,543,073
G
Rps7
ribosomal protein S7
increases expression
ISO
Antimycin A results in increased expression of RPS7 mRNA
CTD
PMID:33512557
NCBI chr 6:45,266,200...45,271,064
Ensembl chr 6:45,223,980...45,271,145
G
Rpsa
ribosomal protein SA
increases expression
ISO
Antimycin A results in increased expression of RPSA mRNA
CTD
PMID:33512557
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
Antimycin A results in increased expression of RRAD mRNA
CTD
PMID:33512557
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression increases expression
ISO
Antimycin A results in decreased expression of RRM2 mRNA Antimycin A results in increased expression of RRM2 mRNA
CTD
PMID:19304788 PMID:33512557
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
Antimycin A results in increased expression of RRM2B mRNA
CTD
PMID:33512557
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
G
Rrp1b
ribosomal RNA processing 1B
increases expression
ISO
Antimycin A results in increased expression of RRP1B mRNA
CTD
PMID:33512557
NCBI chr20:10,123,111...10,148,704
Ensembl chr20:10,123,125...10,147,928
G
Rrp8
ribosomal RNA processing 8
increases expression
ISO
Antimycin A results in increased expression of RRP8 mRNA
CTD
PMID:33512557
NCBI chr 1:160,081,092...160,088,709
Ensembl chr 1:160,084,295...160,089,331
G
Rrs1
ribosome biogenesis regulator 1 homolog
increases expression
ISO
Antimycin A results in increased expression of RRS1 mRNA
CTD
PMID:33512557
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
G
RT1-A2
RT1 class Ia, locus A2
increases expression
ISO
Antimycin A results in increased expression of HLA-E mRNA
CTD
PMID:33512557
NCBI chr20:4,870,939...4,910,183
G
RT1-CE16
RT1 class I, locus CE16
increases expression
ISO
Antimycin A results in increased expression of HLA-A mRNA
CTD
PMID:33512557
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
Rtn4ip1
reticulon 4 interacting protein 1
decreases expression
ISO
Antimycin A results in decreased expression of RTN4IP1 mRNA
CTD
PMID:33512557
NCBI chr20:47,382,251...47,422,747
Ensembl chr20:47,382,234...47,422,338
G
S100a13
S100 calcium binding protein A13
increases expression
ISO
Antimycin A results in increased expression of S100A13 mRNA
CTD
PMID:33512557
NCBI chr 2:175,999,439...176,005,933
G
S100a4
S100 calcium-binding protein A4
increases expression
ISO
Antimycin A results in increased expression of S100A4 mRNA
CTD
PMID:33512557
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Sacm1l
SAC1 like phosphatidylinositide phosphatase
decreases expression
ISO
Antimycin A results in decreased expression of SACM1L mRNA
CTD
PMID:33512557
NCBI chr 8:123,176,017...123,232,413
Ensembl chr 8:123,172,536...123,232,413
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
Antimycin A results in increased expression of SAT1 mRNA
CTD
PMID:33512557
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Satb1
SATB homeobox 1
decreases expression
ISO
Antimycin A results in decreased expression of SATB1 mRNA
CTD
PMID:33512557
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Scoc
short coiled-coil protein
decreases expression
ISO
Antimycin A results in decreased expression of SCOC mRNA
CTD
PMID:33512557
NCBI chr19:24,659,651...24,689,237
Ensembl chr19:24,659,651...24,693,217
G
Sem1
SEM1 26S proteasome subunit
increases expression
ISO
Antimycin A results in increased expression of SEM1 mRNA
CTD
PMID:33512557
NCBI chr 4:34,671,848...34,692,005
Ensembl chr 4:34,671,848...34,692,005
G
Sema5a
semaphorin 5A
increases expression
ISO
Antimycin A results in increased expression of SEMA5A mRNA
CTD
PMID:33512557
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
G
Sema6d
semaphorin 6D
decreases expression
ISO
Antimycin A results in decreased expression of SEMA6D mRNA
CTD
PMID:33512557
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
G
Sertad1
SERTA domain containing 1
increases expression
ISO
Antimycin A results in increased expression of SERTAD1 mRNA
CTD
PMID:33512557
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
G
Sesn2
sestrin 2
increases expression
ISO
Antimycin A results in increased expression of SESN2 mRNA
CTD
PMID:33512557
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Shb
SH2 domain containing adaptor protein B
increases expression
ISO
Antimycin A results in increased expression of SHB mRNA
CTD
PMID:33512557
NCBI chr 5:59,678,066...59,785,443
Ensembl chr 5:59,678,216...59,785,538
G
Shcbp1
SHC binding and spindle associated 1
increases expression
ISO
Antimycin A results in increased expression of SHCBP1 mRNA
CTD
PMID:33512557
NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844
G
Sirt3
sirtuin 3
increases expression multiple interactions
ISO
Antimycin A results in increased expression of SIRT3 mRNA Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of SIRT3 mRNA]
CTD
PMID:35430258
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Six1
SIX homeobox 1
decreases expression
ISO
Antimycin A results in decreased expression of SIX1 mRNA
CTD
PMID:33512557
NCBI chr 6:91,746,739...91,751,975
Ensembl chr 6:91,746,739...91,751,975
G
Slc11a2
solute carrier family 11 member 2
decreases expression
ISO
Antimycin A results in decreased expression of SLC11A2 mRNA
CTD
PMID:33512557
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc17a6
solute carrier family 17 member 6
decreases expression
ISO
Antimycin A results in decreased expression of SLC17A6 mRNA
CTD
PMID:33512557
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Slc18a2
solute carrier family 18 member A2
increases expression
ISO
Antimycin A results in increased expression of SLC18A2 mRNA
CTD
PMID:33512557
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc1a2
solute carrier family 1 member 2
decreases expression
ISO
Antimycin A results in decreased expression of SLC1A2 mRNA
CTD
PMID:33512557
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc25a4
solute carrier family 25 member 4
decreases expression
ISO
Antimycin A results in decreased expression of SLC25A4 mRNA
CTD
PMID:33512557
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc2a6
solute carrier family 2 member 6
decreases expression
ISO
Antimycin A results in decreased expression of SLC2A6 mRNA
CTD
PMID:33512557
NCBI chr 3:10,348,395...10,355,208
Ensembl chr 3:10,348,395...10,355,208
G
Slc30a1
solute carrier family 30 member 1
increases expression
ISO
Antimycin A results in increased expression of SLC30A1 mRNA
CTD
PMID:33512557
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
G
Slc35a5
solute carrier family 35, member A5
decreases expression
ISO
Antimycin A results in decreased expression of SLC35A5 mRNA
CTD
PMID:33512557
NCBI chr11:55,653,376...55,674,476
Ensembl chr11:55,653,394...55,674,473
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
Antimycin A results in increased expression of SLC3A2 mRNA
CTD
PMID:33512557
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc6a2
solute carrier family 6 member 2
increases expression
ISO
Antimycin A results in increased expression of SLC6A2 mRNA
CTD
PMID:33512557
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
G
Slc7a5
solute carrier family 7 member 5
increases expression
ISO
Antimycin A results in increased expression of SLC7A5 mRNA
CTD
PMID:33512557
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Smc4
structural maintenance of chromosomes 4
increases expression
ISO
Antimycin A results in increased expression of SMC4 mRNA
CTD
PMID:33512557
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
Antimycin A results in increased expression of SNAI2 mRNA
CTD
PMID:19304788 PMID:33512557
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snca
synuclein alpha
increases expression
ISO
Antimycin A results in increased expression of SNCA mRNA
CTD
PMID:33512557
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
increases expression
ISO
Antimycin A results in increased expression of SNRPD3 mRNA
CTD
PMID:33512557
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
G
Snx13
sorting nexin 13
decreases expression
ISO
Antimycin A results in decreased expression of SNX13 mRNA
CTD
PMID:33512557
NCBI chr 6:51,758,258...51,862,260
Ensembl chr 6:51,753,036...51,860,224
G
Snx7
sorting nexin 7
decreases expression
ISO
Antimycin A results in decreased expression of SNX7 mRNA
CTD
PMID:33512557
NCBI chr 2:205,843,164...205,927,737
Ensembl chr 2:205,842,837...205,927,763
G
Socs2
suppressor of cytokine signaling 2
decreases expression
ISO
Antimycin A results in decreased expression of SOCS2 mRNA
CTD
PMID:33512557
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
Antimycin A results in increased expression of SOCS3 mRNA
CTD
PMID:33512557
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO EXP
Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of SOD2 mRNA]; Antimycin A inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] Antimycin A results in increased expression of SOD2 mRNA; Antimycin A results in increased expression of SOD2 protein [Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA; [Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein; FOXO1 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO1 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein]; FOXO3 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO3 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein]; FOXO4 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 mRNA]; FOXO4 mutant form affects the reaction [[Antimycin A co-treated with Resveratrol] affects the expression of SOD2 protein] Antimycin A inhibits the reaction [Lipopolysaccharides results in increased expression of SOD2 mRNA]
CTD
PMID:11264281 PMID:22718889 PMID:24040102 PMID:35430258
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Spag5
sperm associated antigen 5
increases expression
ISO
Antimycin A results in increased expression of SPAG5 mRNA
CTD
PMID:33512557
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Spc25
SPC25 component of NDC80 kinetochore complex
increases expression
ISO
Antimycin A results in increased expression of SPC25 mRNA
CTD
PMID:33512557
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spdef
SAM pointed domain containing ets transcription factor
decreases expression
ISO
Antimycin A results in decreased expression of SPDEF mRNA
CTD
PMID:33512557
NCBI chr20:5,771,440...5,785,893
Ensembl chr20:5,771,441...5,785,893
G
Sqstm1
sequestosome 1
increases expression multiple interactions
ISO
Antimycin A results in increased expression of SQSTM1 mRNA [oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA]
CTD
PMID:19304788 PMID:28366621
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srd5a1
steroid 5 alpha-reductase 1
decreases expression
ISO
Antimycin A results in decreased expression of SRD5A1 mRNA
CTD
PMID:33512557
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
decreases expression
ISO
Antimycin A results in decreased expression of SRGAP3 mRNA
CTD
PMID:33770205
NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575
G
Srsf10
serine and arginine rich splicing factor 10
increases expression
ISO
Antimycin A results in increased expression of SRSF10 mRNA
CTD
PMID:33512557
NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768
G
Ssr1
signal sequence receptor subunit 1
decreases expression
ISO
Antimycin A results in decreased expression of SSR1 mRNA
CTD
PMID:33512557
NCBI chr17:26,833,720...26,861,821
Ensembl chr17:26,833,741...26,861,821
G
Star
steroidogenic acute regulatory protein
decreases expression
ISO
Antimycin A results in decreased expression of STAR protein
CTD
PMID:16469751
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stat4
signal transducer and activator of transcription 4
decreases expression
ISO
Antimycin A results in decreased expression of STAT4 mRNA
CTD
PMID:33512557
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Steap1
STEAP family member 1
decreases expression
ISO
Antimycin A results in decreased expression of STEAP1 mRNA
CTD
PMID:33512557
NCBI chr 4:28,276,972...28,287,484
Ensembl chr 4:28,276,909...28,287,479
G
Stk25
serine/threonine kinase 25
decreases expression
ISO
Antimycin A results in decreased expression of STK25 mRNA
CTD
PMID:33512557
NCBI chr 9:94,161,834...94,174,095
Ensembl chr 9:94,161,836...94,174,244
G
Swt1
SWT1 RNA endoribonuclease homolog
decreases expression
ISO
Antimycin A results in decreased expression of SWT1 mRNA
CTD
PMID:33770205
NCBI chr13:63,452,494...63,509,982
Ensembl chr13:63,452,496...63,509,980
G
Syp
synaptophysin
decreases expression
ISO
Antimycin A results in decreased expression of SYP mRNA
CTD
PMID:33512557
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
G
Sytl1
synaptotagmin-like 1
increases expression
ISO
Antimycin A results in increased expression of SYTL1 mRNA
CTD
PMID:33512557
NCBI chr 5:145,452,524...145,462,940
Ensembl chr 5:145,422,669...145,462,940
G
Tacc3
transforming, acidic coiled-coil containing protein 3
increases expression
ISO
Antimycin A results in increased expression of TACC3 mRNA
CTD
PMID:33512557
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
G
Taf7
TATA-box binding protein associated factor 7
increases expression
ISO
Antimycin A results in increased expression of TAF7 mRNA
CTD
PMID:33512557
NCBI chr18:29,459,937...29,462,086
Ensembl chr18:29,452,943...29,462,134
G
Taf9
TATA-box binding protein associated factor 9
increases expression
ISO
Antimycin A results in increased expression of TAF9 mRNA
CTD
PMID:33512557
NCBI chr 2:31,794,316...31,798,324
Ensembl chr 2:31,794,142...31,798,769
G
Tagln
transgelin
increases expression
ISO
Antimycin A results in increased expression of TAGLN mRNA
CTD
PMID:33512557
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tapbp
TAP binding protein
decreases expression
ISO
Antimycin A results in decreased expression of TAPBP mRNA
CTD
PMID:33512557
NCBI chr20:4,956,937...4,966,191
Ensembl chr20:4,956,937...4,966,181
G
Tarbp1
TAR (HIV-1) RNA binding protein 1
decreases expression
ISO
Antimycin A results in decreased expression of TARBP1 mRNA
CTD
PMID:33512557
NCBI chr19:54,398,268...54,449,293
Ensembl chr19:54,398,253...54,449,261
G
Tceal9
transcription elongation factor A like 9
increases expression
ISO
Antimycin A results in increased expression of TCEAL9 mRNA
CTD
PMID:33512557
NCBI chr X:99,245,645...99,247,720
Ensembl chr X:99,228,458...99,247,763
G
Tcf4
transcription factor 4
decreases expression
ISO
Antimycin A results in decreased expression of TCF4 mRNA
CTD
PMID:33512557
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
G
Tcta
T-cell leukemia translocation altered
decreases expression
ISO
Antimycin A results in decreased expression of TCTA mRNA
CTD
PMID:33512557
NCBI chr 8:108,988,588...108,992,324
Ensembl chr 8:108,988,590...108,991,564
G
Tctn1
tectonic family member 1
decreases expression
ISO
Antimycin A results in decreased expression of TCTN1 mRNA
CTD
PMID:33512557
NCBI chr12:34,309,795...34,347,190
Ensembl chr12:34,309,897...34,342,267
G
Tfam
transcription factor A, mitochondrial
decreases expression
ISO
Antimycin A results in decreased expression of TFAM mRNA
CTD
PMID:34302933
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tfap2a
transcription factor AP-2 alpha
decreases expression
ISO
Antimycin A results in decreased expression of TFAP2A mRNA
CTD
PMID:33512557
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tfdp1
transcription factor Dp-1
decreases expression
ISO
Antimycin A results in decreased expression of TFDP1 mRNA
CTD
PMID:33512557
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
G
Tfeb
transcription factor EB
multiple interactions
ISO
[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]
CTD
PMID:28366621
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Antimycin A results in increased expression of TGFB1 mRNA
CTD
PMID:33512557
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb3
transforming growth factor, beta 3
decreases expression
ISO
Antimycin A results in decreased expression of TGFB3 mRNA
CTD
PMID:33512557
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
Antimycin A results in increased expression of TIPARP mRNA
CTD
PMID:33512557
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tipin
timeless interacting protein
increases expression
ISO
Antimycin A results in increased expression of TIPIN mRNA
CTD
PMID:33512557
NCBI chr 8:64,780,813...64,801,358
Ensembl chr 8:64,780,828...64,801,352
G
Tlk2
tousled-like kinase 2
decreases expression
ISO
Antimycin A results in decreased expression of TLK2 mRNA
CTD
PMID:33512557
NCBI chr10:90,154,449...90,248,562
Ensembl chr10:90,156,813...90,248,561
G
Tm2d2
TM2 domain containing 2
decreases expression
ISO
Antimycin A results in decreased expression of TM2D2 mRNA
CTD
PMID:33512557
NCBI chr16:67,016,683...67,022,206
Ensembl chr16:67,012,675...67,022,226
G
Tm9sf3
transmembrane 9 superfamily member 3
decreases expression
ISO
Antimycin A results in decreased expression of TM9SF3 mRNA
CTD
PMID:33512557
NCBI chr 1:240,032,060...240,085,125
Ensembl chr 1:240,035,003...240,084,776
G
Tmem185a
transmembrane protein 185A
decreases expression
ISO
Antimycin A results in decreased expression of TMEM185A mRNA
CTD
PMID:33512557
NCBI chr X:149,143,026...149,167,757
Ensembl chr X:149,143,031...149,167,757
G
Tnc
tenascin C
decreases expression
ISO
Antimycin A results in decreased expression of TNC mRNA
CTD
PMID:33512557
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
increases expression multiple interactions
ISO
Antimycin A results in increased expression of TNF protein Antimycin A inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; Antimycin A promotes the reaction [TNF protein results in increased expression of CXCL8 mRNA]; Antimycin A promotes the reaction [TNF protein results in increased expression of CXCL8 protein] 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Antimycin A results in increased expression of and results in increased secretion of TNF protein]; 23-epi-26-deoxyactein inhibits the reaction [Antimycin A results in increased expression of TNF protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Antimycin A results in increased expression of and results in increased secretion of TNF protein]; Antimycin A inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]; Antimycin A inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; Antimycin A inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; Antimycin A inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; Antimycin A results in increased expression of and results in increased secretion of TNF protein; Cyclosporine inhibits the reaction [Antimycin A results in increased expression of and results in increased secretion of TNF protein]; sciadopitysin inhibits the reaction [Antimycin A results in increased expression of TNF protein]
CTD
PMID:11264281 PMID:21381053 PMID:21910134 PMID:22549761 PMID:23624148 PMID:24316229 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
Antimycin A inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]
CTD
PMID:24316229
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf11b
TNF receptor superfamily member 11B
decreases expression
ISO
Antimycin A results in decreased expression of TNFRSF11B protein
CTD
PMID:21381053
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
ISO
Antimycin A results in increased expression of TNFRSF12A mRNA
CTD
PMID:33512557
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfsf11
TNF superfamily member 11
increases expression multiple interactions
ISO
Antimycin A results in increased expression of TNFSF11 protein 23-epi-26-deoxyactein inhibits the reaction [Antimycin A results in increased expression of TNFSF11 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Antimycin A results in increased expression of TNFSF11 protein]
CTD
PMID:21381053 PMID:21910134
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Tnfsf13b
TNF superfamily member 13b
increases expression
ISO
Antimycin A results in increased expression of TNFSF13B mRNA
CTD
PMID:33512557
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
G
Tnip1
TNFAIP3 interacting protein 1
decreases expression
ISO
Antimycin A results in decreased expression of TNIP1 mRNA
CTD
PMID:33512557
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
G
Tnxb
tenascin XB
decreases expression
ISO
Antimycin A results in decreased expression of TNXB mRNA
CTD
PMID:19304788
G
Top2a
DNA topoisomerase II alpha
increases expression
ISO
Antimycin A results in increased expression of TOP2A mRNA
CTD
PMID:33512557
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
multiple interactions increases response to substance increases acetylation
ISO
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Antimycin A results in increased acetylation of TRP53 protein]; Resveratrol inhibits the reaction [Antimycin A results in increased acetylation of TRP53 protein] TRP53 protein results in increased susceptibility to Antimycin A
CTD
PMID:24040102
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
Antimycin A results in increased expression of TP53I3 mRNA
CTD
PMID:33512557
NCBI chr 6:27,818,327...27,825,753
G
Tpx2
TPX2, microtubule nucleation factor
increases expression
ISO
Antimycin A results in increased expression of TPX2 mRNA
CTD
PMID:33512557
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
G
Trib1
tribbles pseudokinase 1
increases expression
ISO
Antimycin A results in increased expression of TRIB1 mRNA
CTD
PMID:33512557
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
Antimycin A results in increased expression of TRIB3 mRNA
CTD
PMID:19304788 PMID:33512557
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim13
tripartite motif-containing 13
decreases expression
ISO
Antimycin A results in decreased expression of TRIM13 mRNA
CTD
PMID:33512557
NCBI chr15:35,733,548...35,772,676
Ensembl chr15:35,734,107...35,772,677
G
Trip12
thyroid hormone receptor interactor 12
decreases expression
ISO
Antimycin A results in decreased expression of TRIP12 mRNA
CTD
PMID:19304788
NCBI chr 9:85,916,691...86,043,312
Ensembl chr 9:85,916,691...86,051,403
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
decreases expression
ISO
Antimycin A results in decreased expression of TRPV1 mRNA
CTD
PMID:33512557
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Tsg101
tumor susceptibility 101
decreases expression
ISO
Antimycin A results in decreased expression of TSG101 mRNA
CTD
PMID:33512557
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tshz2
teashirt zinc finger homeobox 2
decreases expression
ISO
Antimycin A results in decreased expression of TSHZ2 mRNA
CTD
PMID:19304788
NCBI chr 3:158,405,469...158,666,915
Ensembl chr 3:158,405,423...158,850,128
G
Tsku
tsukushi, small leucine rich proteoglycan
decreases expression
ISO
Antimycin A results in decreased expression of TSKU mRNA
CTD
PMID:33512557
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Tspan3
tetraspanin 3
decreases expression
ISO
Antimycin A results in decreased expression of TSPAN3 mRNA
CTD
PMID:33512557
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
Antimycin A results in decreased expression of TST mRNA
CTD
PMID:33512557
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
ISO
Antimycin A results in decreased expression of TUBB2A mRNA
CTD
PMID:33512557 PMID:33770205
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb2b
tubulin, beta 2B class IIb
decreases expression
ISO
Antimycin A results in decreased expression of TUBB2B mRNA
CTD
PMID:33512557
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Tut7
terminal uridylyl transferase 7
decreases expression
ISO
Antimycin A results in decreased expression of TUT7 mRNA
CTD
PMID:33512557
NCBI chr17:4,849,287...4,903,542
Ensembl chr17:4,849,283...4,903,169
G
Txndc5
thioredoxin domain containing 5
increases expression
ISO
Antimycin A results in increased expression of TXNDC5 mRNA
CTD
PMID:33512557
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
Antimycin A results in decreased expression of TXNIP mRNA
CTD
PMID:33512557
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Antimycin A results in increased expression of TXNRD1 mRNA
CTD
PMID:33512557
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
Antimycin A results in increased expression of TXNRD2 mRNA
CTD
PMID:33512557
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Tyms
thymidylate synthetase
increases expression
ISO
Antimycin A results in increased expression of TYMS mRNA
CTD
PMID:33512557
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ubb
ubiquitin B
increases expression
ISO
Antimycin A results in increased expression of UBB mRNA
CTD
PMID:33512557
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
G
Ube2c
ubiquitin-conjugating enzyme E2C
increases expression
ISO
Antimycin A results in increased expression of UBE2C mRNA
CTD
PMID:33512557
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2q2
ubiquitin conjugating enzyme E2 Q2
decreases expression
ISO
Antimycin A results in decreased expression of UBE2Q2 mRNA
CTD
PMID:33512557
NCBI chr 8:55,518,402...55,578,342
Ensembl chr 8:55,519,147...55,577,212
G
Uchl1
ubiquitin C-terminal hydrolase L1
decreases expression
ISO
Antimycin A results in decreased expression of UCHL1 mRNA
CTD
PMID:33512557
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ucp2
uncoupling protein 2
increases expression decreases expression
ISO
Antimycin A results in increased expression of UCP2 protein Antimycin A results in decreased expression of UCP2 mRNA; Antimycin A results in decreased expression of UCP2 protein
CTD
PMID:18082129 PMID:34302933
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ulk1
unc-51 like autophagy activating kinase 1
increases expression multiple interactions
ISO
Antimycin A results in increased expression of ULK1 mRNA; Antimycin A results in increased expression of ULK1 protein Antimycin A inhibits the reaction [Cycloheximide results in decreased expression of ULK1 protein]; Antimycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; Antimycin A promotes the reaction [ATG13 protein results in increased expression of ULK1 protein]; ATG13 protein promotes the reaction [Antimycin A results in increased expression of ULK1 protein]; Cycloheximide inhibits the reaction [Antimycin A results in increased expression of ULK1 protein]; Nitrogen deficiency inhibits the reaction [Antimycin A results in increased expression of ULK1 protein]
CTD
PMID:27629431
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Unc50
unc-50 inner nuclear membrane RNA binding protein
decreases expression
ISO
Antimycin A results in decreased expression of UNC50 mRNA
CTD
PMID:33512557
NCBI chr 9:39,664,944...39,674,369
Ensembl chr 9:39,664,971...39,672,890
G
Uqcc3
ubiquinol-cytochrome c reductase complex assembly factor 3
decreases expression
ISO
Antimycin A results in decreased expression of UQCC3 mRNA
CTD
PMID:34302933
NCBI chr 1:205,773,591...205,774,369
Ensembl chr 1:205,772,780...205,774,376
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
decreases expression
ISO
Antimycin A results in decreased expression of UQCRFS1 mRNA
CTD
PMID:33512557
NCBI chr17:33,977,908...33,982,478
Ensembl chr17:33,977,921...33,982,479
G
Utp14a
UTP14A small subunit processome component
increases expression
ISO
Antimycin A results in increased expression of UTP14A mRNA
CTD
PMID:33512557
NCBI chr X:127,439,282...127,464,634
Ensembl chr X:127,439,268...127,464,633
G
Uts2
urotensin 2
increases expression
ISO
Antimycin A results in increased expression of UTS2 mRNA
CTD
PMID:19304788
NCBI chr 5:161,450,846...161,456,235
Ensembl chr 5:161,450,846...161,456,237
G
Vapb
VAMP associated protein B and C
decreases expression
ISO
Antimycin A results in decreased expression of VAPB mRNA
CTD
PMID:33512557 PMID:34642769
NCBI chr 3:162,535,974...162,578,747
Ensembl chr 3:162,535,905...162,573,763
G
Vav3
vav guanine nucleotide exchange factor 3
decreases expression
ISO
Antimycin A results in decreased expression of VAV3 mRNA
CTD
PMID:33512557
NCBI chr 2:197,011,901...197,354,321
Ensembl chr 2:197,011,831...197,354,321
G
Vdac1
voltage-dependent anion channel 1
decreases expression
ISO
Antimycin A results in decreased expression of VDAC1 mRNA
CTD
PMID:33512557
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vegfa
vascular endothelial growth factor A
decreases expression multiple interactions increases expression
ISO
Antimycin A results in decreased expression of VEGFA protein Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of VEGFA mRNA]
CTD
PMID:20116850 PMID:33512557 PMID:35430258
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vgll4
vestigial-like family member 4
decreases expression
ISO
Antimycin A results in decreased expression of VGLL4 mRNA
CTD
PMID:33512557
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:147,927,034...148,038,471
G
Vim
vimentin
increases expression
ISO
Antimycin A results in increased expression of VIM mRNA
CTD
PMID:33512557
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vps72
vacuolar protein sorting 72 homolog
decreases expression
ISO
Antimycin A results in decreased expression of VPS72 mRNA
CTD
PMID:33512557
NCBI chr 2:182,678,594...182,690,185
Ensembl chr 2:182,678,609...182,690,182
G
Wars1
tryptophanyl-tRNA synthetase 1
increases expression
ISO
Antimycin A results in increased expression of WARS1 mRNA
CTD
PMID:33512557
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Wdr43
WD repeat domain 43
increases expression
ISO
Antimycin A results in increased expression of WDR43 mRNA
CTD
PMID:33512557
NCBI chr 6:23,845,499...23,884,846
Ensembl chr 6:23,845,499...23,884,846
G
Wdr7
WD repeat domain 7
decreases expression
ISO
Antimycin A results in decreased expression of WDR7 mRNA
CTD
PMID:33512557
NCBI chr18:57,165,482...57,448,568
Ensembl chr18:57,165,488...57,448,540
G
Wdtc1
WD and tetratricopeptide repeats 1
decreases expression
ISO
Antimycin A results in decreased expression of WDTC1 mRNA
CTD
PMID:33512557
NCBI chr 5:145,491,460...145,559,631
Ensembl chr 5:145,491,466...145,540,408
G
Wnt7a
Wnt family member 7A
increases expression
ISO
Antimycin A results in increased expression of WNT7A mRNA
CTD
PMID:19304788
NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
G
Xbp1
X-box binding protein 1
increases expression
EXP ISO
Antimycin A results in increased expression of XBP1 protein Antimycin A results in increased expression of XBP1 mRNA
CTD
PMID:21337367 PMID:33512557
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Yes1
YES proto-oncogene 1, Src family tyrosine kinase
decreases expression
ISO
Antimycin A results in decreased expression of YES1 mRNA
CTD
PMID:33770205
NCBI chr 9:113,200,256...113,275,942
Ensembl chr 9:113,200,256...113,299,837
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
decreases expression
ISO
Antimycin A results in decreased expression of YWHAB mRNA
CTD
PMID:33512557
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Zbtb21
zinc finger and BTB domain containing 21
increases expression
ISO
Antimycin A results in increased expression of ZBTB21 mRNA
CTD
PMID:33512557
NCBI chr11:37,312,337...37,327,040
Ensembl chr11:37,312,378...37,326,996
G
Zbtb41
zinc finger and BTB domain containing 41
decreases expression
ISO
Antimycin A results in decreased expression of ZBTB41 mRNA
CTD
PMID:33512557
NCBI chr13:51,042,948...51,065,768
Ensembl chr13:51,042,948...51,065,768
G
Zeb2
zinc finger E-box binding homeobox 2
decreases expression
ISO
Antimycin A results in decreased expression of ZEB2 mRNA
CTD
PMID:33512557
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
ISO
Antimycin A results in increased expression of ZFAND2A mRNA
CTD
PMID:33512557
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfp383
zinc finger protein 383
increases expression
ISO
Antimycin A results in increased expression of ZNF383 mRNA
CTD
PMID:33770205
G
Zfp469
zinc finger protein 469
increases expression
ISO
Antimycin A results in increased expression of ZNF469 mRNA
CTD
PMID:33512557
NCBI chr19:50,282,337...50,324,010
G
Zhx1
zinc fingers and homeoboxes 1
decreases expression
ISO
Antimycin A results in decreased expression of ZHX1 mRNA
CTD
PMID:19304788
NCBI chr 7:89,582,363...89,611,337
Ensembl chr 7:89,582,243...89,611,264
G
Zranb2
zinc finger RANBP2-type containing 2
increases expression
ISO
Antimycin A results in increased expression of ZRANB2 mRNA
CTD
PMID:33512557
NCBI chr 2:246,573,110...246,586,942
Ensembl chr 2:246,573,166...246,586,942
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions increases expression
ISO
NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GCLM mRNA] benphothiamine metabolite results in increased expression of GCLM mRNA; benphothiamine results in increased expression of GCLM mRNA
CTD
PMID:29860433
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gsr
glutathione-disulfide reductase
multiple interactions increases expression
ISO
NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GSR mRNA]
CTD
PMID:29860433
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO
benphothiamine metabolite results in increased expression of HMOX1 mRNA; benphothiamine results in increased expression of HMOX1 mRNA benphothiamine inhibits the reaction [MAPT protein results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of HMOX1 mRNA]
CTD
PMID:29860433
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[benphothiamine co-treated with MAPT protein] results in decreased expression of IL1B protein
CTD
PMID:29860433
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Mapt
microtubule-associated protein tau
decreases phosphorylation multiple interactions
ISO
benphothiamine results in decreased phosphorylation of MAPT protein [benphothiamine co-treated with MAPT protein] results in decreased expression of IL1B protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of NOS2 protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of PTGS2 protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of RELA protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of TNF protein; [benphothiamine co-treated with MAPT protein] results in increased expression of NQO1 mRNA; [benphothiamine co-treated with MAPT protein] results in increased expression of TXN mRNA; benphothiamine inhibits the reaction [MAPT protein results in decreased activity of TKT protein]; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of NOS2 mRNA]; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of PPARGC1A protein]; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of SOD1 protein]; benphothiamine inhibits the reaction [MAPT protein results in increased expression of HMOX1 mRNA]
CTD
PMID:29860433
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GSR mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of NQO1 mRNA]
CTD
PMID:29860433
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
[benphothiamine co-treated with MAPT protein] results in decreased expression of NOS2 protein; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of NOS2 mRNA]
CTD
PMID:29860433
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
benphothiamine metabolite results in increased expression of NQO1 mRNA; benphothiamine results in increased expression of NQO1 mRNA [benphothiamine co-treated with MAPT protein] results in increased expression of NQO1 mRNA; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of NQO1 mRNA]
CTD
PMID:29860433
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO
benphothiamine inhibits the reaction [MAPT protein results in decreased expression of PPARGC1A protein]
CTD
PMID:29860433
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[benphothiamine co-treated with MAPT protein] results in decreased expression of PTGS2 protein
CTD
PMID:29860433
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[benphothiamine co-treated with MAPT protein] results in decreased expression of RELA protein
CTD
PMID:29860433
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
benphothiamine inhibits the reaction [MAPT protein results in decreased expression of SOD1 protein]
CTD
PMID:29860433
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Tkt
transketolase
multiple interactions
EXP ISO
[benphothiamine co-treated with Streptozocin] results in increased activity of TKT protein benphothiamine inhibits the reaction [MAPT protein results in decreased activity of TKT protein]
CTD
PMID:12592403 PMID:29860433
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[benphothiamine co-treated with MAPT protein] results in decreased expression of TNF protein
CTD
PMID:29860433
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Txn1
thioredoxin 1
multiple interactions
ISO
[benphothiamine co-treated with MAPT protein] results in increased expression of TXN mRNA
CTD
PMID:29860433
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Slc14a1
solute carrier family 14 member 1 (Kidd blood group)
affects transport
ISO
SLC14A1 protein affects the transport of formamide
CTD
PMID:17506977
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
decreases expression
EXP
Dimethylformamide results in decreased expression of ABCB1B mRNA
CTD
PMID:12883083
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of BAX protein]
CTD
PMID:29984871
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2l1
Bcl2-like 1
multiple interactions increases expression
EXP ISO
[Dimethylformamide co-treated with Carbon Tetrachloride] results in decreased expression of BCL2L1 protein Dimethylformamide results in increased expression of BCL2L1 protein Thiocarbamates analog inhibits the reaction [Dimethylformamide results in decreased expression of BCL2L1 protein]
CTD
PMID:20097184 PMID:29984871
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Casp3
caspase 3
multiple interactions increases expression
EXP ISO
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased activity of CASP3 protein Dimethylformamide results in increased expression of CASP3 protein modified form CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]
CTD
PMID:20097184 PMID:29984871
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions increases expression
ISO
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]
CTD
PMID:29984871
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]
CTD
PMID:29984871
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
affects metabolic processing increases response to substance increases abundance multiple interactions increases expression increases metabolic processing increases oxidation
ISO EXP
CYP2E1 protein polymorphism affects the metabolism of Dimethylformamide CYP2E1 protein results in increased susceptibility to Dimethylformamide CYP2E1 polymorphism results in increased abundance of Dimethylformamide metabolite CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein] Dimethylformamide results in increased expression of CYP2E1 protein CYP2E1 protein results in increased metabolism of Dimethylformamide CYP2E1 protein affects the metabolism of Dimethylformamide CYP2E1 protein results in increased oxidation of Dimethylformamide
CTD
PMID:9817075 PMID:10207612 PMID:11305777 PMID:15772367 PMID:29984871 PMID:31501917 More...
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
EXP
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of DDIT3 mRNA
CTD
PMID:20097184
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions
EXP
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of EIF2AK3 protein modified form
CTD
PMID:20097184
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases activity
ISO
CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein]
CTD
PMID:31501917
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsr
glutathione-disulfide reductase
decreases expression
EXP
Dimethylformamide results in decreased expression of GSR mRNA
CTD
PMID:12883083
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
H2ax
H2A.X variant histone
increases expression
ISO
Dimethylformamide results in increased expression of H2AX protein
CTD
PMID:26387567
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hmox1
heme oxygenase 1
multiple interactions decreases expression
ISO
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein] Dimethylformamide results in decreased expression of HMOX1 mRNA; Dimethylformamide results in decreased expression of HMOX1 protein
CTD
PMID:31875996
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsp90b1
heat shock protein 90 beta family member 1
multiple interactions increases expression
EXP ISO
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSP90B1 protein Dimethylformamide results in increased expression of HSP90B1 protein CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein]
CTD
PMID:20097184 PMID:31501917
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
EXP
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA; [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 protein
CTD
PMID:20097184
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Ltf
lactotransferrin
increases expression
ISO
Dimethylformamide results in increased expression of LTF mRNA
CTD
PMID:18063697
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
ISO
U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK1 protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK1 protein
CTD
PMID:31875996
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO
[Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK3 protein U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:31875996
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mpo
myeloperoxidase
increases expression
ISO
Dimethylformamide results in increased expression of MPO mRNA
CTD
PMID:18063697
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mre11
MRE11 homolog, double strand break repair nuclease
increases expression
ISO
Dimethylformamide results in increased expression of MRE11 mRNA; Dimethylformamide results in increased expression of MRE11 protein
CTD
PMID:26387567
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
G
Ncf1
neutrophil cytosolic factor 1
increases expression
ISO
Dimethylformamide results in increased expression of NCF1 mRNA
CTD
PMID:18063697
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nefh
neurofilament heavy chain
affects expression
EXP
Dimethylformamide affects the expression of NEFH mRNA
CTD
PMID:22954530
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions decreases activity
ISO
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein]
CTD
PMID:31875996
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions decreases expression
ISO
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein] Dimethylformamide results in decreased expression of NQO1 mRNA; Dimethylformamide results in decreased expression of NQO1 protein
CTD
PMID:31875996
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased cleavage of PARP1 protein
CTD
PMID:20097184
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Rad50
RAD50 double strand break repair protein
increases expression
ISO
Dimethylformamide results in increased expression of RAD50 mRNA; Dimethylformamide results in increased expression of RAD50 protein
CTD
PMID:26387567
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rad51
RAD51 recombinase
increases expression
ISO
Dimethylformamide results in increased expression of RAD51 mRNA; Dimethylformamide results in increased expression of RAD51 protein
CTD
PMID:26387567
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rxra
retinoid X receptor alpha
decreases degradation multiple interactions increases phosphorylation
ISO
Dimethylformamide results in decreased degradation of RXRA protein Alitretinoin inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; [Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein
CTD
PMID:31875996
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Sod1
superoxide dismutase 1
increases expression
ISO
Dimethylformamide results in increased expression of SOD1 mRNA
CTD
PMID:35238128
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sult1a1
sulfotransferase family 1A member 1
multiple interactions
ISO
Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 1-hydroxypyrene]; Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 4-nitrophenol]
CTD
PMID:14570759
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Sult2a1
sulfotransferase family 2A member 1
multiple interactions
ISO
Dimethylformamide inhibits the reaction [SULT2A1 protein results in increased sulfation of 1-hydroxypyrene]
CTD
PMID:14570759
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
Dimethylformamide results in increased expression of TNFSF10 mRNA; Dimethylformamide results in increased expression of TNFSF10 protein
CTD
PMID:18063697
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein] Dimethylformamide results in increased expression of TP53 protein modified form
CTD
PMID:29984871
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trim28
tripartite motif-containing 28
decreases expression
ISO
Dimethylformamide results in decreased expression of TRIM28 mRNA
CTD
PMID:35238128
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
G
Xrcc2
X-ray repair cross complementing 2
increases expression affects expression
ISO
Dimethylformamide results in increased expression of XRCC2 protein Dimethylformamide affects the expression of XRCC2 mRNA
CTD
PMID:26387567
NCBI chr 4:9,423,873...9,502,980
Ensembl chr 4:9,423,898...9,442,482
G
Xrcc3
X-ray repair cross complementing 3
increases expression
ISO
Dimethylformamide results in increased expression of XRCC3 mRNA; Dimethylformamide results in increased expression of XRCC3 protein
CTD
PMID:26387567
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
G
Zp2
zona pellucida glycoprotein 2
increases expression
ISO
Dimethylformamide results in increased expression of ZP2 mRNA
CTD
PMID:35238128
NCBI chr 1:174,513,507...174,525,288
Ensembl chr 1:174,513,511...174,525,288
G
Adamts7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
affects expression
ISO
methylformamide affects the expression of ADAMTS7 mRNA; methylformamide analog affects the expression of ADAMTS7 mRNA
CTD
PMID:17040096
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
G
Ampd2
adenosine monophosphate deaminase 2
decreases expression
ISO
methylformamide analog results in decreased expression of AMPD2 mRNA; methylformamide results in decreased expression of AMPD2 mRNA
CTD
PMID:17040096
NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271
G
Angptl4
angiopoietin-like 4
increases expression
ISO
methylformamide analog results in increased expression of ANGPTL4 mRNA; methylformamide results in increased expression of ANGPTL4 mRNA
CTD
PMID:17040096
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ankrd10
ankyrin repeat domain 10
decreases expression
ISO
methylformamide analog results in decreased expression of ANKRD10 mRNA; methylformamide results in decreased expression of ANKRD10 mRNA
CTD
PMID:17040096
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
G
Anxa6
annexin A6
decreases expression
ISO
methylformamide analog results in decreased expression of ANXA6 mRNA; methylformamide results in decreased expression of ANXA6 mRNA
CTD
PMID:17040096
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
G
Aox1
aldehyde oxidase 1
increases expression
ISO
methylformamide analog results in increased expression of AOX1 mRNA; methylformamide results in increased expression of AOX1 mRNA
CTD
PMID:17040096
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Arl4a
ADP-ribosylation factor like GTPase 4A
affects expression
ISO
methylformamide affects the expression of ARL4A mRNA; methylformamide analog affects the expression of ARL4A mRNA
CTD
PMID:17040096
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
decreases expression
ISO
methylformamide analog results in decreased expression of B3GALNT1 mRNA; methylformamide results in decreased expression of B3GALNT1 mRNA
CTD
PMID:17040096
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression
ISO
methylformamide analog results in decreased expression of BIRC2 mRNA; methylformamide results in decreased expression of BIRC2 mRNA
CTD
PMID:17040096
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Brd2
bromodomain containing 2
increases expression
ISO
methylformamide analog results in increased expression of BRD2 mRNA; methylformamide results in increased expression of BRD2 mRNA
CTD
PMID:17040096
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
G
Cacybp
calcyclin binding protein
increases expression
ISO
methylformamide analog results in increased expression of CACYBP mRNA; methylformamide results in increased expression of CACYBP mRNA
CTD
PMID:17040096
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
G
Cavin2
caveolae associated protein 2
decreases expression
ISO
methylformamide analog results in decreased expression of CAVIN2 mRNA; methylformamide results in decreased expression of CAVIN2 mRNA
CTD
PMID:17040096
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
methylformamide analog results in increased expression of CCL3 mRNA; methylformamide results in increased expression of CCL3 mRNA
CTD
PMID:17040096
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccn2
cellular communication network factor 2
increases expression
ISO
methylformamide analog results in increased expression of CCN2 mRNA; methylformamide results in increased expression of CCN2 mRNA
CTD
PMID:17040096
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccnd1
cyclin D1
decreases expression
ISO
methylformamide analog results in decreased expression of CCND1 mRNA; methylformamide results in decreased expression of CCND1 mRNA
CTD
PMID:17040096
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
decreases expression
ISO
methylformamide analog results in decreased expression of CCND2 mRNA; methylformamide results in decreased expression of CCND2 mRNA
CTD
PMID:17040096
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Cdc45
cell division cycle 45
increases expression
ISO
methylformamide analog results in increased expression of CDC45 mRNA; methylformamide results in increased expression of CDC45 mRNA
CTD
PMID:17040096
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
G
Cish
cytokine inducible SH2-containing protein
decreases expression
ISO
methylformamide analog results in decreased expression of CISH mRNA; methylformamide results in decreased expression of CISH mRNA
CTD
PMID:17040096
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Clstn2
calsyntenin 2
increases expression
ISO
methylformamide analog results in increased expression of CLSTN2 mRNA; methylformamide results in increased expression of CLSTN2 mRNA
CTD
PMID:17040096
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
G
Csnk1d
casein kinase 1, delta
affects expression
ISO
methylformamide affects the expression of CSNK1D mRNA; methylformamide analog affects the expression of CSNK1D mRNA
CTD
PMID:17040096
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Cxadr
CXADR, Ig-like cell adhesion molecule
affects expression
ISO
methylformamide affects the expression of CXADR mRNA; methylformamide analog affects the expression of CXADR mRNA
CTD
PMID:17040096
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases metabolic processing multiple interactions
ISO EXP
CYP2E1 protein results in increased metabolism of methylformamide 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; Ditiocarb inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; Fomepizole promotes the reaction [CYP2E1 protein results in increased metabolism of methylformamide]
CTD
PMID:1538706
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
increases expression
ISO
methylformamide analog results in increased expression of DNAJA1 mRNA; methylformamide results in increased expression of DNAJA1 mRNA
CTD
PMID:17040096
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
G
Dnmt3a
DNA methyltransferase 3 alpha
affects expression
ISO
methylformamide affects the expression of DNMT3A mRNA; methylformamide analog affects the expression of DNMT3A mRNA
CTD
PMID:17040096
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dusp10
dual specificity phosphatase 10
affects expression
ISO
methylformamide affects the expression of DUSP10 mRNA; methylformamide analog affects the expression of DUSP10 mRNA
CTD
PMID:17040096
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp6
dual specificity phosphatase 6
increases expression
ISO
methylformamide analog results in increased expression of DUSP6 mRNA; methylformamide results in increased expression of DUSP6 mRNA
CTD
PMID:17040096
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp7
dual specificity phosphatase 7
decreases expression
ISO
methylformamide analog results in decreased expression of DUSP7 mRNA; methylformamide results in decreased expression of DUSP7 mRNA
CTD
PMID:17040096
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
methylformamide analog results in decreased expression of EGFR mRNA; methylformamide results in decreased expression of EGFR mRNA
CTD
PMID:17040096
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
affects expression
ISO
methylformamide affects the expression of ENTPD5 mRNA; methylformamide analog affects the expression of ENTPD5 mRNA
CTD
PMID:17040096
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
G
Fgf21
fibroblast growth factor 21
increases expression
ISO
methylformamide analog results in increased expression of FGF21 mRNA; methylformamide results in increased expression of FGF21 mRNA
CTD
PMID:17040096
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Fn1
fibronectin 1
decreases expression
ISO
methylformamide analog results in decreased expression of FN1 mRNA; methylformamide results in decreased expression of FN1 mRNA
CTD
PMID:17040096
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
methylformamide analog results in increased expression of FOS mRNA; methylformamide results in increased expression of FOS mRNA
CTD
PMID:17040096
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
ISO
methylformamide analog results in increased expression of GABARAPL1 mRNA; methylformamide results in increased expression of GABARAPL1 mRNA
CTD
PMID:17040096
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gas2
growth arrest-specific 2
decreases expression
ISO
methylformamide analog results in decreased expression of GAS2 mRNA; methylformamide results in decreased expression of GAS2 mRNA
CTD
PMID:17040096
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gclc
glutamate-cysteine ligase, catalytic subunit
affects expression
ISO
methylformamide affects the expression of GCLC mRNA; methylformamide analog affects the expression of GCLC mRNA
CTD
PMID:17040096
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gdf15
growth differentiation factor 15
increases expression
ISO
methylformamide analog results in increased expression of GDF15 mRNA; methylformamide results in increased expression of GDF15 mRNA
CTD
PMID:17040096
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdf9
growth differentiation factor 9
increases expression
ISO
methylformamide analog results in increased expression of GDF9 mRNA; methylformamide results in increased expression of GDF9 mRNA
CTD
PMID:17040096
NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672
G
Grpel2
GrpE-like 2, mitochondrial
increases expression
ISO
methylformamide analog results in increased expression of GRPEL2 mRNA; methylformamide results in increased expression of GRPEL2 mRNA
CTD
PMID:17040096
NCBI chr18:55,167,831...55,180,073
Ensembl chr18:55,168,209...55,180,180
G
Gsdme
gasdermin E
increases expression
ISO
methylformamide analog results in increased expression of GSDME mRNA; methylformamide results in increased expression of GSDME mRNA
CTD
PMID:17040096
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
G
Gsta2
glutathione S-transferase alpha 2
affects expression
ISO
methylformamide affects the expression of GSTA2 mRNA; methylformamide analog affects the expression of GSTA2 mRNA
CTD
PMID:17040096
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gtf2ird1
GTF2I repeat domain containing 1
affects expression
ISO
methylformamide affects the expression of GTF2IRD1 mRNA; methylformamide analog affects the expression of GTF2IRD1 mRNA
CTD
PMID:17040096
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
G
Gtpbp2
GTP binding protein 2
affects expression
ISO
methylformamide affects the expression of GTPBP2 mRNA; methylformamide analog affects the expression of GTPBP2 mRNA
CTD
PMID:17040096
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
G
Habp2
hyaluronan binding protein 2
increases expression
ISO
methylformamide analog results in increased expression of HABP2 mRNA; methylformamide results in increased expression of HABP2 mRNA
CTD
PMID:17040096
NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:255,315,915...255,350,160
G
Hbp1
HMG-box transcription factor 1
increases expression
ISO
methylformamide analog results in increased expression of HBP1 mRNA; methylformamide results in increased expression of HBP1 mRNA
CTD
PMID:17040096
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
affects expression
ISO
methylformamide affects the expression of HMGCR mRNA; methylformamide analog affects the expression of HMGCR mRNA
CTD
PMID:17040096
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
affects expression
ISO
methylformamide affects the expression of HMOX1 mRNA; methylformamide analog affects the expression of HMOX1 mRNA
CTD
PMID:17040096
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
ISO
methylformamide analog results in decreased expression of HNRNPA2B1 mRNA; methylformamide results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:17040096
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
affects expression
ISO
methylformamide affects the expression of HSPA1B mRNA; methylformamide analog affects the expression of HSPA1B mRNA
CTD
PMID:17040096
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression
ISO
methylformamide analog results in increased expression of HSPA8 mRNA; methylformamide results in increased expression of HSPA8 mRNA
CTD
PMID:17040096
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb1
heat shock protein family B (small) member 1
affects expression
ISO
methylformamide affects the expression of HSPB1 mRNA; methylformamide analog affects the expression of HSPB1 mRNA
CTD
PMID:17040096
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspb8
heat shock protein family B (small) member 8
affects expression
ISO
methylformamide affects the expression of HSPB8 mRNA; methylformamide analog affects the expression of HSPB8 mRNA
CTD
PMID:17040096
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
ISO
methylformamide analog results in increased expression of HSPD1 mRNA; methylformamide results in increased expression of HSPD1 mRNA
CTD
PMID:17040096
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
methylformamide analog results in increased expression of HSPH1 mRNA; methylformamide results in increased expression of HSPH1 mRNA
CTD
PMID:17040096
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
affects expression
ISO
methylformamide affects the expression of IKBKG mRNA; methylformamide analog affects the expression of IKBKG mRNA
CTD
PMID:17040096
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il15ra
interleukin 15 receptor subunit alpha
decreases expression
ISO
methylformamide analog results in decreased expression of IL15RA mRNA; methylformamide results in decreased expression of IL15RA mRNA
CTD
PMID:17040096
NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
G
Il1rap
interleukin 1 receptor accessory protein
decreases expression
ISO
methylformamide analog results in decreased expression of IL1RAP mRNA; methylformamide results in decreased expression of IL1RAP mRNA
CTD
PMID:17040096
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
G
Inpp1
inositol polyphosphate-1-phosphatase
decreases expression
ISO
methylformamide analog results in decreased expression of INPP1 mRNA; methylformamide results in decreased expression of INPP1 mRNA
CTD
PMID:17040096
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
G
Kcnk5
potassium two pore domain channel subfamily K member 5
decreases expression
ISO
methylformamide analog results in decreased expression of KCNK5 mRNA; methylformamide results in decreased expression of KCNK5 mRNA
CTD
PMID:17040096
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
G
Kdm2b
lysine demethylase 2B
decreases expression
ISO
methylformamide analog results in decreased expression of KDM2B mRNA; methylformamide results in decreased expression of KDM2B mRNA
CTD
PMID:17040096
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
G
Klf6
KLF transcription factor 6
affects expression
ISO
methylformamide affects the expression of KLF6 mRNA; methylformamide analog affects the expression of KLF6 mRNA
CTD
PMID:17040096
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Lgals7
galectin 7
affects expression
ISO
methylformamide affects the expression of LGALS7 mRNA; methylformamide analog affects the expression of LGALS7 mRNA
CTD
PMID:17040096
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
G
Lipg
lipase G, endothelial type
decreases expression
ISO
methylformamide analog results in decreased expression of LIPG mRNA; methylformamide results in decreased expression of LIPG mRNA
CTD
PMID:17040096
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lpin2
lipin 2
increases expression
ISO
methylformamide analog results in increased expression of LPIN2 mRNA; methylformamide results in increased expression of LPIN2 mRNA
CTD
PMID:17040096
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
G
Ly96
lymphocyte antigen 96
affects expression
ISO
methylformamide affects the expression of LY96 mRNA; methylformamide analog affects the expression of LY96 mRNA
CTD
PMID:17040096
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Mafk
MAF bZIP transcription factor K
affects expression
ISO
methylformamide affects the expression of MAFK mRNA; methylformamide analog affects the expression of MAFK mRNA
CTD
PMID:17040096
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Nde1
nudE neurodevelopment protein 1
decreases expression
ISO
methylformamide analog results in decreased expression of NDE1 mRNA; methylformamide results in decreased expression of NDE1 mRNA
CTD
PMID:17040096
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
G
Noct
nocturnin
decreases expression
ISO
methylformamide analog results in decreased expression of NOCT mRNA; methylformamide results in decreased expression of NOCT mRNA
CTD
PMID:17040096
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
ISO
methylformamide analog results in increased expression of NR1D2 mRNA; methylformamide results in increased expression of NR1D2 mRNA
CTD
PMID:17040096
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
Pgd
phosphogluconate dehydrogenase
affects expression
ISO
methylformamide affects the expression of PGD mRNA; methylformamide analog affects the expression of PGD mRNA
CTD
PMID:17040096
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Plk3
polo-like kinase 3
increases expression
ISO
methylformamide analog results in increased expression of PLK3 mRNA; methylformamide results in increased expression of PLK3 mRNA
CTD
PMID:17040096
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Pnrc1
proline-rich nuclear receptor coactivator 1
affects expression
ISO
methylformamide affects the expression of PNRC1 mRNA; methylformamide analog affects the expression of PNRC1 mRNA
CTD
PMID:17040096
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression
ISO
methylformamide analog results in increased expression of PPP1R10 mRNA; methylformamide results in increased expression of PPP1R10 mRNA
CTD
PMID:17040096
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Rbpms
RNA binding protein, mRNA processing factor
affects expression
ISO
methylformamide affects the expression of RBPMS mRNA; methylformamide analog affects the expression of RBPMS mRNA
CTD
PMID:17040096
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
G
Rcan1
regulator of calcineurin 1
affects expression
ISO
methylformamide affects the expression of RCAN1 mRNA; methylformamide analog affects the expression of RCAN1 mRNA
CTD
PMID:17040096
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rtp3
receptor (chemosensory) transporter protein 3
decreases expression
ISO
methylformamide analog results in decreased expression of RTP3 mRNA; methylformamide results in decreased expression of RTP3 mRNA
CTD
PMID:17040096
NCBI chr 8:110,970,154...110,975,000
Ensembl chr 8:110,970,160...110,974,699
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
methylformamide analog results in increased expression of SGK1 mRNA; methylformamide results in increased expression of SGK1 mRNA
CTD
PMID:17040096
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sgk2
serum/glucocorticoid regulated kinase 2
increases expression
ISO
methylformamide analog results in increased expression of SGK2 mRNA; methylformamide results in increased expression of SGK2 mRNA
CTD
PMID:17040096
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Sirt1
sirtuin 1
increases expression
ISO
methylformamide analog results in increased expression of SIRT1 mRNA; methylformamide results in increased expression of SIRT1 mRNA
CTD
PMID:17040096
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc14a1
solute carrier family 14 member 1 (Kidd blood group)
multiple interactions affects transport
ISO
methylformamide inhibits the reaction [SLC14A1 protein affects the transport of Urea] SLC14A1 protein affects the transport of methylformamide
CTD
PMID:17506977
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
G
Slc25a19
solute carrier family 25 member 19
decreases expression
ISO
methylformamide analog results in decreased expression of SLC25A19 mRNA; methylformamide results in decreased expression of SLC25A19 mRNA
CTD
PMID:17040096
NCBI chr10:100,853,554...100,867,517
Ensembl chr10:100,847,168...100,867,447
G
Slc38a2
solute carrier family 38, member 2
increases expression
ISO
methylformamide analog results in increased expression of SLC38A2 mRNA; methylformamide results in increased expression of SLC38A2 mRNA
CTD
PMID:17040096
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc39a8
solute carrier family 39 member 8
increases expression
ISO
methylformamide analog results in increased expression of SLC39A8 mRNA; methylformamide results in increased expression of SLC39A8 mRNA
CTD
PMID:17040096
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Sqstm1
sequestosome 1
affects expression
ISO
methylformamide affects the expression of SQSTM1 mRNA; methylformamide analog affects the expression of SQSTM1 mRNA
CTD
PMID:17040096
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
methylformamide analog results in decreased expression of SREBF1 mRNA; methylformamide results in decreased expression of SREBF1 mRNA
CTD
PMID:17040096
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srpk2
SRSF protein kinase 2
increases expression
ISO
methylformamide analog results in increased expression of SRPK2 mRNA; methylformamide results in increased expression of SRPK2 mRNA
CTD
PMID:17040096
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srxn1
sulfiredoxin 1
affects expression
ISO
methylformamide affects the expression of SRXN1 mRNA; methylformamide analog affects the expression of SRXN1 mRNA
CTD
PMID:17040096
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Thrsp
thyroid hormone responsive
decreases expression
ISO
methylformamide analog results in decreased expression of THRSP mRNA; methylformamide results in decreased expression of THRSP mRNA
CTD
PMID:17040096
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Tnfaip6
TNF alpha induced protein 6
affects expression
ISO
methylformamide affects the expression of TNFAIP6 mRNA; methylformamide analog affects the expression of TNFAIP6 mRNA
CTD
PMID:17040096
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tob1
transducer of ErbB-2.1
decreases expression
ISO
methylformamide analog results in decreased expression of TOB1 mRNA; methylformamide results in decreased expression of TOB1 mRNA
CTD
PMID:17040096
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
G
Topors
TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase
increases expression
ISO
methylformamide analog results in increased expression of TOPORS mRNA; methylformamide results in increased expression of TOPORS mRNA
CTD
PMID:17040096
NCBI chr 5:55,388,033...55,399,937
Ensembl chr 5:55,387,632...55,399,937
G
Trib3
tribbles pseudokinase 3
affects expression
ISO
methylformamide affects the expression of TRIB3 mRNA; methylformamide analog affects the expression of TRIB3 mRNA
CTD
PMID:17040096
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Txnrd1
thioredoxin reductase 1
affects expression
ISO
methylformamide affects the expression of TXNRD1 mRNA; methylformamide analog affects the expression of TXNRD1 mRNA
CTD
PMID:17040096
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ubap1
ubiquitin-associated protein 1
affects expression
ISO
methylformamide affects the expression of UBAP1 mRNA; methylformamide analog affects the expression of UBAP1 mRNA
CTD
PMID:17040096
NCBI chr 5:56,520,722...56,561,153
Ensembl chr 5:56,520,743...56,561,152
G
Ugdh
UDP-glucose 6-dehydrogenase
affects expression
ISO
methylformamide affects the expression of UGDH mRNA; methylformamide analog affects the expression of UGDH mRNA
CTD
PMID:17040096
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
methylformamide analog results in increased expression of UGP2 mRNA; methylformamide results in increased expression of UGP2 mRNA
CTD
PMID:17040096
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Usp9x
ubiquitin specific peptidase 9, X-linked
increases expression
ISO
methylformamide analog results in increased expression of USP9X mRNA; methylformamide results in increased expression of USP9X mRNA
CTD
PMID:17040096
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
G
Vegfd
vascular endothelial growth factor D
increases expression
ISO
methylformamide analog results in increased expression of VEGFD mRNA; methylformamide results in increased expression of VEGFD mRNA
CTD
PMID:17040096
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
G
Zfp467
zinc finger protein 467
decreases expression
ISO
methylformamide analog results in decreased expression of ZFP467 mRNA; methylformamide results in decreased expression of ZFP467 mRNA
CTD
PMID:17040096
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
G
Zfx
zinc finger protein X-linked
increases expression
ISO
methylformamide analog results in increased expression of ZFX mRNA; methylformamide results in increased expression of ZFX mRNA
CTD
PMID:17040096
NCBI chr X:58,804,690...58,853,155
Ensembl chr X:58,804,691...58,853,265
G
Zwint
ZW10 interacting kinetochore protein
affects expression
ISO
methylformamide affects the expression of ZWINT mRNA; methylformamide analog affects the expression of ZWINT mRNA
CTD
PMID:17040096
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
G
Abhd12
abhydrolase domain containing 12, lysophospholipase
decreases activity
ISO
orlistat results in decreased activity of ABHD12 protein
CTD
PMID:18657971
NCBI chr 3:139,659,315...139,719,529
Ensembl chr 3:139,659,317...139,719,564
G
Abhd16a
abhydrolase domain containing 16A, phospholipase
decreases activity
ISO
orlistat results in decreased activity of ABHD16A protein
CTD
PMID:18657971
NCBI chr20:3,719,089...3,733,952
Ensembl chr20:3,719,091...3,733,927
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions decreases expression
ISO
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA] Orlistat results in decreased expression of ACACA mRNA
CTD
PMID:32347045 PMID:33476690
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Ache
acetylcholinesterase
decreases activity
ISO
Orlistat results in decreased activity of ACHE protein
CTD
PMID:33844597
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acot8
acyl-CoA thioesterase 8
decreases expression
ISO
Orlistat results in decreased expression of ACOT8 protein
CTD
PMID:30667213
NCBI chr 3:153,531,192...153,542,851
Ensembl chr 3:153,531,193...153,542,851
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP ISO
orlistat inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]
CTD
PMID:25087745 PMID:33476690
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Triglycerides]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein]
CTD
PMID:32045588
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
App
amyloid beta precursor protein
multiple interactions
ISO
[1,1,1,2,2-pentafluoro-7-phenylheptan-3-one co-treated with Orlistat] inhibits the reaction [APP protein modified form results in increased secretion of Arachidonic Acid]
CTD
PMID:28721267
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Atf4
activating transcription factor 4
increases expression
ISO
orlistat results in increased expression of ATF4 mRNA
CTD
PMID:17283163
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in increased expression of BAX mRNA]
CTD
PMID:32450208
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]
CTD
PMID:32450208
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity increases cleavage multiple interactions
ISO EXP
orlistat results in increased activity of CASP3 protein orlistat results in increased cleavage of CASP3 protein Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP3 mRNA]
CTD
PMID:17283163 PMID:20805790 PMID:21723078 PMID:32450208
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO EXP
orlistat analog results in increased cleavage of and results in increased activity of CASP8 protein; orlistat results in increased cleavage of and results in increased activity of CASP8 protein Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP8 mRNA]
CTD
PMID:18796435 PMID:20577697 PMID:32450208
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity multiple interactions
ISO EXP
orlistat results in increased activity of CASP9 protein Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP9 mRNA]
CTD
PMID:20805790 PMID:32450208
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions decreases expression
EXP ISO
Orlistat inhibits the reaction [Dietary Fats results in decreased activity of CAT protein]; Orlistat inhibits the reaction [Dietary Fats results in decreased expression of CAT mRNA]; Orlistat inhibits the reaction [Dietary Fats results in decreased expression of CAT protein] Orlistat results in decreased expression of CAT protein
CTD
PMID:25087745 PMID:30667213 PMID:32450208
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cck
cholecystokinin
multiple interactions decreases secretion
ISO
[[orlistat results in decreased abundance of Fatty Acids, Nonesterified] which results in decreased secretion of CCK protein] which results in decreased secretion of PNLIP protein; orlistat inhibits the reaction [Fats results in increased secretion of CCK protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of CCK protein] orlistat results in decreased secretion of CCK protein
CTD
PMID:11408251 PMID:18303078 PMID:18647814
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Ccna2
cyclin A2
decreases expression
ISO
Orlistat results in decreased expression of CCNA2 protein
CTD
PMID:30667213
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnd1
cyclin D1
increases expression multiple interactions
ISO
Orlistat results in increased expression of CCND1 protein Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]
CTD
PMID:30667213 PMID:32045588
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
increases expression
ISO
Orlistat results in increased expression of CCNE1 protein
CTD
PMID:30667213
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cd34
CD34 molecule
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]
CTD
PMID:32045588
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Orlistat results in decreased expression of CDK1 protein
CTD
PMID:30667213
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Orlistat results in decreased expression of CDK2 protein
CTD
PMID:30667213
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Orlistat results in decreased expression of CDK4 protein
CTD
PMID:30667213
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Orlistat results in increased expression of CDKN1A protein
CTD
PMID:30667213
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
orlistat results in increased expression of CDKN1B protein
CTD
PMID:15138278
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
CTD
PMID:33476690
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cel
carboxyl ester lipase
decreases activity
ISO
orlistat results in decreased activity of CEL protein
CTD
PMID:11592731 PMID:12381337
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
G
Clps
colipase
multiple interactions
ISO
orlistat inhibits the reaction [[PNLIP protein co-treated with CLPS protein] results in increased hydrolysis of Olive Oil]
CTD
PMID:15158758
NCBI chr20:6,620,529...6,622,709
Ensembl chr20:6,620,529...6,622,689
G
Cpb2
carboxypeptidase B2
decreases expression
ISO
orlistat results in decreased expression of CPB2 protein
CTD
PMID:16959692
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
ISO
Orlistat results in decreased expression of CPT1A protein
CTD
PMID:30667213
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cpt2
carnitine palmitoyltransferase 2
decreases expression
ISO
Orlistat results in decreased expression of CPT2 protein
CTD
PMID:30667213
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
Orlistat results in increased expression of CYP3A4 mRNA; Orlistat results in increased expression of CYP3A4 protein
CTD
PMID:20599501
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Dagla
diacylglycerol lipase, alpha
decreases activity
ISO
orlistat results in decreased activity of DAGLA protein
CTD
PMID:16466961
NCBI chr 1:206,890,635...206,947,332
Ensembl chr 1:206,890,638...206,947,232
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
orlistat results in increased expression of DDIT3 mRNA
CTD
PMID:17283163
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
orlistat results in increased expression of DDIT4 mRNA
CTD
PMID:18796435
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation multiple interactions
ISO
orlistat results in increased phosphorylation of EIF2A protein orlistat promotes the reaction [EIF2AK3 protein results in increased phosphorylation of EIF2A protein] Cycloheximide inhibits the reaction [orlistat results in increased phosphorylation of EIF2A protein] orlistat analog results in increased phosphorylation of EIF2A protein; orlistat results in increased phosphorylation of EIF2A protein
CTD
PMID:17283163 PMID:20577697
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases response to substance multiple interactions
ISO
EIF2AK3 gene mutant form results in increased susceptibility to orlistat orlistat promotes the reaction [EIF2AK3 protein results in increased phosphorylation of EIF2A protein]
CTD
PMID:17283163
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif4e
eukaryotic translation initiation factor 4E
increases phosphorylation
ISO
orlistat results in increased phosphorylation of EIF4E protein
CTD
PMID:18796435
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
G
Erbb2
erb-b2 receptor tyrosine kinase 2
affects response to substance decreases expression affects localization
ISO
ERBB2 protein affects the susceptibility to orlistat orlistat results in decreased expression of ERBB2 mRNA; orlistat results in decreased expression of ERBB2 protein orlistat affects the localization of ERBB2 protein
CTD
PMID:15870086
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
orlistat affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA]
CTD
PMID:17283163
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Etv4
ETS variant transcription factor 4
increases expression
ISO
orlistat results in increased expression of ETV4 protein
CTD
PMID:15870086
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
G
Fabp1
fatty acid binding protein 1
decreases expression
ISO
Orlistat results in decreased expression of FABP1 protein
CTD
PMID:30667213
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fas
Fas cell surface death receptor
decreases expression
ISO
Orlistat results in decreased expression of FAS mRNA
CTD
PMID:32347045
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
affects binding decreases expression decreases activity multiple interactions affects response to substance
ISO
orlistat analog binds to FASN protein Orlistat results in decreased expression of FASN protein orlistat results in decreased activity of FASN protein [orlistat results in decreased activity of FASN protein] which affects the abundance of Fatty Acids, Nonesterified; orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid] orlistat analog results in decreased activity of FASN protein; orlistat results in decreased activity of FASN protein [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids; [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines; [Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine; [Orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids; [Orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein; Orlistat binds to and results in decreased activity of FASN protein; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin]; Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] FASN protein affects the susceptibility to orlistat
CTD
PMID:15026345 PMID:15138278 PMID:15870086 PMID:17012255 PMID:17618296 PMID:17847090 PMID:18281512 PMID:18710210 PMID:18723500 PMID:20148945 PMID:20577697 PMID:21213365 PMID:30667213 PMID:32045588 PMID:33476690 More...
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Gcg
glucagon
multiple interactions decreases expression decreases secretion
ISO
orlistat inhibits the reaction [Dietary Fats results in increased secretion of GCG protein]; orlistat inhibits the reaction [Olive Oil results in increased secretion of GCG protein] orlistat results in decreased expression of GCG protein orlistat results in decreased secretion of GCG protein
CTD
PMID:12915676 PMID:18647814 PMID:19837920
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Ghrl
ghrelin and obestatin prepropeptide
multiple interactions
ISO
orlistat inhibits the reaction [Olive Oil results in decreased expression of GHRL protein]; orlistat inhibits the reaction [Triglycerides results in decreased secretion of GHRL protein]
CTD
PMID:15998659 PMID:17138722
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Gip
gastric inhibitory polypeptide
decreases expression
ISO
orlistat results in decreased expression of GIP protein
CTD
PMID:12915676
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
orlistat inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]
CTD
PMID:29479035
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in decreased expression of GPX1 mRNA]
CTD
PMID:32450208
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx8
glutathione peroxidase 8
increases expression
ISO
orlistat results in increased expression of GPX8 mRNA
CTD
PMID:18796435
NCBI chr 2:44,676,448...44,680,042
Ensembl chr 2:44,676,454...44,680,195
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in decreased expression of GSR protein]
CTD
PMID:32450208
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
ISO
orlistat results in decreased expression of HBA1 protein modified form
CTD
PMID:19207292 PMID:19461584
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
EXP
orlistat inhibits the reaction [Dietary Fats results in increased expression of HMGCR protein]
CTD
PMID:25087745
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
orlistat results in increased expression of HSPA5 mRNA
CTD
PMID:17283163
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Il10
interleukin 10
increases expression
EXP
Orlistat results in increased expression of IL10 mRNA
CTD
PMID:32450208
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in increased expression of IL1B mRNA]
CTD
PMID:32450208
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
CTD
PMID:21088047 PMID:32045588
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in increased expression of INS1 protein]
CTD
PMID:25087745
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
decreases expression increases expression affects expression multiple interactions
ISO
orlistat results in decreased expression of INS protein orlistat results in increased expression of INS protein orlistat affects the expression of INS protein [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
CTD
PMID:10095983 PMID:11274935 PMID:12915676 PMID:33476690
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
increases expression
ISO
orlistat results in increased expression of KDELR3 mRNA
CTD
PMID:18796435
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
G
Kdr
kinase insert domain receptor
decreases expression
ISO
orlistat results in decreased expression of KDR protein
CTD
PMID:17012255
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Krt81
keratin 81
increases expression
ISO
orlistat results in increased expression of KRT81 mRNA
CTD
PMID:18796435
NCBI chr 7:132,577,112...132,582,238
Ensembl chr 7:132,576,492...132,582,170
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
EXP
orlistat inhibits the reaction [Dietary Fats results in decreased expression of LCAT protein]
CTD
PMID:25087745
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lep
leptin
multiple interactions
ISO EXP
orlistat inhibits the reaction [Dietary Fats results in increased expression of LEP protein]
CTD
PMID:21332399 PMID:25087745
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lipf
lipase F, gastric type
decreases activity
ISO
orlistat results in decreased activity of LIPF protein
CTD
PMID:11408251 PMID:12381337
NCBI chr 1:231,493,498...231,511,845
Ensembl chr 1:231,493,498...231,511,845
G
Lpl
lipoprotein lipase
decreases activity multiple interactions
ISO EXP
orlistat results in decreased activity of LPL protein orlistat inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] orlistat inhibits the reaction [[LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides]; orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein]; orlistat inhibits the reaction [very low density lipoprotein triglyceride results in increased activity of LPL protein] [orlistat results in decreased activity of LPL protein] which affects the uptake of Triglycerides
CTD
PMID:12388125 PMID:12573449 PMID:15910848 PMID:15994321 PMID:18698144 PMID:25087745 More...
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]
CTD
PMID:32045588
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]
CTD
PMID:32045588
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Met
MET proto-oncogene, receptor tyrosine kinase
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Triglycerides]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CCND1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of CD34 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of FASN protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of IL6 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK1 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of MAPK3 protein]; Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein]
CTD
PMID:32045588
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Napepld
N-acyl phosphatidylethanolamine phospholipase D
decreases activity
EXP
orlistat results in decreased activity of NAPEPLD protein
CTD
PMID:16466961
NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP ISO
Orlistat inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA
CTD
PMID:32450208 PMID:33476690
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in increased expression of NOS2 mRNA]; Orlistat inhibits the reaction [Dietary Fats results in increased expression of NOS2 protein]
CTD
PMID:32450208
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Npy
neuropeptide Y
increases expression
ISO
orlistat results in increased expression of NPY protein
CTD
PMID:15962606
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
orlistat results in increased activity of NR1I2 protein
CTD
PMID:20599501
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
Orlistat binds to and results in increased activity of NR1I3 protein alternative form
CTD
PMID:31312845
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nts
neurotensin
multiple interactions
ISO
Orlistat inhibits the reaction [Fats results in increased secretion of NTS protein]; Orlistat inhibits the reaction [Olive Oil results in increased secretion of NTS protein]
CTD
PMID:18303078
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
[orlistat co-treated with Thapsigargin] results in increased cleavage of PARP1 protein orlistat results in increased cleavage of PARP1 protein
CTD
PMID:15870086 PMID:17283163
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PCNA protein]
CTD
PMID:32045588
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pla2g7
phospholipase A2 group VII
decreases activity multiple interactions
ISO
orlistat results in decreased activity of PLA2G7 protein [orlistat co-treated with Ezetimibe] results in decreased activity of PLA2G7 protein; [orlistat co-treated with Fenofibrate] results in decreased activity of PLA2G7 protein
CTD
PMID:16911813 PMID:18513463 PMID:18657971
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Pnlip
pancreatic lipase
decreases secretion decreases activity multiple interactions affects folding
ISO EXP
orlistat results in decreased secretion of PNLIP protein orlistat results in decreased activity of PNLIP protein orlistat inhibits the reaction [Taurocholic Acid results in increased activity of PNLIP protein] orlistat affects the folding of PNLIP protein [[orlistat results in decreased abundance of Fatty Acids, Nonesterified] which results in decreased secretion of CCK protein] which results in decreased secretion of PNLIP protein; orlistat inhibits the reaction [[PNLIP protein co-treated with CLPS protein] results in increased hydrolysis of Olive Oil]
CTD
PMID:11408251 PMID:11668201 PMID:12381337 PMID:15158758 PMID:19346257
NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654
G
Pnliprp2
pancreatic lipase related protein 2
decreases activity
ISO EXP
orlistat results in decreased activity of PNLIPRP2 protein Orlistat results in decreased activity of PNLIPRP2 protein
CTD
PMID:9822688 PMID:17401110
NCBI chr 1:257,897,766...257,916,434
Ensembl chr 1:257,897,766...257,916,434
G
Pon1
paraoxonase 1
increases activity
ISO
orlistat results in increased activity of PON1 protein
CTD
PMID:11820148 PMID:17134960
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppard
peroxisome proliferator-activated receptor delta
multiple interactions
ISO
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]
CTD
PMID:33476690
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
Orlistat results in increased expression of PPARG mRNA
CTD
PMID:32347045
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppt1
palmitoyl-protein thioesterase 1
decreases expression
ISO
Orlistat results in decreased expression of PPT1 protein
CTD
PMID:30667213
NCBI chr 5:135,121,164...135,142,048
Ensembl chr 5:135,121,163...135,142,048
G
Ppy
pancreatic polypeptide
multiple interactions
ISO
orlistat inhibits the reaction [Triglycerides results in increased secretion of PPY protein]
CTD
PMID:15998659
NCBI chr10:87,054,747...87,056,044
Ensembl chr10:87,054,756...87,055,455
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
multiple interactions
EXP ISO
orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of PRKAA1 protein] orlistat inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; orlistat inhibits the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of PRKAA1 protein]
CTD
PMID:18390901 PMID:19167487
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Pten
phosphatase and tensin homolog
increases expression multiple interactions
ISO
Orlistat results in increased expression of PTEN protein Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein]
CTD
PMID:32045588
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of PTGS2 protein]
CTD
PMID:32045588
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pyy
peptide YY
decreases secretion multiple interactions
ISO
orlistat results in decreased secretion of PYY protein orlistat inhibits the reaction [Olive Oil results in increased expression of PYY protein]; orlistat inhibits the reaction [Triglycerides results in increased secretion of PYY protein]
CTD
PMID:15998659 PMID:17138722 PMID:18647814
NCBI chr10:87,061,155...87,062,278
Ensembl chr10:87,061,161...87,061,815
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
orlistat results in decreased phosphorylation of RB1 protein
CTD
PMID:15138278
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in increased expression of RELA mRNA]
CTD
PMID:32450208
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rps6
ribosomal protein S6
multiple interactions
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased phosphorylation of RPS6 protein]
CTD
PMID:32045588
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases expression
ISO
orlistat results in increased expression of SEC24D mRNA
CTD
PMID:18796435
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
G
Skp2
S-phase kinase associated protein 2
multiple interactions decreases expression
ISO
[orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein orlistat results in decreased expression of SKP2 protein
CTD
PMID:15138278
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
orlistat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression
ISO
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of SREBF1 protein] Orlistat results in decreased expression of SREBF1 protein
CTD
PMID:32045588
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tf
transferrin
multiple interactions
ISO
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
CTD
PMID:33476690
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA
CTD
PMID:33476690
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased expression of TNF protein]; Orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein] Orlistat inhibits the reaction [Dietary Fats results in increased expression of TNF mRNA]
CTD
PMID:15994321 PMID:32045588 PMID:32450208
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
increases response to substance
ISO
orlistat results in increased susceptibility to TNFSF10 protein
CTD
PMID:18796435 PMID:21406729
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
multiple interactions
EXP
Orlistat inhibits the reaction [Dietary Fats results in increased expression of TP53 mRNA]
CTD
PMID:32450208
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ucp1
uncoupling protein 1
multiple interactions
ISO
Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]
CTD
PMID:33476690
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Xbp1
X-box binding protein 1
multiple interactions
ISO
orlistat affects the reaction [ERN1 protein affects the splicing of XBP1 mRNA]
CTD
PMID:17283163
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
triforine binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Aamdc
adipogenesis associated, Mth938 domain containing
increases expression
ISO
Vincristine results in increased expression of AAMDC mRNA
CTD
PMID:23649840
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA1 mRNA
CTD
PMID:19944135
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abca12
ATP binding cassette subfamily A member 12
increases expression multiple interactions
ISO
Vincristine results in increased expression of ABCA12 mRNA [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA12 mRNA
CTD
PMID:19944135 PMID:23649840
NCBI chr 9:72,822,661...72,995,748
Ensembl chr 9:72,823,350...72,996,049
G
Abca4
ATP binding cassette subfamily A member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA4 mRNA
CTD
PMID:19944135
NCBI chr 2:210,164,813...210,302,069
Ensembl chr 2:210,164,813...210,302,069
G
Abca5
ATP binding cassette subfamily A member 5
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCA5 mRNA
CTD
PMID:19944135
NCBI chr10:95,240,159...95,309,195
Ensembl chr10:95,240,154...95,308,976
G
Abca8
ATP binding cassette subfamily A member 8
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCA8 mRNA
CTD
PMID:19944135
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects response to substance increases expression multiple interactions increases transport decreases uptake decreases response to substance affects uptake
ISO EXP
ABCB1 protein affects the susceptibility to Vincristine Vincristine results in increased expression of ABCB1A mRNA Vincristine results in increased expression of ABCB1 protein [Estradiol results in decreased expression of ABCB1 protein] which results in increased uptake of and results in increased susceptibility to Vincristine; [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Vincristine; [Paclitaxel results in increased expression of ABCB1] which results in decreased susceptibility to Vincristine; [Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB1 mRNA; [Vincristine results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; CEP 33779 inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Cyclosporine inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Fenofibrate inhibits the reaction [ABCB1 protein results in increased transport of Vincristine]; Flupenthixol analog inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; NR1I2 protein promotes the reaction [Vincristine results in increased expression of ABCB1 protein]; pinostrobin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; tectochrysin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine]; zosuquidar trihydrochloride inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine] ABCB1 protein results in decreased uptake of Vincristine ABCB1 protein affects the uptake of Vincristine
CTD
PMID:7905786 PMID:10617675 PMID:11792417 PMID:11934808 PMID:15239124 PMID:15645438 PMID:16038730 PMID:16221289 PMID:16316932 PMID:16925584 PMID:19944135 PMID:20041327 PMID:21344920 PMID:21833476 PMID:25058526 PMID:32497533 PMID:37259354 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects uptake
EXP
ABCB1B protein affects the uptake of Vincristine
CTD
PMID:11934808
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB4 mRNA
CTD
PMID:19944135
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcb6
ATP binding cassette subfamily B member 6
multiple interactions decreases response to substance
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB6 mRNA ABCB6 protein results in decreased susceptibility to Vincristine
CTD
PMID:19944135 PMID:25202056
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
G
Abcc1
ATP binding cassette subfamily C member 1
increases response to substance increases expression multiple interactions decreases response to substance affects transport affects response to substance affects export
ISO EXP
ABCC1 gene SNP results in increased susceptibility to Vincristine Vincristine results in increased expression of ABCC1 mRNA [Genistein results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [Indomethacin results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [Probenecid results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [Sulfinpyrazone results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine; [verlukast results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine ABCC1 protein results in decreased susceptibility to Vincristine; ABCC1 results in decreased susceptibility to Vincristine [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine; [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCC1 mRNA; ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine; Buthionine Sulfoximine inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Cyclosporine inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Doxorubicin inhibits the reaction [ABCC1 protein affects the transport of Vincristine]; GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; myricetin inhibits the reaction [ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine]; myricetin inhibits the reaction [ABCC1 protein affects the export of Vincristine]; myricetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Quercetin promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon]; Vincristine inhibits the reaction [Glutathione promotes the reaction [ABCC1 results in increased transport of methylarsine analog]]; zafirlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] ABCC1 protein affects the transport of Vincristine; ABCC1 protein mutant form affects the transport of Vincristine ABCC1 protein affects the susceptibility to Vincristine
CTD
PMID:7954421 PMID:8649356 PMID:8968083 PMID:10348353 PMID:10685512 PMID:10900222 PMID:11278867 PMID:11306701 PMID:11778547 PMID:12067707 PMID:12731862 PMID:12893836 PMID:15044619 PMID:15180633 PMID:15581632 PMID:15896345 PMID:16042792 PMID:16221289 PMID:19232821 PMID:19944135 PMID:20864405 PMID:21918036 PMID:22095822 More...
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc10
ATP binding cassette subfamily C member 10
multiple interactions decreases response to substance
ISO
Imatinib Mesylate inhibits the reaction [ABCC10 protein results in decreased susceptibility to Vincristine]; nilotinib inhibits the reaction [ABCC10 protein results in decreased susceptibility to Vincristine]
CTD
PMID:19841739
NCBI chr 9:14,657,242...14,677,178
Ensembl chr 9:14,657,264...14,677,178
G
Abcc2
ATP binding cassette subfamily C member 2
affects export multiple interactions decreases response to substance
ISO
ABCC2 protein affects the export of Vincristine [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCC2 mRNA; ABCC2 protein affects the export of and results in decreased susceptibility to Vincristine; myricetin inhibits the reaction [ABCC2 protein affects the export of and results in decreased susceptibility to Vincristine]; myricetin inhibits the reaction [ABCC2 protein affects the export of Vincristine]; myricetin inhibits the reaction [ABCC2 protein results in decreased susceptibility to Vincristine]
CTD
PMID:15896345 PMID:19944135 PMID:22095822
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCC3 mRNA
CTD
PMID:19944135
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCC4 mRNA
CTD
PMID:19944135
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcc5
ATP binding cassette subfamily C member 5
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCC5 mRNA
CTD
PMID:19944135
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Abcc6
ATP binding cassette subfamily C member 6
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCC6 mRNA
CTD
PMID:19944135
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
G
Abcd3
ATP binding cassette subfamily D member 3
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCD3 mRNA
CTD
PMID:19944135
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
G
Abcg1
ATP binding cassette subfamily G member 1
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCG1 mRNA
CTD
PMID:19944135
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
[Paclitaxel results in decreased expression of ABCG2] which results in decreased susceptibility to Vincristine; [Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCG2 mRNA
CTD
PMID:19944135 PMID:21833476
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg4
ATP binding cassette subfamily G member 4
multiple interactions
ISO
[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCG4 mRNA
CTD
PMID:19944135
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
G
Abhd11
abhydrolase domain containing 11
decreases expression
ISO
Vincristine results in decreased expression of ABHD11 mRNA
CTD
PMID:23649840
NCBI chr12:21,682,206...21,685,331
Ensembl chr12:21,682,202...21,685,398
G
Abtb2
ankyrin repeat and BTB domain containing 2
increases expression
ISO
Vincristine results in increased expression of ABTB2 mRNA
CTD
PMID:23649840
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
G
Acad9
acyl-CoA dehydrogenase family, member 9
decreases expression
ISO
Vincristine results in decreased expression of ACAD9 mRNA
CTD
PMID:23649840
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
G
Ache
acetylcholinesterase
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of ACHE protein xaliproden inhibits the reaction [Vincristine results in decreased expression of ACHE protein]
CTD
PMID:8413926
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ackr3
atypical chemokine receptor 3
increases expression
ISO
Vincristine results in increased expression of ACKR3 mRNA
CTD
PMID:23649840
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Actr2
actin related protein 2
increases expression
ISO
Vincristine results in increased expression of ACTR2 mRNA
CTD
PMID:23649840
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
G
Adat2
adenosine deaminase, tRNA-specific 2
decreases expression
ISO
Vincristine results in decreased expression of ADAT2 mRNA
CTD
PMID:23649840
NCBI chr 1:7,954,520...7,975,254
Ensembl chr 1:7,954,631...7,975,251
G
Adgrf4
adhesion G protein-coupled receptor F4
increases expression
ISO
Vincristine results in increased expression of ADGRF4 mRNA
CTD
PMID:23649840
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
G
Adrb1
adrenoceptor beta 1
decreases expression
ISO
Vincristine results in decreased expression of ADRB1 mRNA
CTD
PMID:23649840
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
increases response to substance
ISO
ADRB2 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agbl3
AGBL carboxypeptidase 3
decreases expression
ISO
Vincristine results in decreased expression of AGBL3 mRNA
CTD
PMID:23649840
NCBI chr 4:63,448,789...63,535,538
Ensembl chr 4:63,453,940...63,531,188
G
Ahsa2
activator of HSP90 ATPase homolog 2
decreases expression
ISO
Vincristine results in decreased expression of AHSA2P mRNA
CTD
PMID:23649840
NCBI chr14:97,476,304...97,485,725
Ensembl chr14:97,476,817...97,485,657
G
Aim2
absent in melanoma 2
increases expression
ISO
Vincristine results in increased expression of AIM2 mRNA
CTD
PMID:23649840
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:85,866,284...85,906,975
G
Ak1
adenylate kinase 1
decreases expression
EXP
Vincristine results in decreased expression of AK1 mRNA
CTD
PMID:20624997
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Ak3
adenylate kinase 3
decreases expression
ISO
Vincristine results in decreased expression of AK3 mRNA
CTD
PMID:23649840
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
G
Akap10
A-kinase anchoring protein 10
increases expression
ISO
Vincristine results in increased expression of AKAP10 mRNA
CTD
PMID:23649840
NCBI chr10:46,545,371...46,608,730
Ensembl chr10:46,551,532...46,608,769
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases expression
ISO EXP
Vincristine inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] Vincristine results in decreased expression of AKT1 mRNA Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT1 mRNA] Vincristine promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]]
CTD
PMID:16740780 PMID:18590705 PMID:33038355
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of AKT2 mRNA Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT2 mRNA]
CTD
PMID:33038355
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Aldoc
aldolase, fructose-bisphosphate C
decreases expression
ISO
Vincristine results in decreased expression of ALDOC mRNA
CTD
PMID:23649840
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alms1
ALMS1, centrosome and basal body associated protein
decreases expression
ISO
Vincristine results in decreased expression of ALMS1 mRNA
CTD
PMID:23649840
NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
G
Alpk2
alpha-kinase 2
increases expression
ISO
Vincristine results in increased expression of ALPK2 mRNA
CTD
PMID:23649840
NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
G
Amh
anti-Mullerian hormone
decreases secretion
ISO
Vincristine results in decreased secretion of AMH protein
CTD
PMID:30657998
NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282
G
Anapc5
anaphase-promoting complex subunit 5
increases expression
ISO
Vincristine results in increased expression of ANAPC5 mRNA
CTD
PMID:23649840
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
G
Ankdd1a
ankyrin repeat and death domain containing 1A
decreases expression
ISO
Vincristine results in decreased expression of ANKDD1A mRNA
CTD
PMID:23649840
NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
G
Ankhd1
ankyrin repeat and KH domain containing 1
increases expression
ISO
Vincristine results in increased expression of ANKHD1 mRNA
CTD
PMID:23649840
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
G
Ankra2
ankyrin repeat family A member 2
increases expression
ISO
Vincristine results in increased expression of ANKRA2 mRNA
CTD
PMID:23649840
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
G
Ankrd13c
ankyrin repeat domain 13C
decreases expression
ISO
Vincristine results in decreased expression of ANKRD13C mRNA
CTD
PMID:23649840
NCBI chr 2:247,023,040...247,070,433
Ensembl chr 2:247,022,286...247,070,433
G
Ankrd33b
ankyrin repeat domain 33B
increases expression
ISO
Vincristine results in increased expression of ANKRD33B mRNA
CTD
PMID:23649840
NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872
G
Ankrd37
ankyrin repeat domain 37
decreases expression
ISO
Vincristine results in decreased expression of ANKRD37 mRNA
CTD
PMID:23649840
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Anp32e
acidic nuclear phosphoprotein 32 family member E
decreases expression
ISO
Vincristine results in decreased expression of ANP32E mRNA
CTD
PMID:23649840
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
G
Anxa1
annexin A1
increases expression
ISO
Vincristine results in increased expression of ANXA1 mRNA
CTD
PMID:23649840
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
increases expression
ISO
Vincristine results in increased expression of ANXA2 mRNA
CTD
PMID:23649840
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Ap1s2
adaptor related protein complex 1 subunit sigma 2
decreases expression
ISO
Vincristine results in decreased expression of AP1S2 mRNA
CTD
PMID:23649840
NCBI chr X:30,572,746...30,598,961
Ensembl chr X:30,572,751...30,597,262
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
decreases expression
ISO
Vincristine results in decreased expression of APEX2 mRNA
CTD
PMID:23649840
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
G
Apln
apelin
decreases expression
EXP
Vincristine results in decreased expression of APLN mRNA
CTD
PMID:20624997
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Apod
apolipoprotein D
increases expression
ISO
Vincristine results in increased expression of APOD mRNA
CTD
PMID:23649840
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
Apold1
apolipoprotein L domain containing 1
increases expression
ISO
Vincristine results in increased expression of APOLD1 mRNA
CTD
PMID:23649840
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
Aqp9
aquaporin 9
increases expression
ISO
Vincristine results in increased expression of AQP9 mRNA
CTD
PMID:23649840
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Arap2
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
decreases expression
ISO
Vincristine results in decreased expression of ARAP2 mRNA
CTD
PMID:23649840
NCBI chr14:46,717,657...46,917,326
Ensembl chr14:46,718,760...46,917,154
G
Arf1
ADP-ribosylation factor 1
increases expression
ISO
Vincristine results in increased expression of ARF1 mRNA
CTD
PMID:23649840
NCBI chr10:43,997,983...44,014,461
Ensembl chr10:43,997,986...44,014,434
G
Arhgap15
Rho GTPase activating protein 15
increases expression
ISO
Vincristine results in increased expression of ARHGAP15 mRNA
CTD
PMID:23649840
NCBI chr 3:27,989,368...28,592,722
Ensembl chr 3:27,989,633...28,600,265
G
Arhgap18
Rho GTPase activating protein 18
decreases expression
ISO
Vincristine results in decreased expression of ARHGAP18 mRNA
CTD
PMID:23649840
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgap5
Rho GTPase activating protein 5
decreases expression
ISO
Vincristine results in decreased expression of ARHGAP5 mRNA
CTD
PMID:23649840
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Arhgef6
Rac/Cdc42 guanine nucleotide exchange factor 6
increases expression
ISO
Vincristine results in increased expression of ARHGEF6 mRNA
CTD
PMID:23649840
NCBI chr X:135,145,447...135,264,636
Ensembl chr X:135,146,786...135,275,304
G
Arhgef7
Rho guanine nucleotide exchange factor 7
increases expression
ISO
Vincristine results in increased expression of ARHGEF7 mRNA
CTD
PMID:23649840
NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697
G
Arid2
AT-rich interaction domain 2
increases expression
ISO
Vincristine results in increased expression of ARID2 mRNA
CTD
PMID:23649840
NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
G
Arid4b
AT-rich interaction domain 4B
increases expression
ISO
Vincristine results in increased expression of ARID4B mRNA
CTD
PMID:23649840
NCBI chr17:51,138,419...51,262,894
Ensembl chr17:51,138,535...51,262,906
G
Arl5a
ADP-ribosylation factor like GTPase 5A
decreases expression
ISO
Vincristine results in decreased expression of ARL5A mRNA
CTD
PMID:23649840
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
G
Arl5b
ADP-ribosylation factor like GTPase 5B
increases expression
ISO
Vincristine results in increased expression of ARL5B mRNA
CTD
PMID:23649840
NCBI chr17:77,955,864...77,979,895
Ensembl chr17:77,955,818...77,979,854
G
Arl6ip1
ADP-ribosylation factor like GTPase 6 interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of ARL6IP1 mRNA
CTD
PMID:23649840
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
G
Armc8
armadillo repeat containing 8
decreases expression
ISO
Vincristine results in decreased expression of ARMC8 mRNA
CTD
PMID:23649840
NCBI chr 8:100,036,946...100,131,544
Ensembl chr 8:100,036,946...100,131,520
G
Aspm
assembly factor for spindle microtubules
increases expression
ISO
Vincristine results in increased expression of ASPM mRNA
CTD
PMID:17374387
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Asxl1
ASXL transcriptional regulator 1
increases expression
ISO
Vincristine results in increased expression of ASXL1 mRNA
CTD
PMID:23649840
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Atad2
ATPase family, AAA domain containing 2
decreases expression
ISO
Vincristine results in decreased expression of ATAD2 mRNA
CTD
PMID:23649840
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
increases expression
ISO
Vincristine results in increased expression of ATF3 mRNA
CTD
PMID:23649840
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf5
activating transcription factor 5
increases expression
ISO
Vincristine results in increased expression of ATF5 mRNA
CTD
PMID:23649840
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
multiple interactions increases expression
EXP
Quercetin inhibits the reaction [Vincristine results in increased expression of ATF6 mRNA]
CTD
PMID:33038355
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atp2b4
ATPase plasma membrane Ca2+ transporting 4
increases expression
ISO
Vincristine results in increased expression of ATP2B4 mRNA
CTD
PMID:23649840
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
G
Atp5f1c
ATP synthase F1 subunit gamma
decreases expression
ISO
Vincristine results in decreased expression of ATP5F1C mRNA
CTD
PMID:23649840
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
increases expression
ISO
Vincristine results in increased expression of ATP6V0E1 mRNA
CTD
PMID:23649840
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
G
Atp7a
ATPase copper transporting alpha
decreases response to substance
ISO
ATP7A protein results in decreased susceptibility to Vincristine
CTD
PMID:17510416
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp8a1
ATPase phospholipid transporting 8A1
decreases expression
ISO
Vincristine results in decreased expression of ATP8A1 mRNA
CTD
PMID:23649840
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
G
Aurka
aurora kinase A
increases response to substance increases expression
ISO
AURKA gene SNP results in increased susceptibility to Vincristine Vincristine results in increased expression of AURKA mRNA
CTD
PMID:17374387 PMID:20864405
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression
ISO
Vincristine results in decreased expression of AURKB mRNA
CTD
PMID:23649840
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Avp
arginine vasopressin
increases expression
ISO
Vincristine results in increased expression of AVP protein
CTD
PMID:4356234
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
B3galt6
Beta-1,3-galactosyltransferase 6
decreases expression
ISO
Vincristine results in decreased expression of B3GALT6 mRNA
CTD
PMID:23649840
NCBI chr 5:166,584,202...166,586,338
Ensembl chr 5:166,584,202...166,586,338
G
B3gnt5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
increases expression
ISO
Vincristine results in increased expression of B3GNT5 mRNA
CTD
PMID:23649840
NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166
G
Bak1
BCL2-antagonist/killer 1
affects response to substance
ISO
BAK1 protein affects the susceptibility to Vincristine
CTD
PMID:22178383
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
Vincristine results in increased expression of BAMBI mRNA
CTD
PMID:23649840
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bard1
BRCA1 associated RING domain 1
decreases expression
ISO
Vincristine results in decreased expression of BARD1 mRNA
CTD
PMID:23649840
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Basp1
brain abundant, membrane attached signal protein 1
increases expression
ISO
Vincristine results in increased expression of BASP1 mRNA
CTD
PMID:23649840
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
ISO
Vincristine results in increased expression of BATF mRNA
CTD
PMID:23649840
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression multiple interactions increases expression affects response to substance
ISO EXP
Vincristine results in decreased expression of BAX mRNA KN 93 inhibits the reaction [Vincristine results in increased expression of BAX mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of BAX protein] Vincristine results in increased expression of BAX mRNA; Vincristine results in increased expression of BAX protein Quercetin inhibits the reaction [Vincristine results in increased expression of BAX mRNA] BAX protein affects the susceptibility to Vincristine [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BAX protein; Vincristine results in increased cleavage of and results in increased expression of BAX protein
CTD
PMID:9815696 PMID:15131059 PMID:16001973 PMID:22178383 PMID:33038355 PMID:34286406 PMID:36808657 More...
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcat1
branched chain amino acid transaminase 1
increases expression
ISO
Vincristine results in increased expression of BCAT1 mRNA
CTD
PMID:23649840
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Bcl2
BCL2, apoptosis regulator
decreases response to substance multiple interactions decreases expression increases phosphorylation
ISO EXP
BCL2 protein results in decreased susceptibility to Vincristine KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA]; KN 93 inhibits the reaction [Vincristine results in decreased expression of BCL2 protein] Vincristine results in decreased expression of BCL2 mRNA; Vincristine results in decreased expression of BCL2 protein Quercetin inhibits the reaction [Vincristine results in decreased expression of BCL2 mRNA] Vincristine results in increased phosphorylation of BCL2 protein [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein; [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein; [MIR497 results in decreased expression of BCL2 protein] which results in increased susceptibility to Vincristine; TYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]
CTD
PMID:9815696 PMID:15907805 PMID:20162574 PMID:21182165 PMID:21258880 PMID:33038355 PMID:34286406 PMID:36808657 More...
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2a1
BCL2-related protein A1
increases expression
ISO
Vincristine results in increased expression of BCL2A1 mRNA
CTD
PMID:23649840
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
increases expression affects response to substance
ISO
Vincristine results in increased expression of BCL2L1 mRNA BCL2L1 protein affects the susceptibility to Vincristine
CTD
PMID:22178383 PMID:23649840
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bclaf1
BCL2-associated transcription factor 1
decreases expression
ISO
Vincristine results in decreased expression of BCLAF1 mRNA
CTD
PMID:23649840
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
G
Bcor
BCL6 co-repressor
increases expression
ISO
Vincristine results in increased expression of BCOR mRNA
CTD
PMID:23649840
NCBI chr X:10,609,756...10,729,613
Ensembl chr X:10,687,732...10,729,613
G
Bdkrb1
bradykinin receptor B1
multiple interactions
EXP
[HOE 140, desArg(10)- binds to and results in decreased activity of BDKRB1 protein] which results in decreased susceptibility to Vincristine
CTD
PMID:17989505
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
multiple interactions
EXP
[icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Vincristine
CTD
PMID:17989505
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Birc2
baculoviral IAP repeat-containing 2
increases expression
ISO
Vincristine results in increased expression of BIRC2 mRNA
CTD
PMID:23649840
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
Vincristine results in increased expression of BIRC3 mRNA
CTD
PMID:23649840
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Blm
BLM RecQ like helicase
decreases expression
ISO
Vincristine results in decreased expression of BLM mRNA
CTD
PMID:23649840
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
G
Bmp2
bone morphogenetic protein 2
increases expression
ISO
Vincristine results in increased expression of BMP2 mRNA
CTD
PMID:23649840
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Bnip3
BCL2 interacting protein 3
decreases expression multiple interactions
ISO
Vincristine results in decreased expression of BNIP3 mRNA Vincristine affects the reaction [Valproic Acid affects the localization of BNIP3 protein]
CTD
PMID:23649840 PMID:25446377
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bnip3l
BCL2 interacting protein 3 like
decreases expression
ISO
Vincristine results in decreased expression of BNIP3L mRNA
CTD
PMID:23649840
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
G
Borcs7
BLOC-1 related complex subunit 7
increases expression
ISO
Vincristine results in increased expression of BORCS7 mRNA
CTD
PMID:23649840
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
G
Brip1
BRCA1 interacting helicase 1
decreases expression
ISO
Vincristine results in decreased expression of BRIP1 mRNA
CTD
PMID:23649840
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
G
Brwd1
bromodomain and WD repeat domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of BRWD1 mRNA
CTD
PMID:23649840
NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768
G
Btg1
BTG anti-proliferation factor 1
increases expression
ISO
Vincristine results in increased expression of BTG1 mRNA
CTD
PMID:23649840
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Vincristine results in increased expression of BTG2 mRNA
CTD
PMID:23649840
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg4
BTG anti-proliferation factor 4
increases expression
ISO
Vincristine results in increased expression of BTG4 mRNA
CTD
PMID:23649840
NCBI chr 8:51,410,774...51,425,802
Ensembl chr 8:51,422,061...51,425,796
G
Bub3
BUB3 mitotic checkpoint protein
decreases expression
ISO
Vincristine results in decreased expression of BUB3 mRNA
CTD
PMID:23649840
NCBI chr 1:186,330,358...186,340,969
Ensembl chr 1:186,327,931...186,395,036
G
C13h1orf74
similar to human chromosome 1 open reading frame 74
decreases expression
ISO
Vincristine results in decreased expression of C1ORF74 mRNA
CTD
PMID:23649840
NCBI chr13:104,692,769...104,695,368
Ensembl chr13:104,692,824...104,695,470
G
C1galt1
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
decreases expression
ISO
Vincristine results in decreased expression of C1GALT1 mRNA
CTD
PMID:23649840
NCBI chr 4:35,930,981...35,966,100
Ensembl chr 4:35,928,104...35,961,831
G
C7h12orf54
similar to human chromosome 12 open reading frame 54
increases expression
ISO
Vincristine results in increased expression of C12ORF54 mRNA
CTD
PMID:23649840
NCBI chr 7:129,529,811...129,548,676
G
C8h15orf39
similar to human chromosome 15 open reading frame 39
decreases expression
ISO
Vincristine results in decreased expression of C15ORF39 mRNA
CTD
PMID:23649840
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
G
Cables2
Cdk5 and Abl enzyme substrate 2
decreases expression
ISO
Vincristine results in decreased expression of CABLES2 mRNA
CTD
PMID:23649840
NCBI chr 3:167,347,527...167,362,274
Ensembl chr 3:167,347,461...167,362,279
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
increases expression multiple interactions
ISO
Vincristine results in increased expression of CACNA1H mRNA; Vincristine results in increased expression of CACNA1H protein Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of CACNA1H mRNA]; Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]; KN 62 inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of CACNA1H mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]; zinc chloride inhibits the reaction [Vincristine results in increased expression of CACNA1H protein]
CTD
PMID:34286406
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
increases expression
ISO
Vincristine results in increased expression of CACNB2 mRNA
CTD
PMID:23649840
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
G
Cald1
caldesmon 1
increases expression
ISO
Vincristine results in increased expression of CALD1 mRNA
CTD
PMID:23649840
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Calm2
calmodulin 2
decreases expression
ISO
Vincristine results in decreased expression of CALM2 mRNA
CTD
PMID:23649840
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Calu
calumenin
increases expression
ISO
Vincristine results in increased expression of CALU mRNA
CTD
PMID:23649840
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
decreases expression
ISO
Vincristine results in decreased expression of CAMK2D mRNA
CTD
PMID:23649840
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Camkk1
calcium/calmodulin-dependent protein kinase kinase 1
increases response to substance
ISO
CAMKK1 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498
G
Capg
capping actin protein, gelsolin like
increases expression
ISO
Vincristine results in increased expression of CAPG mRNA
CTD
PMID:23649840
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
Vincristine results in decreased expression of CARHSP1 mRNA
CTD
PMID:23649840
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Casp1
caspase 1
increases expression
ISO
Vincristine results in increased expression of CASP1 mRNA
CTD
PMID:23649840
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases cleavage multiple interactions increases expression
EXP ISO
Vincristine results in increased cleavage of CASP3 protein KN 93 inhibits the reaction [Vincristine results in increased cleavage of CASP3 protein] coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [Vincristine results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Vincristine results in increased expression of CASP3 protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of CASP3 mRNA]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of CASP3 protein] Vincristine results in increased expression of CASP3 mRNA; Vincristine results in increased expression of CASP3 protein
CTD
PMID:20624997 PMID:29958920 PMID:33038355 PMID:34286406 PMID:34939713 PMID:36808657 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
ISO
Vincristine results in increased expression of CASP6 mRNA
CTD
PMID:16001973
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
increases expression increases response to substance multiple interactions
ISO
Vincristine results in increased expression of CASP8 mRNA CASP8 protein results in increased susceptibility to Vincristine Vincristine results in increased expression of and results in increased cleavage of CASP8 protein
CTD
PMID:16001973 PMID:22010212
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
affects response to substance decreases activity decreases expression multiple interactions
ISO EXP
CAT protein affects the susceptibility to Vincristine Vincristine results in decreased activity of CAT protein Vincristine results in decreased expression of CAT protein Quercetin inhibits the reaction [Vincristine results in decreased activity of CAT protein]; tetrahydrocurcumin inhibits the reaction [Vincristine results in decreased expression of CAT protein]; Vincristine inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; Vincristine inhibits the reaction [Isoproterenol results in decreased expression of CAT protein]
CTD
PMID:11178967 PMID:24201307 PMID:25537132 PMID:26102012 PMID:36808657
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbx3
chromobox 3
decreases expression
ISO
Vincristine results in decreased expression of CBX3 mRNA
CTD
PMID:23649840
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
G
Cbx5
chromobox 5
decreases expression
ISO
Vincristine results in decreased expression of CBX5 mRNA
CTD
PMID:23649840
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
G
Ccar1
cell division cycle and apoptosis regulator 1
decreases expression
ISO
Vincristine results in decreased expression of CCAR1 mRNA
CTD
PMID:23649840
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
G
Ccdc12
coiled-coil domain containing 12
decreases expression
ISO
Vincristine results in decreased expression of CCDC12 mRNA
CTD
PMID:23649840
NCBI chr 8:110,635,276...110,686,417
Ensembl chr 8:110,635,710...110,686,417
G
Ccdc186
coiled-coil domain containing 186
decreases expression
ISO
Vincristine results in decreased expression of CCDC186 mRNA
CTD
PMID:23649840
NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935
G
Ccdc198
coiled-coil domain containing 198
decreases expression
ISO
Vincristine results in decreased expression of CCDC198 mRNA
CTD
PMID:23649840
NCBI chr15:22,500,181...22,527,011
Ensembl chr15:22,502,687...22,526,992
G
Ccdc32
coiled-coil domain containing 32
decreases expression
ISO
Vincristine results in decreased expression of CCDC32 mRNA
CTD
PMID:23649840
NCBI chr 3:105,998,429...106,010,985
Ensembl chr 3:105,998,430...106,010,975
G
Ccdc82
coiled-coil domain containing 82
increases expression
ISO
Vincristine results in increased expression of CCDC82 mRNA
CTD
PMID:23649840
NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963
G
Cchcr1
coiled-coil alpha-helical rod protein 1
decreases expression
ISO
Vincristine results in decreased expression of CCHCR1 mRNA
CTD
PMID:23649840
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
G
Ccl1
C-C motif chemokine ligand 1
increases expression
ISO
Vincristine results in increased expression of CCL1 mRNA
CTD
PMID:23649840
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO EXP
Vincristine results in increased expression of CCL2 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Vincristine results in increased expression of CCL20 mRNA
CTD
PMID:23649840
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
increases expression
ISO
Vincristine results in increased expression of CCL22 mRNA
CTD
PMID:23649840
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
Vincristine results in increased expression of CCL4 mRNA
CTD
PMID:23649840
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
Vincristine results in increased expression of CCL5 mRNA
CTD
PMID:23649840
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn2
cellular communication network factor 2
decreases response to substance
ISO
CCN2 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:24154679
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccnb1
cyclin B1
affects response to substance increases expression
ISO
CCNB1 protein affects the susceptibility to Vincristine Vincristine results in increased expression of CCNB1 mRNA
CTD
PMID:22178383 PMID:23649840
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
increases expression
ISO
Vincristine results in increased expression of CCNB2 mRNA
CTD
PMID:23649840
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
decreases expression
ISO
Vincristine results in decreased expression of CCNE1 mRNA
CTD
PMID:23649840
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
decreases expression
ISO
Vincristine results in decreased expression of CCNE2 mRNA
CTD
PMID:23649840
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccnl1
cyclin L1
decreases expression
ISO
Vincristine results in decreased expression of CCNL1 mRNA
CTD
PMID:23649840
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Cd109
CD109 molecule
increases expression
ISO
Vincristine results in increased expression of CD109 mRNA
CTD
PMID:23649840
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
G
Cd14
CD14 molecule
increases expression
EXP
Vincristine results in increased expression of CD14 mRNA
CTD
PMID:20624997
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd200
Cd200 molecule
increases expression
ISO
Vincristine results in increased expression of CD200 mRNA
CTD
PMID:23649840
NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648
G
Cd274
CD274 molecule
increases expression
ISO
Vincristine results in increased expression of CD274 mRNA
CTD
PMID:23649840
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd36
CD36 molecule
increases expression
EXP
Vincristine results in increased expression of CD36 mRNA
CTD
PMID:20624997
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
increases expression
ISO
Vincristine results in increased expression of CD40 mRNA
CTD
PMID:23649840
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd44
CD44 molecule
increases expression
ISO
Vincristine results in increased expression of CD44 mRNA
CTD
PMID:23649840
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd48
Cd48 molecule
increases expression
ISO
Vincristine results in increased expression of CD48 mRNA
CTD
PMID:23649840
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
Vincristine results in increased expression of CD55 mRNA
CTD
PMID:23649840
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd69
Cd69 molecule
increases expression
ISO
Vincristine results in increased expression of CD69 mRNA
CTD
PMID:23649840
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
G
Cd80
Cd80 molecule
increases expression
ISO
Vincristine results in increased expression of CD80 mRNA
CTD
PMID:23649840
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd83
CD83 molecule
increases expression
ISO
Vincristine results in increased expression of CD83 mRNA
CTD
PMID:23649840
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd86
CD86 molecule
increases expression
ISO
Vincristine results in increased expression of CD86 mRNA
CTD
PMID:23649840
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdc42ep3
CDC42 effector protein 3
increases expression
ISO
Vincristine results in increased expression of CDC42EP3 mRNA
CTD
PMID:23649840
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
G
Cdc42ep4
CDC42 effector protein 4
increases expression
ISO
Vincristine results in increased expression of CDC42EP4 mRNA
CTD
PMID:23649840
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdc42se1
CDC42 small effector 1
increases expression
ISO
Vincristine results in increased expression of CDC42SE1 mRNA
CTD
PMID:23649840
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
G
Cdc6
cell division cycle 6
decreases expression
ISO
Vincristine results in decreased expression of CDC6 mRNA
CTD
PMID:23649840
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
Vincristine results in decreased expression of CDCA3 mRNA
CTD
PMID:23649840
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca7
cell division cycle associated 7
decreases expression
ISO
Vincristine results in decreased expression of CDCA7 mRNA
CTD
PMID:23649840
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
G
Cdh1
cadherin 1
increases expression
ISO
Vincristine results in increased expression of CDH1 mRNA
CTD
PMID:23649840
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Vincristine results in decreased expression of CDK1 mRNA
CTD
PMID:23649840
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
Vincristine results in decreased expression of CDK10 mRNA
CTD
PMID:23649840
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk19
cyclin-dependent kinase 19
decreases expression
ISO
Vincristine results in decreased expression of CDK19 mRNA
CTD
PMID:23649840
NCBI chr20:43,770,409...43,910,629
Ensembl chr20:43,770,409...43,910,628
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Vincristine results in decreased expression of CDK2 mRNA
CTD
PMID:23649840
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
EXP ISO
Vincristine results in increased expression of CDKN1A mRNA [XL019 compound co-treated with Vincristine] results in increased expression of CDKN1A protein; Resveratrol inhibits the reaction [Vincristine results in increased expression of CDKN1A mRNA]
CTD
PMID:20624997 PMID:23649840 PMID:26055805 PMID:29187454
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases response to substance
ISO
CDKN2A protein results in increased susceptibility to Vincristine
CTD
PMID:16786135
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
Vincristine results in decreased expression of CDKN2C mRNA
CTD
PMID:23649840
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Ceacam1
CEA cell adhesion molecule 1
increases expression
ISO
Vincristine results in increased expression of CEACAM1 mRNA
CTD
PMID:23649840
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Vincristine results in increased expression of CEBPB mRNA
CTD
PMID:16001973
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Celf1
CUGBP, Elav-like family member 1
decreases expression
ISO
Vincristine results in decreased expression of CELF1 mRNA
CTD
PMID:23649840
NCBI chr 3:76,924,591...76,999,429
Ensembl chr 3:76,924,613...76,999,426
G
Cenpc
centromere protein C
decreases expression
ISO
Vincristine results in decreased expression of CENPC1 mRNA
CTD
PMID:23649840
NCBI chr14:21,988,067...22,046,732
Ensembl chr14:21,988,144...22,055,476
G
Cenpf
centromere protein F
decreases expression
ISO
Vincristine results in decreased expression of CENPF mRNA
CTD
PMID:23649840
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpi
centromere protein I
decreases expression
ISO
Vincristine results in decreased expression of CENPI mRNA
CTD
PMID:23649840
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
G
Cenpu
centromere protein U
decreases expression
ISO
Vincristine results in decreased expression of CENPU mRNA
CTD
PMID:23649840
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cep135
centrosomal protein 135
increases expression
ISO
Vincristine results in increased expression of CEP135 mRNA
CTD
PMID:23649840
NCBI chr14:31,530,538...31,595,812
Ensembl chr14:31,531,482...31,595,772
G
Ces5a
carboxylesterase 5A
increases expression
ISO
Vincristine results in increased expression of CES5A mRNA
CTD
PMID:23649840
NCBI chr19:11,469,431...11,499,007
Ensembl chr19:11,469,469...11,499,006
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
Vincristine results in increased expression of CFLAR mRNA
CTD
PMID:23649840
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Chd1l
chromodomain helicase DNA binding protein 1-like
increases expression
ISO
Vincristine results in increased expression of CHD1L mRNA
CTD
PMID:23649840
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
G
Chek2
checkpoint kinase 2
decreases expression
ISO
Vincristine results in decreased expression of CHEK2 mRNA
CTD
PMID:23649840
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Chm
CHM Rab escort protein
increases expression
ISO
Vincristine results in increased expression of CHM mRNA
CTD
PMID:23649840
NCBI chr X:78,203,200...78,361,996
Ensembl chr X:78,203,204...78,361,943
G
Chml
CHM like Rab escort protein
decreases expression
ISO
Vincristine results in decreased expression of CHML mRNA
CTD
PMID:23649840
NCBI chr13:87,609,647...87,619,868
Ensembl chr13:87,589,298...87,619,862
G
Chtf18
chromosome transmission fidelity factor 18
decreases expression
ISO
Vincristine results in decreased expression of CHTF18 mRNA
CTD
PMID:23649840
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Ciapin1
cytokine induced apoptosis inhibitor 1
decreases response to substance
ISO
CIAPIN1 protein results in decreased susceptibility to Vincristine
CTD
PMID:18389626
NCBI chr19:10,179,963...10,195,511
Ensembl chr19:10,180,100...10,195,503
G
Cirbp
cold inducible RNA binding protein
decreases expression
ISO
Vincristine results in decreased expression of CIRBP mRNA
CTD
PMID:23649840
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
G
Clasp2
cytoplasmic linker associated protein 2
increases expression
ISO
Vincristine results in increased expression of CLASP2 mRNA
CTD
PMID:23649840
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
G
Clec2d
C-type lectin domain family 2, member D
decreases expression
ISO
Vincristine results in decreased expression of CLEC2D mRNA
CTD
PMID:23649840
NCBI chr 4:162,216,052...162,239,530
Ensembl chr 4:162,216,572...162,239,527
G
Clic2
chloride intracellular channel 2
increases expression
ISO
Vincristine results in increased expression of CLIC2 mRNA
CTD
PMID:23649840
NCBI chr20:149,337...164,375
Ensembl chr20:148,907...164,355
G
Clspn
claspin
decreases expression
ISO
Vincristine results in decreased expression of CLSPN mRNA
CTD
PMID:23649840
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Cnksr2
connector enhancer of kinase suppressor of Ras 2
decreases expression
ISO
Vincristine results in decreased expression of CNKSR2 mRNA
CTD
PMID:23649840
NCBI chr X:36,908,135...37,148,337
Ensembl chr X:36,907,850...37,150,555
G
Cnot3
CCR4-NOT transcription complex, subunit 3
decreases expression
ISO
Vincristine results in decreased expression of CNOT3 mRNA
CTD
PMID:23649840
NCBI chr 1:65,555,924...65,572,167
Ensembl chr 1:65,555,924...65,572,167
G
Cnot6l
CCR4-NOT transcription complex, subunit 6-like
decreases expression
ISO
Vincristine results in decreased expression of CNOT6L mRNA
CTD
PMID:23649840
NCBI chr14:13,410,499...13,502,511
Ensembl chr14:13,411,281...13,498,203
G
Cntln
centlein
decreases expression
ISO
Vincristine results in decreased expression of CNTLN mRNA
CTD
PMID:23649840
NCBI chr 5:99,295,865...99,576,402
Ensembl chr 5:99,296,000...99,576,396
G
Col15a1
collagen type XV alpha 1 chain
decreases response to substance
ISO
COL15A1 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
G
Col1a2
collagen type I alpha 2 chain
increases response to substance
ISO
COL1A2 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases response to substance
ISO
COL3A1 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col5a2
collagen type V alpha 2 chain
decreases response to substance
ISO
COL5A2 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Comtd1
catechol-O-methyltransferase domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of COMTD1 mRNA
CTD
PMID:23649840
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
G
Cp
ceruloplasmin
increases expression
EXP
Vincristine results in increased expression of CP mRNA
CTD
PMID:20624997
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpeb2
cytoplasmic polyadenylation element binding protein 2
increases expression
ISO
Vincristine results in increased expression of CPEB2 mRNA
CTD
PMID:23649840
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
G
Cpne3
copine 3
decreases expression
ISO
Vincristine results in decreased expression of CPNE3 mRNA
CTD
PMID:23649840
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Cpsf6
cleavage and polyadenylation specific factor 6
decreases expression
ISO
Vincristine results in decreased expression of CPSF6 mRNA
CTD
PMID:23649840
NCBI chr 7:52,956,589...53,001,783
Ensembl chr 7:52,956,589...52,988,122
G
Crebbp
CREB binding protein
increases expression
ISO
Vincristine results in increased expression of CREBBP mRNA
CTD
PMID:23649840
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
Vincristine results in increased expression of CREBRF mRNA
CTD
PMID:23649840
NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999
G
Crebzf
CREB/ATF bZIP transcription factor
decreases expression
ISO
Vincristine results in decreased expression of CREBZF mRNA
CTD
PMID:23649840
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Crtap
cartilage associated protein
decreases expression
ISO
Vincristine results in decreased expression of CRTAP mRNA
CTD
PMID:23649840
NCBI chr 8:114,047,929...114,067,636
Ensembl chr 8:114,047,933...114,067,631
G
Crtc3
CREB regulated transcription coactivator 3
increases expression
ISO
Vincristine results in increased expression of CRTC3 mRNA
CTD
PMID:23649840
NCBI chr 1:134,552,830...134,655,929
Ensembl chr 1:134,554,696...134,655,500
G
Csad
cysteine sulfinic acid decarboxylase
decreases expression
ISO
Vincristine results in decreased expression of CSAD mRNA
CTD
PMID:23649840
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csf2
colony stimulating factor 2
increases expression
ISO
Vincristine results in increased expression of CSF2 mRNA
CTD
PMID:23649840
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csnk1a1
casein kinase 1, alpha 1
increases expression
ISO
Vincristine results in increased expression of CSNK1A1 mRNA
CTD
PMID:23649840
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
G
Csnk1g1
casein kinase 1, gamma 1
increases expression
ISO
Vincristine results in increased expression of CSNK1G1 mRNA
CTD
PMID:23649840
NCBI chr 8:66,439,760...66,577,247
Ensembl chr 8:66,439,864...66,572,826
G
Csta
cystatin A
increases expression
ISO
Vincristine results in increased expression of CSTA mRNA
CTD
PMID:23649840
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
G
Cstf1
cleavage stimulation factor subunit 1
decreases expression
ISO
Vincristine results in decreased expression of CSTF1 mRNA
CTD
PMID:23649840
NCBI chr 3:161,144,522...161,156,294
Ensembl chr 3:161,144,548...161,156,300
G
Ctc1
CST telomere replication complex component 1
decreases expression
ISO
Vincristine results in decreased expression of CTC1 mRNA
CTD
PMID:23649840
NCBI chr10:53,714,614...53,735,298
Ensembl chr10:53,714,644...53,735,298
G
Cth
cystathionine gamma-lyase
increases expression
ISO
Vincristine results in increased expression of CTH mRNA
CTD
PMID:23649840
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnnal1
catenin alpha-like 1
decreases expression
ISO
Vincristine results in decreased expression of CTNNAL1 mRNA
CTD
PMID:23649840
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
G
Ctnnb1
catenin beta 1
increases expression decreases response to substance
ISO
Vincristine results in increased expression of CTNNB1 mRNA CTNNB1 results in decreased susceptibility to Vincristine
CTD
PMID:22000491 PMID:23649840
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cul4a
cullin 4A
increases expression
ISO
Vincristine results in increased expression of CUL4A mRNA
CTD
PMID:23649840
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
Vincristine results in increased expression of CXCL10 mRNA
CTD
PMID:23649840
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
increases expression
ISO
Vincristine results in increased expression of CXCL11 mRNA
CTD
PMID:23649840
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl12
C-X-C motif chemokine ligand 12
increases expression multiple interactions
ISO
Vincristine results in increased expression of CXCL12 mRNA KN 93 inhibits the reaction [Vincristine results in increased expression of CXCL12 mRNA]
CTD
PMID:34286406
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl9
C-X-C motif chemokine ligand 9
increases expression
ISO
Vincristine results in increased expression of CXCL9 mRNA
CTD
PMID:23649840
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyld
CYLD lysine 63 deubiquitinase
increases expression
ISO
Vincristine results in increased expression of CYLD mRNA
CTD
PMID:23649840
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
increases response to substance
ISO
CYP2C9 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases response to substance
ISO
CYP2C8 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases metabolic processing
ISO
CYP3A4 protein results in increased metabolism of Vincristine
CTD
PMID:19346885
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions increases metabolic processing
ISO
[CYP3A5 gene polymorphism results in increased activity of CYP3A5 protein] which results in increased metabolism of Vincristine CYP3A5 protein results in increased metabolism of Vincristine
CTD
PMID:21225912
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
increases expression
ISO
Vincristine results in increased expression of CYP4F3 mRNA
CTD
PMID:23649840
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
G
Cyp4v3
cytochrome P450, family 4, subfamily v, polypeptide 3
decreases expression
ISO
Vincristine results in decreased expression of CYP4V2 mRNA
CTD
PMID:23649840
NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395
G
Cysltr1
cysteinyl leukotriene receptor 1
decreases expression
ISO
Vincristine results in decreased expression of CYSLTR1 mRNA
CTD
PMID:23649840
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Daam1
dishevelled associated activator of morphogenesis 1
increases expression
ISO
Vincristine results in increased expression of DAAM1 mRNA
CTD
PMID:23649840
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
G
Dcaf8
DDB1 and CUL4 associated factor 8
increases expression
ISO
Vincristine results in increased expression of DCAF8 mRNA
CTD
PMID:23649840
NCBI chr13:84,609,838...84,667,025
Ensembl chr13:84,610,248...84,669,726
G
Dcn
decorin
decreases response to substance
ISO
DCN mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Dcun1d1
defective in cullin neddylation 1 domain containing 1
increases expression
ISO
Vincristine results in increased expression of DCUN1D1 mRNA
CTD
PMID:23649840
NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602
G
Dcun1d4
defective in cullin neddylation 1 domain containing 4
decreases expression
ISO
Vincristine results in decreased expression of DCUN1D4 mRNA
CTD
PMID:23649840
NCBI chr14:34,652,723...34,733,122
Ensembl chr14:34,652,723...34,733,207
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Vincristine results in increased expression of DDIT3 mRNA
CTD
PMID:23649840
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddx50
DExD-box helicase 50
increases expression
ISO
Vincristine results in increased expression of DDX50 mRNA
CTD
PMID:23649840
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
G
Ddx52
DExD-box helicase 52
increases expression
ISO
Vincristine results in increased expression of DDX52 mRNA
CTD
PMID:23649840
NCBI chr10:68,824,594...68,847,400
Ensembl chr10:68,824,645...68,848,266
G
Ddx60
DEXD/H-box helicase 60
increases expression
ISO
Vincristine results in increased expression of DDX60 mRNA
CTD
PMID:23649840
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dennd5a
DENN domain containing 5A
increases expression
ISO
Vincristine results in increased expression of DENND5A mRNA
CTD
PMID:23649840
NCBI chr 1:163,928,183...163,994,207
Ensembl chr 1:163,928,183...163,994,316
G
Dgcr8
DGCR8 microprocessor complex subunit
decreases expression
ISO
Vincristine results in decreased expression of DGCR8 mRNA
CTD
PMID:23649840
NCBI chr11:82,704,673...82,737,251
Ensembl chr11:82,704,729...82,737,242
G
Dhfr
dihydrofolate reductase
decreases expression
ISO
Vincristine results in decreased expression of DHFR mRNA
CTD
PMID:23649840
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Dhrs11
dehydrogenase/reductase 11
decreases expression
ISO
Vincristine results in decreased expression of DHRS11 mRNA
CTD
PMID:23649840
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
G
Dhrs2
dehydrogenase/reductase 2
increases expression
ISO
Vincristine results in increased expression of DHRS2 mRNA
CTD
PMID:23649840
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
G
Dhrs7
dehydrogenase/reductase 7
increases expression
ISO
Vincristine results in increased expression of DHRS7 mRNA
CTD
PMID:23649840
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Diablo
diablo, IAP-binding mitochondrial protein
decreases expression
ISO
Vincristine results in decreased expression of DIABLO mRNA
CTD
PMID:23649840
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dido1
death inducer-obliterator 1
decreases expression
ISO
Vincristine results in decreased expression of DIDO1 mRNA
CTD
PMID:23649840
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
G
Dip2a
disco-interacting protein 2 homolog A
increases expression
ISO
Vincristine results in increased expression of DIP2A mRNA
CTD
PMID:23649840
NCBI chr20:12,284,566...12,371,068
Ensembl chr20:12,284,654...12,370,217
G
Dmd
dystrophin
increases expression
ISO
Vincristine results in increased expression of DMD mRNA
CTD
PMID:23649840
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
Vincristine results in decreased expression of DNAJB1 mRNA
CTD
PMID:23649840
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajc7
DnaJ heat shock protein family (Hsp40) member C7
increases expression
ISO
Vincristine results in increased expression of DNAJC7 mRNA
CTD
PMID:23649840
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
G
Dnase1l3
deoxyribonuclease 1-like 3
decreases expression
ISO
Vincristine results in decreased expression of DNASE1L3 mRNA
CTD
PMID:23649840
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Dnmbp
dynamin binding protein
decreases expression
ISO
Vincristine results in decreased expression of DNMBP mRNA
CTD
PMID:23649840
NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:242,736,189...242,802,604
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
Vincristine results in increased expression of DOCK4 mRNA
CTD
PMID:23649840
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
G
Dock8
dedicator of cytokinesis 8
decreases expression
ISO
Vincristine results in decreased expression of DOCK8 mRNA
CTD
PMID:23649840
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
G
Dok4
docking protein 4
increases expression
ISO
Vincristine results in increased expression of DOK4 mRNA
CTD
PMID:23649840
NCBI chr19:10,146,520...10,157,187
Ensembl chr19:10,146,474...10,158,203
G
Donson
DNA replication fork stabilization factor DONSON
decreases expression
ISO
Vincristine results in decreased expression of DONSON mRNA
CTD
PMID:23649840
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dpp4
dipeptidylpeptidase 4
decreases expression
ISO
Vincristine results in decreased expression of DPP4 mRNA
CTD
PMID:23649840
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Dpyd
dihydropyrimidine dehydrogenase
increases response to substance
ISO
DPYD gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20864405
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dram1
DNA-damage regulated autophagy modulator 1
increases expression
ISO
Vincristine results in increased expression of DRAM1 mRNA
CTD
PMID:23649840
NCBI chr 7:22,742,794...22,776,888
Ensembl chr 7:22,742,849...22,776,765
G
Dtl
denticleless E3 ubiquitin protein ligase homolog
decreases expression
ISO
Vincristine results in decreased expression of DTL mRNA
CTD
PMID:23649840
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Vincristine results in increased expression of DUSP1 mRNA
CTD
PMID:23649840
NCBI chr10:16,680,478...16,683,275
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Vincristine results in increased expression of DUSP10 mRNA
CTD
PMID:23649840
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
Vincristine results in increased expression of DUSP16 mRNA
CTD
PMID:23649840
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp2
dual specificity phosphatase 2
increases expression
ISO
Vincristine results in increased expression of DUSP2 mRNA
CTD
PMID:23649840
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
Vincristine results in increased expression of DUSP4 mRNA
CTD
PMID:23649840
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dynlt2
dynein light chain Tctex-type 2
decreases expression
ISO
Vincristine results in decreased expression of DYNLT2 mRNA
CTD
PMID:23649840
NCBI chr 1:55,971,285...55,983,249
Ensembl chr 1:55,971,283...55,983,307
G
E2f8
E2F transcription factor 8
decreases expression
ISO
Vincristine results in decreased expression of E2F8 mRNA
CTD
PMID:23649840
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Ebf1
EBF transcription factor 1
increases expression
ISO
Vincristine results in increased expression of EBF1 mRNA
CTD
PMID:23649840
NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665
G
Ednrb
endothelin receptor type B
increases expression
EXP
Vincristine results in increased expression of EDNRB mRNA
CTD
PMID:20624997
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Efna4
ephrin A4
decreases expression
ISO
Vincristine results in decreased expression of EFNA4 mRNA
CTD
PMID:23649840
NCBI chr 2:174,748,729...174,752,979
Ensembl chr 2:174,748,724...174,752,979
G
Egfl6
EGF-like-domain, multiple 6
decreases response to substance
ISO
EGFL6 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
G
Egr1
early growth response 1
increases expression
ISO
Vincristine results in increased expression of EGR1 mRNA
CTD
PMID:12706485 PMID:23649840
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr3
early growth response 3
increases expression
ISO
Vincristine results in increased expression of EGR3 mRNA
CTD
PMID:23649840
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehbp1l1
EH domain binding protein 1-like 1
decreases expression
ISO
Vincristine results in decreased expression of EHBP1L1 mRNA
CTD
PMID:23649840
NCBI chr 1:202,994,115...203,014,320
Ensembl chr 1:202,994,118...203,014,270
G
Eif1
eukaryotic translation initiation factor 1
decreases expression
ISO
Vincristine results in decreased expression of EIF1 mRNA
CTD
PMID:23649840
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
G
Eif1ad
eukaryotic translation initiation factor 1A domain containing
decreases expression
ISO
Vincristine results in decreased expression of EIF1AD mRNA
CTD
PMID:23649840
NCBI chr 1:202,674,362...202,679,662
Ensembl chr 1:202,674,185...202,679,658
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression multiple interactions
EXP
Vincristine results in increased expression of EIF2AK3 mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of EIF2AK3 mRNA]
CTD
PMID:33038355
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif3b
eukaryotic translation initiation factor 3, subunit B
decreases expression
ISO
Vincristine results in decreased expression of EIF3B mRNA
CTD
PMID:23649840
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
increases expression
ISO
Vincristine results in increased expression of EIF3M mRNA
CTD
PMID:23649840
NCBI chr 3:91,424,754...91,442,358
Ensembl chr 3:91,416,325...91,442,392
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
ISO
Vincristine results in increased expression of EIF4A1 mRNA
CTD
PMID:23649840
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Eif4a2
eukaryotic translation initiation factor 4A2
decreases expression
ISO
Vincristine results in decreased expression of EIF4A2 mRNA
CTD
PMID:23649840
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
G
Elf3
E74 like ETS transcription factor 3
increases expression
ISO
Vincristine results in increased expression of ELF3 mRNA
CTD
PMID:23649840
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Elk3
ETS transcription factor ELK3
increases expression
ISO
Vincristine results in increased expression of ELK3 mRNA
CTD
PMID:23649840
NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084
G
Eme2
essential meiotic structure-specific endonuclease subunit 2
decreases expression
ISO
Vincristine results in decreased expression of EME2 mRNA
CTD
PMID:23649840
NCBI chr10:13,913,216...13,915,991
Ensembl chr10:13,913,221...13,915,968
G
Eml6
EMAP like 6
decreases expression
ISO
Vincristine results in decreased expression of EML6 mRNA
CTD
PMID:23649840
NCBI chr14:103,471,537...103,806,120
Ensembl chr14:103,476,372...103,805,849
G
Enox1
ecto-NOX disulfide-thiol exchanger 1
increases expression
ISO
Vincristine results in increased expression of ENOX1 mRNA
CTD
PMID:23649840
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases expression
ISO
Vincristine results in increased expression of ENPP2 mRNA
CTD
PMID:23649840
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Ensa
endosulfine alpha
decreases expression
ISO
Vincristine results in decreased expression of ENSA mRNA
CTD
PMID:23649840
NCBI chr 2:183,185,552...183,192,888
Ensembl chr 2:183,185,552...183,194,847
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
increases expression
ISO
Vincristine results in increased expression of ENTPD2 mRNA
CTD
PMID:23649840
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
G
Eomes
eomesodermin
decreases expression
ISO
Vincristine results in decreased expression of EOMES mRNA
CTD
PMID:23649840
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
G
Epg5
ectopic P-granules 5 autophagy tethering factor
increases expression
ISO
Vincristine results in increased expression of EPG5 mRNA
CTD
PMID:23649840
NCBI chr18:71,403,990...71,502,079
Ensembl chr18:71,404,010...71,501,502
G
Ephb1
Eph receptor B1
decreases expression
ISO
Vincristine results in decreased expression of EPHB1 mRNA
CTD
PMID:23649840
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
G
Ephx1
epoxide hydrolase 1
decreases expression
ISO
Vincristine results in decreased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epm2aip1
EPM2A interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of EPM2AIP1 mRNA
CTD
PMID:23649840
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
G
Epor
erythropoietin receptor
decreases expression
ISO
Vincristine results in decreased expression of EPOR mRNA
CTD
PMID:23649840
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
EXP
Vincristine results in increased expression of EPRS1 mRNA
CTD
PMID:20624997
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Epsti1
epithelial stromal interaction 1
increases expression
ISO
Vincristine results in increased expression of EPSTI1 mRNA
CTD
PMID:23649840
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
G
Erich3
glutamate-rich 3
decreases expression
ISO
Vincristine results in decreased expression of ERICH3 mRNA
CTD
PMID:23649840
NCBI chr 2:243,615,777...243,717,973
Ensembl chr 2:243,615,872...243,715,317
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression multiple interactions
EXP
Vincristine results in increased expression of ERN1 mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of ERN1 mRNA]
CTD
PMID:33038355
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
decreases expression
ISO
Vincristine results in decreased expression of ESCO2 mRNA
CTD
PMID:23649840
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esd
esterase D
decreases expression
ISO
Vincristine results in decreased expression of ESD mRNA
CTD
PMID:23649840
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Esm1
endothelial cell-specific molecule 1
decreases expression
EXP
Vincristine results in decreased expression of ESM1 mRNA
CTD
PMID:20624997
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Esr1
estrogen receptor 1
multiple interactions decreases expression
ISO
bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR1 mRNA]; bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR1 protein]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR1 mRNA]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR1 protein]; Vincristine binds to and results in decreased activity of ESR1 protein Vincristine results in decreased expression of ESR1 mRNA; Vincristine results in decreased expression of ESR1 protein
CTD
PMID:25752796 PMID:35263089
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions decreases expression
ISO
bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR2 mRNA]; bisphenol A inhibits the reaction [Vincristine results in decreased expression of ESR2 protein]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR2 mRNA]; Diethylhexyl Phthalate inhibits the reaction [Vincristine results in decreased expression of ESR2 protein] Vincristine results in decreased expression of ESR2 mRNA; Vincristine results in decreased expression of ESR2 protein
CTD
PMID:35263089
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Evc
EvC ciliary complex subunit 1
increases expression
ISO
Vincristine results in increased expression of EVC mRNA
CTD
PMID:23649840
NCBI chr14:73,456,181...73,498,955
Ensembl chr14:73,456,222...73,498,099
G
Exo1
exonuclease 1
decreases expression
ISO
Vincristine results in decreased expression of EXO1 mRNA
CTD
PMID:23649840
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Exog
exo/endonuclease G
decreases expression
ISO
Vincristine results in decreased expression of EXOG mRNA
CTD
PMID:23649840
NCBI chr 8:119,184,974...119,204,819
Ensembl chr 8:119,185,136...119,204,672
G
Ext1
exostosin glycosyltransferase 1
increases expression
ISO
Vincristine results in increased expression of EXT1 mRNA
CTD
PMID:23649840
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
G
F2
coagulation factor II, thrombin
affects expression
ISO
Vincristine affects the expression of F2 protein
CTD
PMID:12542493
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
F3
coagulation factor III, tissue factor
increases expression
ISO EXP
Vincristine results in increased expression of F3 mRNA; Vincristine results in increased expression of F3 protein
CTD
PMID:12542493 PMID:20624997
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fam13b
family with sequence similarity 13, member B
increases expression
ISO
Vincristine results in increased expression of FAM13B mRNA
CTD
PMID:23649840
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
G
Fam13c
family with sequence similarity 13, member C
increases expression
ISO
Vincristine results in increased expression of FAM13C mRNA
CTD
PMID:23649840
NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592
G
Fam171b
family with sequence similarity 171, member B
decreases expression
ISO
Vincristine results in decreased expression of FAM171B mRNA
CTD
PMID:23649840
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
G
Fam174a
family with sequence similarity 174, member A
increases expression
ISO
Vincristine results in increased expression of FAM174A mRNA
CTD
PMID:23649840
NCBI chr 9:95,742,815...95,761,083
Ensembl chr 9:95,742,927...95,761,081
G
Fam76b
family with sequence similarity 76, member B
decreases expression
ISO
Vincristine results in decreased expression of FAM76B mRNA
CTD
PMID:23649840
NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861
G
Fam81a
family with sequence similarity 81, member A
decreases expression
ISO
Vincristine results in decreased expression of FAM81A mRNA
CTD
PMID:23649840
NCBI chr 8:70,762,852...70,821,898
Ensembl chr 8:70,763,614...70,821,875
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
Vincristine results in decreased expression of FAM83D mRNA
CTD
PMID:23649840
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fancf
FA complementation group F
decreases expression
ISO
Vincristine results in decreased expression of FANCF mRNA
CTD
PMID:23649840
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
G
Fancg
FA complementation group G
decreases expression
ISO
Vincristine results in decreased expression of FANCG mRNA
CTD
PMID:23649840
NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029
G
Fas
Fas cell surface death receptor
increases expression
ISO
Vincristine results in increased expression of FAS mRNA
CTD
PMID:23649840
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
increases expression
ISO
Vincristine results in increased expression of FASLG protein
CTD
PMID:11716366
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fastkd2
FAST kinase domains 2
decreases expression
ISO
Vincristine results in decreased expression of FASTKD2 mRNA
CTD
PMID:23649840
NCBI chr 9:65,166,148...65,188,184
Ensembl chr 9:65,168,228...65,188,174
G
Fbxl20
F-box and leucine-rich repeat protein 20
decreases expression
ISO
Vincristine results in decreased expression of FBXL20 mRNA
CTD
PMID:23649840
NCBI chr10:83,080,568...83,143,680
Ensembl chr10:83,086,551...83,144,162
G
Fbxl4
F-box and leucine-rich repeat protein 4
decreases expression
ISO
Vincristine results in decreased expression of FBXL4 mRNA
CTD
PMID:23649840
NCBI chr 5:35,955,801...36,029,446
Ensembl chr 5:35,955,812...36,029,443
G
Fbxo33
F-box protein 33
decreases expression
ISO
Vincristine results in decreased expression of FBXO33 mRNA
CTD
PMID:23649840
NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
G
Fbxo5
F-box protein 5
decreases expression
ISO
Vincristine results in decreased expression of FBXO5 mRNA
CTD
PMID:23649840
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fbxo9
f-box protein 9
decreases expression
ISO
Vincristine results in decreased expression of FBXO9 mRNA
CTD
PMID:23649840
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fcgr2b
Fc gamma receptor 2B
increases expression
EXP
Vincristine results in increased expression of FCGR2B mRNA
CTD
PMID:20624997
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
ISO
Vincristine results in increased expression of FDFT1 mRNA
CTD
PMID:23649840
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fermt2
FERM domain containing kindlin 2
increases expression
ISO
Vincristine results in increased expression of FERMT2 mRNA
CTD
PMID:23649840
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
G
Ffar2
free fatty acid receptor 2
decreases expression
ISO
Vincristine results in decreased expression of FFAR2 mRNA
CTD
PMID:23649840
NCBI chr 1:86,071,855...86,075,049
Ensembl chr 1:86,072,184...86,075,033
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Vincristine results in decreased expression of FGR mRNA
CTD
PMID:23649840
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Flot2
flotillin 2
decreases expression
ISO
Vincristine results in decreased expression of FLOT2 mRNA
CTD
PMID:23649840
NCBI chr10:62,926,047...62,947,759
Ensembl chr10:62,920,665...62,947,756
G
Flt1
Fms related receptor tyrosine kinase 1
decreases expression
ISO
Vincristine results in decreased expression of FLT1 mRNA
CTD
PMID:23649840
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fmnl3
formin-like 3
increases expression
ISO
Vincristine results in increased expression of FMNL3 mRNA
CTD
PMID:23649840
NCBI chr 7:130,454,270...130,505,626
Ensembl chr 7:130,454,275...130,505,626
G
Fnbp1
formin binding protein 1
increases expression
ISO
Vincristine results in increased expression of FNBP1 mRNA
CTD
PMID:23649840
NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881
G
Fnbp4
formin binding protein 4
increases expression
ISO
Vincristine results in increased expression of FNBP4 mRNA
CTD
PMID:23649840
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Vincristine results in increased expression of FOS protein
CTD
PMID:18930597
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
ISO
Vincristine results in increased expression of FOSL2 mRNA
CTD
PMID:23649840
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxk2
forkhead box K2
decreases expression
ISO
Vincristine results in decreased expression of FOXK2 mRNA
CTD
PMID:23649840
NCBI chr10:106,542,643...106,592,569
Ensembl chr10:106,542,566...106,592,563
G
Foxo1
forkhead box O1
multiple interactions decreases expression
EXP
Quercetin inhibits the reaction [Vincristine results in decreased expression of FOXO1 mRNA]
CTD
PMID:33038355
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Foxp1
forkhead box P1
increases expression
ISO
Vincristine results in increased expression of FOXP1 mRNA
CTD
PMID:23649840
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Fry
FRY microtubule binding protein
decreases expression
ISO
Vincristine results in decreased expression of FRY mRNA
CTD
PMID:23649840
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
G
Fscn1
fascin actin-bundling protein 1
increases expression
ISO
Vincristine results in increased expression of FSCN1 mRNA
CTD
PMID:23649840
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Fsd1l
fibronectin type III and SPRY domain containing 1-like
increases expression
ISO
Vincristine results in increased expression of FSD1L mRNA
CTD
PMID:23649840
NCBI chr 5:68,258,877...68,334,931
Ensembl chr 5:68,258,932...68,334,928
G
Fubp1
far upstream element binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of FUBP1 mRNA
CTD
PMID:23649840
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fut11
fucosyltransferase 11
decreases expression
ISO
Vincristine results in decreased expression of FUT11 mRNA
CTD
PMID:23649840
NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356
G
G3bp1
G3BP stress granule assembly factor 1
increases expression
ISO
Vincristine results in increased expression of G3BP1 mRNA
CTD
PMID:23649840
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP ISO
Vincristine results in increased expression of GADD45A mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
EXP
Vincristine results in increased expression of GADD45B mRNA
CTD
PMID:20624997
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
EXP
Vincristine results in increased expression of GADD45G mRNA
CTD
PMID:20624997
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Garin1b
golgi associated RAB2 interactor 1B
increases expression
ISO
Vincristine results in increased expression of GARIN1B mRNA
CTD
PMID:23649840
NCBI chr 4:57,915,184...57,938,593
Ensembl chr 4:57,920,790...57,938,591
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
decreases expression
ISO
Vincristine results in decreased expression of GART mRNA
CTD
PMID:23649840
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gas7
growth arrest specific 7
decreases expression
EXP
Vincristine results in decreased expression of GAS7 mRNA
CTD
PMID:20624997
NCBI chr10:52,152,718...52,383,283
Ensembl chr10:52,152,493...52,383,276
G
Gbp1
guanylate binding protein 1
increases expression
ISO
Vincristine results in increased expression of GBP1 mRNA
CTD
PMID:23649840
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp2
guanylate binding protein 2
increases expression
ISO
Vincristine results in increased expression of GBP2 mRNA
CTD
PMID:23649840
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp6
guanylate binding protein family member 6
decreases expression
ISO
Vincristine results in decreased expression of GBP6 mRNA
CTD
PMID:23649840
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine
CTD
PMID:10900222
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions decreases expression
ISO
[GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine Vincristine results in decreased expression of GCLM mRNA
CTD
PMID:10900222 PMID:23649840
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Vincristine results in increased expression of GDF15 mRNA
CTD
PMID:23649840
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gfap
glial fibrillary acidic protein
increases expression multiple interactions
EXP ISO
Vincristine results in increased expression of GFAP protein Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GFAP protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of GFAP protein] Quercetin inhibits the reaction [Vincristine results in increased expression of GFAP protein]
CTD
PMID:33038355 PMID:34286406
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gfi1
growth factor independent 1 transcriptional repressor
decreases expression
ISO
Vincristine results in decreased expression of GFI1 mRNA
CTD
PMID:23649840
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
G
Gfm1
G elongation factor, mitochondrial 1
increases expression
ISO
Vincristine results in increased expression of GFM1 mRNA
CTD
PMID:23649840
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
G
Gja1
gap junction protein, alpha 1
increases expression multiple interactions
ISO
Vincristine results in increased expression of GJA1 mRNA; Vincristine results in increased expression of GJA1 protein Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; Ascorbic Acid inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; gap 27 peptide inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; gap 27 peptide inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL1B protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL6 protein]; KN 62 inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of GJA1 mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of GJA1 protein]; zinc chloride inhibits the reaction [Vincristine results in increased expression of GJA1 protein]
CTD
PMID:34286406
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjc1
gap junction protein, gamma 1
decreases expression
ISO
Vincristine results in decreased expression of GJC1 mRNA
CTD
PMID:23649840
NCBI chr10:87,758,192...87,785,443
Ensembl chr10:87,760,528...87,785,867
G
Gli1
GLI family zinc finger 1
increases response to substance
ISO
GLI1 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20864405
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
Vincristine results in increased expression of GLIPR1 mRNA
CTD
PMID:23649840
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Gmfb
glia maturation factor, beta
increases expression
ISO
Vincristine results in increased expression of GMFB mRNA
CTD
PMID:23649840
NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331
G
Gmppb
GDP-mannose pyrophosphorylase B
decreases expression
ISO
Vincristine results in decreased expression of GMPPB mRNA
CTD
PMID:23649840
NCBI chr 8:108,737,429...108,740,437
Ensembl chr 8:108,693,060...108,767,286
G
Gna15
G protein subunit alpha 15
increases expression
ISO
Vincristine results in increased expression of GNA15 mRNA
CTD
PMID:23649840
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
G
Gng2
G protein subunit gamma 2
increases expression
ISO
Vincristine results in increased expression of GNG2 mRNA
CTD
PMID:23649840
NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183
G
Gon4l
gon-4 like
increases expression
ISO
Vincristine results in increased expression of GON4L mRNA
CTD
PMID:23649840
NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
G
Gopc
golgi associated PDZ and coiled-coil motif containing
decreases expression
ISO
Vincristine results in decreased expression of GOPC mRNA
CTD
PMID:23649840
NCBI chr20:31,727,617...31,776,904
Ensembl chr20:31,727,620...31,776,903
G
Gpatch11
G patch domain containing 11
decreases expression
ISO
Vincristine results in decreased expression of GPATCH11 mRNA
CTD
PMID:23649840
NCBI chr 6:16,229,933...16,243,305
Ensembl chr 6:16,233,059...16,243,238
G
Gpatch2
G patch domain containing 2
increases expression
ISO
Vincristine results in increased expression of GPATCH2 mRNA
CTD
PMID:23649840
NCBI chr13:98,784,993...98,925,696
Ensembl chr13:98,784,969...98,925,661
G
Gpatch2l
G patch domain containing 2-like
increases expression
ISO
Vincristine results in increased expression of GPATCH2L mRNA
CTD
PMID:23649840
NCBI chr 6:105,883,383...105,935,644
Ensembl chr 6:105,883,460...105,934,888
G
Gpbp1l1
GC-rich promoter binding protein 1-like 1
increases expression
ISO
Vincristine results in increased expression of GPBP1L1 mRNA
CTD
PMID:23649840
NCBI chr 5:130,009,768...130,050,636
Ensembl chr 5:130,023,137...130,050,459
G
Gpc3
glypican 3
increases response to substance
ISO
GPC3 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
decreases expression
ISO
Vincristine results in decreased expression of GPD2 mRNA
CTD
PMID:23649840
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
G
Gpnmb
glycoprotein nmb
increases expression
ISO
Vincristine results in increased expression of GPNMB mRNA
CTD
PMID:23649840
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr132
G protein-coupled receptor 132
increases expression
ISO
Vincristine results in increased expression of GPR132 mRNA
CTD
PMID:23649840
NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:131,924,160...131,942,168
G
Gpr137b
G protein-coupled receptor 137B
increases expression
ISO
Vincristine results in increased expression of GPR137B mRNA
CTD
PMID:23649840
NCBI chr17:86,003,635...86,041,841
Ensembl chr17:85,966,921...86,041,835
G
Gpr180
G protein-coupled receptor 180
decreases expression
ISO
Vincristine results in decreased expression of GPR180 mRNA
CTD
PMID:23649840
NCBI chr15:95,195,782...95,224,955
Ensembl chr15:95,199,777...95,228,373
G
Gpr55
G protein-coupled receptor 55
increases expression
ISO
Vincristine results in increased expression of GPR55 mRNA
CTD
PMID:23649840
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
G
Gpr63
G protein-coupled receptor 63
decreases expression
ISO
Vincristine results in decreased expression of GPR63 mRNA
CTD
PMID:23649840
NCBI chr 5:38,672,548...38,727,224
Ensembl chr 5:38,635,472...38,727,677
G
Gpr84
G protein-coupled receptor 84
increases expression
ISO
Vincristine results in increased expression of GPR84 mRNA
CTD
PMID:23649840
NCBI chr 7:134,443,904...134,446,173
Ensembl chr 7:134,443,936...134,446,178
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases activity
EXP
Quercetin inhibits the reaction [Vincristine results in increased activity of GPT protein]
CTD
PMID:36808657
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gramd2b
GRAM domain containing 2B
increases expression
ISO
Vincristine results in increased expression of GRAMD2B mRNA
CTD
PMID:23649840
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
G
Grap2
GRB2-related adaptor protein 2
decreases expression
ISO
Vincristine results in decreased expression of GRAP2 mRNA
CTD
PMID:23649840
NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877
G
Gspt1
G1 to S phase transition 1
increases expression
ISO
Vincristine results in increased expression of GSPT1 mRNA
CTD
PMID:23649840
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
G
Gstm1
glutathione S-transferase mu 1
affects response to substance decreases response to substance multiple interactions
ISO
GSTM1 gene polymorphism affects the susceptibility to Vincristine GSTM1 protein results in decreased susceptibility to Vincristine Sulfinpyrazone inhibits the reaction [GSTM1 protein results in decreased susceptibility to Vincristine]
CTD
PMID:15044619 PMID:15713801
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
decreases response to substance multiple interactions
ISO
GSTP1 protein results in decreased susceptibility to Vincristine GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]
CTD
PMID:10900222
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gtf3c3
general transcription factor IIIC subunit 3
increases expression
ISO
Vincristine results in increased expression of GTF3C3 mRNA
CTD
PMID:23649840
NCBI chr 9:55,882,252...55,943,037
Ensembl chr 9:55,883,721...55,942,967
G
Gtpbp3
GTP binding protein 3
decreases expression
ISO
Vincristine results in decreased expression of GTPBP3 mRNA
CTD
PMID:23649840
NCBI chr16:18,175,766...18,180,857
Ensembl chr16:18,175,766...18,180,857
G
H2ax
H2A.X variant histone
multiple interactions
ISO
[CEP 33779 results in increased susceptibility to Vincristine] which results in increased phosphorylation of H2AX protein; [NVP-BSK805 results in increased susceptibility to Vincristine] which results in increased phosphorylation of H2AX protein
CTD
PMID:28669723
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2bc12
H2B clustered histone 12
increases expression
ISO
Vincristine results in increased expression of H2BC12 mRNA
CTD
PMID:23649840
NCBI chr17:42,485,699...42,486,162
G
H2bc6
H2B clustered histone 6
increases expression
ISO
Vincristine results in increased expression of H2BC6 mRNA
CTD
PMID:23649840
NCBI chr17:41,520,775...41,521,238
G
H4c3
H4 clustered histone 3
decreases expression
ISO
Vincristine results in decreased expression of H4C3 mRNA
CTD
PMID:23649840
G
Hamp
hepcidin antimicrobial peptide
decreases expression
ISO
Vincristine results in decreased expression of HAMP mRNA
CTD
PMID:25633564
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Haus2
HAUS augmin like complex subunit 2
decreases expression
ISO
Vincristine results in decreased expression of HAUS2 mRNA
CTD
PMID:23649840
NCBI chr 3:107,553,146...107,565,982
Ensembl chr 3:107,553,161...107,565,157
G
Hbb
hemoglobin subunit beta
decreases expression
ISO
Vincristine results in decreased expression of HBB mRNA
CTD
PMID:23649840
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
G
Hbb-b1
hemoglobin, beta adult major chain
decreases expression
ISO
Vincristine results in decreased expression of HBD mRNA
CTD
PMID:23649840
NCBI chr 1:158,224,175...158,231,675
Ensembl chr 1:158,120,200...158,252,012
G
Hdac1
histone deacetylase 1
decreases expression
EXP
Vincristine results in decreased expression of HDAC1 protein
CTD
PMID:27474498
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hdac4
histone deacetylase 4
decreases expression
EXP
Vincristine results in decreased expression of HDAC4 protein
CTD
PMID:27474498
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hdac9
histone deacetylase 9
decreases expression
ISO
Vincristine results in decreased expression of HDAC9 mRNA
CTD
PMID:23649840
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
G
Hdhd3
haloacid dehalogenase-like hydrolase domain containing 3
decreases expression
ISO
Vincristine results in decreased expression of HDHD3 mRNA
CTD
PMID:23649840
NCBI chr 5:75,951,308...75,954,775
Ensembl chr 5:75,946,013...75,955,266
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
increases expression
ISO
Vincristine results in increased expression of HECTD4 mRNA
CTD
PMID:23649840
NCBI chr12:35,182,165...35,330,935
Ensembl chr12:35,182,154...35,330,987
G
Hells
helicase, lymphoid specific
decreases expression
ISO
Vincristine results in decreased expression of HELLS mRNA
CTD
PMID:23649840
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Heph
hephaestin
increases expression
ISO
Vincristine results in increased expression of HEPH mRNA
CTD
PMID:23649840
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Hhat
hedgehog acyltransferase
increases expression
ISO
Vincristine results in increased expression of HHAT mRNA
CTD
PMID:23649840
NCBI chr13:104,024,507...104,283,580
Ensembl chr13:104,010,916...104,282,893
G
Hic1
HIC ZBTB transcriptional repressor 1
decreases expression
ISO
Vincristine results in decreased expression of HIC1 mRNA
CTD
PMID:23649840
NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475
G
Hilpda
hypoxia inducible lipid droplet-associated
decreases expression
ISO
Vincristine results in decreased expression of HILPDA mRNA
CTD
PMID:23649840
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hint1
histidine triad nucleotide binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of HINT1 mRNA
CTD
PMID:23649840
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
G
Hint3
histidine triad nucleotide binding protein 3
increases expression
ISO
Vincristine results in increased expression of HINT3 mRNA
CTD
PMID:23649840
NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721
G
Hist1h2al1
histone cluster 1 H2A family like 1
increases expression
ISO
Vincristine results in increased expression of H2AC6 mRNA
CTD
PMID:23649840
NCBI chr17:42,707,954...42,708,420
G
Hist1h2bc
histone cluster 1, H2bc
increases expression
ISO
Vincristine results in increased expression of H2BC21 mRNA
CTD
PMID:23649840
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
Vincristine results in increased expression of H2BC5 mRNA
CTD
PMID:23649840
NCBI chr17:42,792,887...42,793,268
G
Hist1h2bq
histone cluster 1 H2B family member Q
increases expression
ISO
Vincristine results in increased expression of H2BC7 mRNA
CTD
PMID:23649840
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
G
Hivep3
HIVEP zinc finger 3
increases expression
ISO
Vincristine results in increased expression of HIVEP3 mRNA
CTD
PMID:23649840
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
G
Hlf
HLF transcription factor, PAR bZIP family member
increases expression
ISO
Vincristine results in increased expression of HLF mRNA
CTD
PMID:23649840
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
G
Hmcn1
hemicentin 1
increases response to substance
ISO
HMCN1 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr13:62,615,461...63,084,524
Ensembl chr13:62,615,461...63,084,524
G
Hmga2
high mobility group AT-hook 2
decreases expression
ISO
Vincristine results in decreased expression of HMGA2 mRNA
CTD
PMID:23649840
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1
high mobility group box 1
decreases expression increases secretion decreases response to substance
EXP ISO
Vincristine results in decreased expression of HMGB1 protein Vincristine results in increased secretion of HMGB1 protein HMGB1 protein results in decreased susceptibility to Vincristine
CTD
PMID:27474498 PMID:27807322
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgn5
high mobility group nucleosome binding domain 5
decreases expression
ISO
Vincristine results in decreased expression of HMGN5 mRNA
CTD
PMID:23649840
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
G
Hmox1
heme oxygenase 1
decreases expression decreases activity multiple interactions increases expression
ISO EXP
Vincristine results in decreased expression of HMOX1 mRNA Vincristine results in decreased expression of HMOX1 protein Vincristine results in decreased activity of HMOX1 protein Quercetin inhibits the reaction [Vincristine results in decreased activity of HMOX1 protein]; Quercetin inhibits the reaction [Vincristine results in decreased expression of HMOX1 protein] Vincristine results in increased expression of HMOX1 mRNA
CTD
PMID:20624997 PMID:23649840 PMID:33038355 PMID:36808657
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
ISO
Vincristine results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:23649840
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpd
heterogeneous nuclear ribonucleoprotein D
decreases expression
ISO
Vincristine results in decreased expression of HNRNPD mRNA
CTD
PMID:23649840
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
decreases expression
ISO
Vincristine results in decreased expression of HNRNPDL mRNA
CTD
PMID:23649840
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hnrnpr
heterogeneous nuclear ribonucleoprotein R
decreases expression
ISO
Vincristine results in decreased expression of HNRNPR mRNA
CTD
PMID:23649840
NCBI chr 5:148,542,999...148,574,888
Ensembl chr 5:148,543,044...148,574,867
G
Hnrnpu
heterogeneous nuclear ribonucleoprotein U
decreases expression
ISO
Vincristine results in decreased expression of HNRNPU mRNA
CTD
PMID:23649840
NCBI chr13:90,069,058...90,086,905
Ensembl chr13:90,074,181...90,086,588
G
Hook1
hook microtubule-tethering protein 1
decreases expression
ISO
Vincristine results in decreased expression of HOOK1 mRNA
CTD
PMID:23649840
NCBI chr 5:110,824,501...110,887,791
Ensembl chr 5:110,824,501...110,887,787
G
Hook3
hook microtubule-tethering protein 3
decreases expression
ISO
Vincristine results in decreased expression of HOOK3 mRNA
CTD
PMID:23649840
NCBI chr16:65,954,293...66,058,812
Ensembl chr16:65,954,350...66,061,338
G
Hoxb7
homeo box B7
decreases expression
ISO
Vincristine results in decreased expression of HOXB7 mRNA
CTD
PMID:23649840
NCBI chr10:81,252,616...81,256,034
Ensembl chr10:81,252,553...81,256,034
G
Hpdl
4-hydroxyphenylpyruvate dioxygenase-like
decreases expression
ISO
Vincristine results in decreased expression of HPDL mRNA
CTD
PMID:23649840
NCBI chr 5:130,286,627...130,288,233
Ensembl chr 5:130,286,631...130,288,233
G
Hras
HRas proto-oncogene, GTPase
increases expression
ISO
Vincristine results in increased expression of HRAS mRNA
CTD
PMID:16001973
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hs2st1
heparan sulfate 2-O-sulfotransferase 1
decreases expression
ISO
Vincristine results in decreased expression of HS2ST1 mRNA
CTD
PMID:23649840
NCBI chr 2:233,508,018...233,641,769
Ensembl chr 2:233,508,021...233,641,769
G
Hspa14
heat shock protein family A (Hsp70) member 14
decreases expression
ISO
Vincristine results in decreased expression of HSPA14 mRNA
CTD
PMID:23649840
NCBI chr17:74,728,945...74,749,727
Ensembl chr17:74,728,899...74,749,727
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression multiple interactions
EXP
Vincristine results in increased expression of HSPA5 mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of HSPA5 mRNA]
CTD
PMID:33038355
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspb2
heat shock protein family B (small) member 2
decreases response to substance
ISO
HSPB2 protein results in decreased susceptibility to Vincristine
CTD
PMID:17524270
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
G
Hspd1
heat shock protein family D (Hsp60) member 1
decreases expression
ISO
Vincristine results in decreased expression of HSPD1 mRNA
CTD
PMID:23649840
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions increases expression
EXP
[alpha-phenyl-1-(2-phenylethyl)-4-piperidinemethanol binds to and results in decreased activity of HTR2A protein] which results in decreased susceptibility to Vincristine Vincristine results in increased expression of HTR2A protein
CTD
PMID:18930597
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Hyls1
HYLS1, centriolar and ciliogenesis associated
decreases expression
ISO
Vincristine results in decreased expression of HYLS1 mRNA
CTD
PMID:23649840
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO EXP
Vincristine results in increased expression of ICAM1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icam4
intercellular adhesion molecule 4, Landsteiner-Wiener blood group
increases expression
ISO
Vincristine results in increased expression of ICAM4 mRNA
CTD
PMID:23649840
NCBI chr 8:19,566,075...19,567,171
Ensembl chr 8:19,566,075...19,567,171
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
Vincristine results in increased expression of ID2 mRNA
CTD
PMID:23649840
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
increases response to substance
ISO
ID3 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Ier3
immediate early response 3
increases expression
ISO
Vincristine results in increased expression of IER3 mRNA
CTD
PMID:23649840
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi44
interferon-induced protein 44
increases expression
ISO
Vincristine results in increased expression of IFI44 mRNA
CTD
PMID:23649840
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
Vincristine results in increased expression of IFI44L mRNA
CTD
PMID:23649840
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
increases expression
ISO
Vincristine results in increased expression of IFIH1 mRNA
CTD
PMID:23649840
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
increases expression
ISO
Vincristine results in increased expression of IFIT2 mRNA
CTD
PMID:23649840
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifng
interferon gamma
increases expression
ISO
Vincristine results in increased expression of IFNG mRNA
CTD
PMID:23649840
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifrd1
interferon-related developmental regulator 1
decreases expression
ISO
Vincristine results in decreased expression of IFRD1 mRNA
CTD
PMID:23649840
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ift20
intraflagellar transport 20
increases expression
ISO
Vincristine results in increased expression of IFT20 mRNA
CTD
PMID:23649840
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
G
Ift25
intraflagellar transport 25
decreases expression
ISO
Vincristine results in decreased expression of IFT25 mRNA
CTD
PMID:23649840
NCBI chr 5:122,035,588...122,062,421
Ensembl chr 5:122,035,581...122,062,421
G
Ift43
intraflagellar transport 43
increases expression
ISO
Vincristine results in increased expression of IFT43 mRNA
CTD
PMID:23649840
NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257
G
Igf1
insulin-like growth factor 1
multiple interactions decreases response to substance
ISO
Vincristine promotes the reaction [NVP ADW742 inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]] IGF1 protein results in decreased susceptibility to Vincristine
CTD
PMID:9452187 PMID:16740780
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ighg1
immunoglobulin heavy constant gamma 1
decreases expression
ISO
Vincristine results in decreased expression of IGHG1 mRNA
CTD
PMID:23649840
Ensembl chr 6:132,389,370...132,393,397
G
Igkc
immunoglobulin kappa constant
decreases expression
ISO
Vincristine results in decreased expression of IGKC mRNA
CTD
PMID:23649840
G
Igkv8-30l1
immunoglobulin kappa chain variable 8-30 like 1
decreases expression
ISO
Vincristine results in decreased expression of IGKV4-1 mRNA
CTD
PMID:23649840
NCBI chr 4:101,838,285...101,839,132
G
Ikzf2
IKAROS family zinc finger 2
decreases expression
ISO
Vincristine results in decreased expression of IKZF2 mRNA
CTD
PMID:23649840
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
G
Il10ra
interleukin 10 receptor subunit alpha
increases expression
ISO
Vincristine results in increased expression of IL10RA mRNA
CTD
PMID:23649840
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
G
Il15
interleukin 15
increases expression
ISO
Vincristine results in increased expression of IL15 mRNA
CTD
PMID:23649840
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17rb
interleukin 17 receptor B
decreases expression
ISO
Vincristine results in decreased expression of IL17RB mRNA
CTD
PMID:23649840
NCBI chr16:5,180,431...5,194,125
Ensembl chr16:5,180,432...5,194,125
G
Il1b
interleukin 1 beta
increases expression multiple interactions increases secretion
EXP ISO
Vincristine results in increased expression of IL1B mRNA; Vincristine results in increased expression of IL1B protein gap 27 peptide inhibits the reaction [Vincristine results in increased secretion of IL1B protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL1B protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of IL1B mRNA] coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of IL1B protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of IL1B mRNA]
CTD
PMID:20624997 PMID:29958920 PMID:34286406 PMID:34939713
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
increases expression
ISO
Vincristine results in increased expression of IL1R1 mRNA
CTD
PMID:23649840
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il2
interleukin 2
multiple interactions increases expression
EXP
tropisetron inhibits the reaction [Vincristine results in increased expression of IL2 protein]
CTD
PMID:24374478
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Vincristine results in increased expression of IL23A mRNA
CTD
PMID:23649840
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il36g
interleukin 36, gamma
increases expression
ISO
Vincristine results in increased expression of IL36G mRNA
CTD
PMID:23649840
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
G
Il6
interleukin 6
affects response to substance multiple interactions increases secretion increases expression
EXP ISO
IL6 protein affects the susceptibility to Vincristine gap 27 peptide inhibits the reaction [Vincristine results in increased secretion of IL6 protein]; GJA1 protein promotes the reaction [Vincristine results in increased secretion of IL6 protein]; KN 93 inhibits the reaction [Vincristine results in increased expression of IL6 mRNA] Vincristine results in increased expression of IL6 mRNA; Vincristine results in increased expression of IL6 protein
CTD
PMID:16001973 PMID:18270703 PMID:18652822 PMID:23649840 PMID:34286406
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7
interleukin 7
increases expression
ISO
Vincristine results in increased expression of IL7 mRNA
CTD
PMID:23649840
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
G
Ildr1
immunoglobulin-like domain containing receptor 1
increases expression
ISO
Vincristine results in increased expression of ILDR1 mRNA
CTD
PMID:23649840
NCBI chr11:64,085,774...64,118,760
Ensembl chr11:64,008,566...64,118,760
G
Ildr2
immunoglobulin-like domain containing receptor 2
decreases expression
ISO
Vincristine results in decreased expression of ILDR2 mRNA
CTD
PMID:23649840
NCBI chr13:78,518,770...78,580,627
Ensembl chr13:78,518,802...78,576,924
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
Vincristine results in decreased expression of IMPA2 mRNA
CTD
PMID:23649840
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Ina
internexin neuronal intermediate filament protein, alpha
multiple interactions
ISO
INA affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine]
CTD
PMID:21246521
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Ing2
inhibitor of growth family, member 2
decreases expression
ISO
Vincristine results in decreased expression of ING2 mRNA
CTD
PMID:23649840
NCBI chr16:44,573,592...44,584,180
Ensembl chr16:44,575,597...44,583,482
G
Inha
inhibin subunit alpha
decreases expression
EXP
Vincristine results in decreased expression of INHA mRNA
CTD
PMID:20624997
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Vincristine results in increased expression of INHBE mRNA
CTD
PMID:23649840
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Inpp1
inositol polyphosphate-1-phosphatase
increases expression
ISO
Vincristine results in increased expression of INPP1 mRNA
CTD
PMID:23649840
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
G
Inpp4b
inositol polyphosphate-4-phosphatase type II B
increases expression
ISO
Vincristine results in increased expression of INPP4B mRNA
CTD
PMID:23649840
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
G
Ints11
integrator complex subunit 11
decreases expression
ISO
Vincristine results in decreased expression of INTS11 mRNA
CTD
PMID:23649840
NCBI chr 5:166,479,134...166,497,956
Ensembl chr 5:166,479,155...166,497,651
G
Ints5
integrator complex subunit 5
decreases expression
ISO
Vincristine results in decreased expression of INTS5 mRNA
CTD
PMID:23649840
NCBI chr 1:205,788,906...205,793,685
Ensembl chr 1:205,788,906...205,793,685
G
Ipo5
importin 5
decreases expression
ISO
Vincristine results in decreased expression of IPO5 mRNA
CTD
PMID:23649840
NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
G
Iqgap2
IQ motif containing GTPase activating protein 2
decreases expression
ISO
Vincristine results in decreased expression of IQGAP2 mRNA
CTD
PMID:23649840
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
G
Irak2
interleukin-1 receptor-associated kinase 2
increases expression
ISO
Vincristine results in increased expression of IRAK2 mRNA
CTD
PMID:23649840
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Ireb2
iron responsive element binding protein 2
increases expression
ISO
Vincristine results in increased expression of IREB2 mRNA
CTD
PMID:23649840
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
G
Irf1
interferon regulatory factor 1
increases expression
ISO
Vincristine results in increased expression of IRF1 mRNA
CTD
PMID:23649840
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
Vincristine results in increased expression of ISG20 mRNA
CTD
PMID:23649840
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
increases expression
ISO
Vincristine results in increased expression of ISLR mRNA
CTD
PMID:23649840
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
G
Itga1
integrin subunit alpha 1
increases response to substance
ISO
ITGA1 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238
G
Itga4
integrin subunit alpha 4
decreases expression
ISO
Vincristine results in decreased expression of ITGA4 mRNA
CTD
PMID:23649840
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itgam
integrin subunit alpha M
increases expression
ISO
Vincristine results in increased expression of ITGAM mRNA
CTD
PMID:23649840
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb1bp2
integrin subunit beta 1 binding protein 2
decreases expression
ISO
Vincristine results in decreased expression of ITGB1BP2 mRNA
CTD
PMID:23649840
NCBI chr X:66,572,537...66,577,174
Ensembl chr X:66,572,537...66,577,174
G
Itgb7
integrin subunit beta 7
decreases expression
ISO
Vincristine results in decreased expression of ITGB7 mRNA
CTD
PMID:23649840
NCBI chr 7:133,347,927...133,364,955
Ensembl chr 7:133,347,960...133,364,876
G
Itgb8
integrin subunit beta 8
increases expression
ISO
Vincristine results in increased expression of ITGB8 mRNA
CTD
PMID:23649840
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
G
Itpkb
inositol-trisphosphate 3-kinase B
decreases expression
ISO
Vincristine results in decreased expression of ITPKB mRNA
CTD
PMID:23649840
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression
ISO
Vincristine results in increased expression of ITPR1 mRNA
CTD
PMID:23649840
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itprid2
ITPR interacting domain containing 2
decreases expression
ISO
Vincristine results in decreased expression of ITPRID2 mRNA
CTD
PMID:23649840
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
G
Itpripl1
ITPRIP like 1
decreases expression
ISO
Vincristine results in decreased expression of ITPRIPL1 mRNA
CTD
PMID:23649840
NCBI chr 3:114,403,123...114,407,917
Ensembl chr 3:114,402,270...114,414,497
G
Ivl
involucrin
increases expression
ISO
Vincristine results in increased expression of IVL mRNA
CTD
PMID:23649840
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Ivns1abp
influenza virus NS1A binding protein
decreases expression
ISO
Vincristine results in decreased expression of IVNS1ABP mRNA
CTD
PMID:23649840
NCBI chr13:63,427,040...63,446,701
Ensembl chr13:63,427,041...63,446,701
G
Jade2
jade family PHD finger 2
increases expression
ISO
Vincristine results in increased expression of JADE2 mRNA
CTD
PMID:23649840
NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984
G
Jchain
joining chain of multimeric IgA and IgM
decreases expression
ISO
Vincristine results in decreased expression of JCHAIN mRNA
CTD
PMID:23649840
NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
G
Jmjd1c
jumonji domain containing 1C
increases expression
ISO
Vincristine results in increased expression of JMJD1C mRNA
CTD
PMID:23649840
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Jpt1
Jupiter microtubule associated homolog 1
decreases expression
ISO
Vincristine results in decreased expression of JPT1 mRNA
CTD
PMID:23649840
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Vincristine results in increased expression of JUN mRNA
CTD
PMID:23649840
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kat2b
lysine acetyltransferase 2B
increases expression
ISO
Vincristine results in increased expression of KAT2B mRNA
CTD
PMID:16001973
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
G
Kcmf1
potassium channel modulatory factor 1
decreases expression
ISO
Vincristine results in decreased expression of KCMF1 mRNA
CTD
PMID:23649840
NCBI chr 4:104,888,452...104,950,234
Ensembl chr 4:104,889,847...104,950,234
G
Kcna5
potassium voltage-gated channel subfamily A member 5
increases response to substance
ISO
KCNA5 protein results in increased susceptibility to Vincristine
CTD
PMID:17428690
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Kcnmb1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
increases expression
ISO
Vincristine results in increased expression of KCNMB1 mRNA
CTD
PMID:23649840
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
increases expression
ISO
Vincristine results in increased expression of KCNN2 mRNA
CTD
PMID:23649840
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Kdm2b
lysine demethylase 2B
increases expression
ISO
Vincristine results in increased expression of KDM2B mRNA
CTD
PMID:23649840
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
G
Kdsr
3-ketodihydrosphingosine reductase
decreases expression
ISO
Vincristine results in decreased expression of KDSR mRNA
CTD
PMID:23649840
NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
G
Klf12
KLF transcription factor 12
decreases expression
ISO
Vincristine results in decreased expression of KLF12 mRNA
CTD
PMID:23649840
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
G
Klf6
KLF transcription factor 6
increases expression
ISO
Vincristine results in increased expression of KLF6 mRNA
CTD
PMID:23649840
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klhl14
kelch-like family member 14
decreases expression
ISO
Vincristine results in decreased expression of KLHL14 mRNA
CTD
PMID:23649840
NCBI chr18:12,804,253...12,917,828
Ensembl chr18:12,804,253...12,917,828
G
Klhl28
kelch-like family member 28
increases expression
ISO
Vincristine results in increased expression of KLHL28 mRNA
CTD
PMID:23649840
NCBI chr 6:82,987,360...83,018,971
Ensembl chr 6:82,990,945...83,016,164
G
Kmt5b
lysine methyltransferase 5B
increases expression
ISO
Vincristine results in increased expression of KMT5B mRNA
CTD
PMID:23649840
NCBI chr 1:201,000,444...201,049,819
Ensembl chr 1:201,000,444...201,049,819
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Vincristine results in decreased expression of KPNA2 mRNA
CTD
PMID:23649840
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Krt23
keratin 23
increases response to substance
ISO
KRT23 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
G
Krt7
keratin 7
increases expression
ISO
Vincristine results in increased expression of KRT7 mRNA
CTD
PMID:23649840
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Kynu
kynureninase
increases expression
ISO
Vincristine results in increased expression of KYNU mRNA
CTD
PMID:23649840
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lactb2
lactamase, beta 2
decreases expression
ISO
Vincristine results in decreased expression of LACTB2 mRNA
CTD
PMID:23649840
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Lama2
laminin subunit alpha 2
increases response to substance
ISO
LAMA2 mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Lamp3
lysosomal-associated membrane protein 3
increases expression
ISO
Vincristine results in increased expression of LAMP3 mRNA
CTD
PMID:23649840
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Larp1b
La ribonucleoprotein 1B
decreases expression
ISO
Vincristine results in decreased expression of LARP1B mRNA
CTD
PMID:23649840
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Lbh
LBH regulator of WNT signaling pathway
decreases expression
ISO
Vincristine results in decreased expression of LBH mRNA
CTD
PMID:23649840
NCBI chr 6:22,569,238...22,593,056
Ensembl chr 6:22,568,834...22,593,079
G
Lce1b
late cornified envelope 1B
increases expression
ISO
Vincristine results in increased expression of LCE1B mRNA
CTD
PMID:23649840
NCBI chr 2:178,255,351...178,257,533
Ensembl chr 2:178,256,213...178,257,985
G
Lcor
ligand dependent nuclear receptor corepressor
increases expression
ISO
Vincristine results in increased expression of LCOR mRNA
CTD
PMID:23649840
NCBI chr 1:240,298,565...240,405,627
Ensembl chr 1:240,298,563...240,402,448
G
Lcorl
ligand dependent nuclear receptor corepressor-like
decreases expression
ISO
Vincristine results in decreased expression of LCORL mRNA
CTD
PMID:23649840
NCBI chr14:65,271,339...65,407,732
Ensembl chr14:65,271,135...65,404,174
G
Lcp2
lymphocyte cytosolic protein 2
increases expression
ISO
Vincristine results in increased expression of LCP2 mRNA
CTD
PMID:23649840
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
G
Ldlrad4
low density lipoprotein receptor class A domain containing 4
increases expression
ISO
Vincristine results in increased expression of LDLRAD4 mRNA
CTD
PMID:23649840
NCBI chr18:61,519,253...61,848,403
Ensembl chr18:61,521,428...61,843,238
G
Ldlrap1
low density lipoprotein receptor adaptor protein 1
decreases expression
ISO
Vincristine results in decreased expression of LDLRAP1 mRNA
CTD
PMID:23649840
NCBI chr 5:146,955,607...146,978,601
Ensembl chr 5:146,955,607...146,978,601
G
Leg1
liver enriched gene 1
increases expression
ISO
Vincristine results in increased expression of C6ORF58 mRNA
CTD
PMID:23649840
NCBI chr 1:28,799,902...28,816,230
Ensembl chr 1:28,799,902...28,815,993
G
Leng8
leukocyte receptor cluster member 8
decreases expression
ISO
Vincristine results in decreased expression of LENG8 mRNA
CTD
PMID:23649840
NCBI chr 1:70,040,785...70,052,662
Ensembl chr 1:70,040,785...70,052,488
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
Vincristine results in increased expression of LIF mRNA
CTD
PMID:23649840
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lima1
LIM domain and actin binding 1
increases expression
ISO
Vincristine results in increased expression of LIMA1 mRNA
CTD
PMID:23649840
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
Vincristine results in increased expression of LIMS1 mRNA
CTD
PMID:23649840
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lmna
lamin A/C
increases expression
ISO
Vincristine results in increased expression of LMNA mRNA
CTD
PMID:23649840
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lnpep
leucyl and cystinyl aminopeptidase
increases expression
ISO
Vincristine results in increased expression of LNPEP mRNA
CTD
PMID:23649840
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
G
LOC102549061
histone H2B type 1-N-like
increases expression
ISO
Vincristine results in increased expression of H2BC3 mRNA
CTD
PMID:23649840
NCBI chr17:41,380,056...41,380,686
G
Lrba
LPS responsive beige-like anchor protein
decreases expression
ISO
Vincristine results in decreased expression of LRBA mRNA
CTD
PMID:23649840
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
G
Lrch3
leucine rich repeats and calponin homology domain containing 3
increases expression
ISO
Vincristine results in increased expression of LRCH3 mRNA
CTD
PMID:23649840
NCBI chr11:67,772,499...67,872,269
Ensembl chr11:67,772,506...67,872,264
G
Lrp8
LDL receptor related protein 8
decreases expression
ISO
Vincristine results in decreased expression of LRP8 mRNA
CTD
PMID:23649840
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
decreases expression
ISO
Vincristine results in decreased expression of LRRC8C mRNA
CTD
PMID:23649840
NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249
G
Lrrcc1
leucine rich repeat and coiled-coil centrosomal protein 1
decreases expression
ISO
Vincristine results in decreased expression of LRRCC1 mRNA
CTD
PMID:23649840
NCBI chr 2:87,025,671...87,060,313
Ensembl chr 2:87,025,598...87,060,294
G
Lrrfip1
LRR binding FLII interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of LRRFIP1 mRNA
CTD
PMID:23649840
NCBI chr 9:91,592,032...91,720,250
Ensembl chr 9:91,643,197...91,720,250
G
Lta
lymphotoxin alpha
increases expression
ISO
Vincristine results in increased expression of LTA mRNA
CTD
PMID:23649840
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Lto1
LTO1 maturation factor of ABCE1
decreases expression
ISO
Vincristine results in decreased expression of LTO1 mRNA
CTD
PMID:23649840
NCBI chr 1:200,074,247...200,080,951
Ensembl chr 1:200,074,253...200,088,061
G
Lum
lumican
decreases response to substance
ISO
LUM mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Ly96
lymphocyte antigen 96
increases expression
ISO
Vincristine results in increased expression of LY96 mRNA
CTD
PMID:23649840
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Lztfl1
leucine zipper transcription factor-like 1
decreases expression
ISO
Vincristine results in decreased expression of LZTFL1 mRNA
CTD
PMID:23649840
NCBI chr 8:123,344,085...123,360,245
Ensembl chr 8:123,344,925...123,360,192
G
Lzts2
leucine zipper tumor suppressor 2
decreases expression
ISO
Vincristine results in decreased expression of LZTS2 mRNA
CTD
PMID:23649840
NCBI chr 1:243,876,665...243,888,489
Ensembl chr 1:243,880,022...243,888,423
G
Macf1
microtubule-actin crosslinking factor 1
increases expression
ISO
Vincristine results in increased expression of MACF1 mRNA
CTD
PMID:23649840
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
G
Macir
macrophage immunometabolism regulator
decreases expression
ISO
Vincristine results in decreased expression of MACIR mRNA
CTD
PMID:23649840
NCBI chr 9:98,420,760...98,440,818
Ensembl chr 9:98,420,376...98,441,733
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Vincristine results in increased expression of MAFF mRNA
CTD
PMID:23649840
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Magt1
magnesium transporter 1
decreases expression
ISO
Vincristine results in decreased expression of MAGT1 mRNA
CTD
PMID:23649840
NCBI chr X:71,038,489...71,079,704
Ensembl chr X:71,038,489...71,079,699
G
Man2a1
mannosidase, alpha, class 2A, member 1
decreases expression
ISO
Vincristine results in decreased expression of MAN2A1 mRNA
CTD
PMID:23649840
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
G
Manea
mannosidase, endo-alpha
decreases expression
ISO
Vincristine results in decreased expression of MANEA mRNA
CTD
PMID:23649840
NCBI chr 5:40,196,373...40,218,540
Ensembl chr 5:40,196,396...40,218,459
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression multiple interactions
ISO EXP
Vincristine results in increased expression of MAP1LC3B mRNA Quercetin inhibits the reaction [Vincristine results in increased expression of MAP1LC3B protein]
CTD
PMID:23649840 PMID:36808657
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
ISO
Vincristine results in decreased expression of MAP3K1 mRNA
CTD
PMID:23649840
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases expression
ISO
Vincristine results in decreased expression of MAP3K7 mRNA
CTD
PMID:23649840
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
Vincristine results in increased expression of MAP3K8 mRNA
CTD
PMID:23649840
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
increases expression
ISO
Vincristine results in increased expression of MAP4K4 mRNA
CTD
PMID:23649840
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
G
Mapkbp1
mitogen activated protein kinase binding protein 1
increases expression
ISO
Vincristine results in increased expression of MAPKBP1 mRNA
CTD
PMID:23649840
NCBI chr 3:106,947,342...106,998,368
Ensembl chr 3:106,947,827...106,996,199
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
decreases localization multiple interactions
ISO
Vincristine results in decreased localization of MAPRE1 protein olesoxime inhibits the reaction [Vincristine results in decreased localization of MAPRE1 protein]
CTD
PMID:20417191
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
multiple interactions affects localization
ISO
olesoxime inhibits the reaction [Vincristine results in decreased localization of MAPRE3 protein] Vincristine affects the localization of MAPRE3 protein
CTD
PMID:20417191
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Marchf7
membrane associated ring-CH-type finger 7
increases expression
ISO
Vincristine results in increased expression of MARCHF7 mRNA
CTD
PMID:23649840
NCBI chr 3:44,680,229...44,720,172
Ensembl chr 3:44,681,632...44,720,168
G
Marcks
myristoylated alanine rich protein kinase C substrate
increases expression
ISO
Vincristine results in increased expression of MARCKS mRNA
CTD
PMID:23649840
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Mars1
methionyl-tRNA synthetase 1
decreases expression
ISO
Vincristine results in decreased expression of MARS1 mRNA
CTD
PMID:23649840
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
G
Mars2
methionyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
Vincristine results in decreased expression of MARS2 mRNA
CTD
PMID:23649840
NCBI chr 9:56,720,408...56,729,991
Ensembl chr 9:56,720,983...56,723,820
G
Matn2
matrilin 2
decreases response to substance
ISO
MATN2 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
G
Matr3
matrin 3
decreases expression
ISO
Vincristine results in decreased expression of MATR3 mRNA
CTD
PMID:23649840
NCBI chr18:27,154,098...27,193,212
Ensembl chr18:27,163,714...27,193,166
G
Max
MYC associated factor X
decreases expression
ISO
Vincristine results in decreased expression of MAX mRNA
CTD
PMID:23649840
NCBI chr 6:95,636,859...95,662,204
Ensembl chr 6:95,636,858...95,662,137
G
Mbd4
methyl-CpG binding domain 4 DNA glycosylase
decreases expression
ISO
Vincristine results in decreased expression of MBD4 mRNA
CTD
PMID:23649840
NCBI chr 4:148,893,049...148,904,833
Ensembl chr 4:148,894,280...148,904,982
G
Mbnl3
muscleblind-like splicing regulator 3
decreases expression
ISO
Vincristine results in decreased expression of MBNL3 mRNA
CTD
PMID:23649840
NCBI chr X:130,641,942...130,737,179
Ensembl chr X:130,648,538...130,737,056
G
Mbtd1
mbt domain containing 1
increases expression
ISO
Vincristine results in increased expression of MBTD1 mRNA
CTD
PMID:23649840
NCBI chr10:78,839,140...78,895,413
Ensembl chr10:78,839,036...78,893,720
G
Mccc2
methylcrotonyl-CoA carboxylase subunit 2
increases expression
ISO
Vincristine results in increased expression of MCCC2 mRNA
CTD
PMID:23649840
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
increases expression
ISO
Vincristine results in increased expression of MCL1 mRNA
CTD
PMID:23649840
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
Vincristine results in decreased expression of MCM4 mRNA
CTD
PMID:23649840
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcmbp
minichromosome maintenance complex binding protein
increases expression
ISO
Vincristine results in increased expression of MCMBP mRNA
CTD
PMID:23649840
NCBI chr 1:183,270,598...183,316,975
Ensembl chr 1:183,271,980...183,316,975
G
Mcoln2
mucolipin TRP cation channel 2
increases expression
ISO
Vincristine results in increased expression of MCOLN2 mRNA
CTD
PMID:23649840
NCBI chr 2:235,053,816...235,102,703
Ensembl chr 2:235,053,816...235,102,702
G
Mdm2
MDM2 proto-oncogene
increases expression decreases expression
ISO
Vincristine results in increased expression of MDM2 mRNA Vincristine results in decreased expression of MDM2 mRNA
CTD
PMID:16001973 PMID:23649840
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mdn1
midasin AAA ATPase 1
increases expression
ISO
Vincristine results in increased expression of MDN1 mRNA
CTD
PMID:23649840
NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332
G
Med29
mediator complex subunit 29
decreases expression
ISO
Vincristine results in decreased expression of MED29 mRNA
CTD
PMID:23649840
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
G
Med31
mediator complex subunit 31
decreases expression
ISO
Vincristine results in decreased expression of MED31 mRNA
CTD
PMID:23649840
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
G
Mettl3
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit
decreases expression
ISO
Vincristine results in decreased expression of METTL3 mRNA
CTD
PMID:23649840
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
G
Mfsd5
major facilitator superfamily domain containing 5
decreases expression
ISO
Vincristine results in decreased expression of MFSD5 mRNA
CTD
PMID:23649840
NCBI chr 7:133,409,096...133,411,377
Ensembl chr 7:133,402,537...133,411,396
G
Mfsd6
major facilitator superfamily domain containing 6
decreases expression
ISO
Vincristine results in decreased expression of MFSD6 mRNA
CTD
PMID:23649840
NCBI chr 9:48,773,171...48,858,471
Ensembl chr 9:48,773,414...48,858,465
G
Mga
MAX dimerization protein MGA
increases expression
ISO
Vincristine results in increased expression of MGA mRNA
CTD
PMID:23649840
NCBI chr 3:106,851,216...106,942,908
Ensembl chr 3:106,851,140...106,941,043
G
Mgat4a
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
decreases expression
ISO
Vincristine results in decreased expression of MGAT4A mRNA
CTD
PMID:23649840
NCBI chr 9:39,673,427...39,786,747
Ensembl chr 9:39,673,430...39,766,890
G
Mgmt
O-6-methylguanine-DNA methyltransferase
multiple interactions
ISO
[MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Vincristine; MGMT affects the susceptibility to [Procarbazine co-treated with Vincristine co-treated with Nitrosourea Compounds]; MGMT protein affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine]
CTD
PMID:11792417 PMID:16033832 PMID:16936459
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mical3
microtubule associated monooxygenase, calponin and LIM domain containing 3
increases expression
ISO
Vincristine results in increased expression of MICAL3 mRNA
CTD
PMID:23649840
NCBI chr 4:154,152,776...154,353,274
Ensembl chr 4:154,153,834...154,302,590
G
Mir132
microRNA 132
increases expression
ISO
Vincristine results in increased expression of MIR132 mRNA
CTD
PMID:32505695
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
G
Mir497
microRNA 497
multiple interactions
ISO
[MIR497 results in decreased expression of BCL2 protein] which results in increased susceptibility to Vincristine
CTD
PMID:21258880
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
G
Mki67
marker of proliferation Ki-67
increases response to substance
ISO
MKI67 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20864405
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mkln1
muskelin 1
increases expression
ISO
Vincristine results in increased expression of MKLN1 mRNA
CTD
PMID:23649840
NCBI chr 4:59,815,912...60,124,047
Ensembl chr 4:60,002,464...60,123,993
G
Mknk2
MAPK interacting serine/threonine kinase 2
increases expression
ISO
Vincristine results in increased expression of MKNK2 mRNA
CTD
PMID:23649840
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
G
Mllt3
MLLT3, super elongation complex subunit
increases expression
ISO
Vincristine results in increased expression of MLLT3 mRNA
CTD
PMID:23649840
NCBI chr 5:102,259,075...102,515,447
Ensembl chr 5:102,260,011...102,515,361
G
Mmd
monocyte to macrophage differentiation-associated
increases expression
ISO
Vincristine results in increased expression of MMD mRNA
CTD
PMID:23649840
NCBI chr10:75,073,278...75,101,528
Ensembl chr10:75,073,365...75,101,528
G
Mnd1
meiotic nuclear divisions 1
decreases expression
ISO
Vincristine results in decreased expression of MND1 mRNA
CTD
PMID:23649840
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mpz
myelin protein zero
increases response to substance
ISO
MPZ gene results in increased susceptibility to Vincristine
CTD
PMID:16676325
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
G
Mr1
major histocompatibility complex, class I-related
increases expression
ISO
Vincristine results in increased expression of MR1 mRNA
CTD
PMID:23649840
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mrpl30
mitochondrial ribosomal protein L30
decreases expression
ISO
Vincristine results in decreased expression of MRPL30 mRNA
CTD
PMID:23649840
NCBI chr 9:40,125,352...40,136,189
Ensembl chr 9:40,125,430...40,137,257
G
Mrpl39
mitochondrial ribosomal protein L39
decreases expression
ISO
Vincristine results in decreased expression of MRPL39 mRNA
CTD
PMID:23649840
NCBI chr11:23,779,655...23,795,146
Ensembl chr11:23,779,662...23,795,125
G
Mrpl50
mitochondrial ribosomal protein L50
decreases expression
ISO
Vincristine results in decreased expression of MRPL50 mRNA
CTD
PMID:23649840
NCBI chr 5:63,867,437...63,872,591
G
Mrps16
mitochondrial ribosomal protein S16
decreases expression
ISO
Vincristine results in decreased expression of MRPS16 mRNA
CTD
PMID:23649840
NCBI chr15:3,918,621...3,921,024
Ensembl chr15:3,918,615...3,921,656
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
increases expression
ISO
Vincristine results in increased expression of ND6 mRNA
CTD
PMID:23649840
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mt1m
metallothionein 1M
increases expression
ISO
Vincristine results in increased expression of MT1HL1 mRNA
CTD
PMID:23649840
NCBI chr20:3,159,037...3,159,409
Ensembl chr 5:119,728,811...119,730,073
G
Mt2A
metallothionein 2A
increases expression
ISO
Vincristine results in increased expression of MT2A mRNA
CTD
PMID:23649840
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mta3
metastasis associated 1 family, member 3
decreases expression
ISO
Vincristine results in decreased expression of MTA3 mRNA
CTD
PMID:23649840
NCBI chr 6:10,867,028...10,987,221
Ensembl chr 6:10,867,011...10,986,883
G
Mtcp1
mature T-cell proliferation 1
decreases expression
ISO
Vincristine results in decreased expression of MTCP1 mRNA
CTD
PMID:23649840
NCBI chr18:126,189...130,123
G
Mtfr2
mitochondrial fission regulator 2
decreases expression
ISO
Vincristine results in decreased expression of MTFR2 mRNA
CTD
PMID:23649840
NCBI chr 1:15,123,232...15,138,632
Ensembl chr 1:15,070,894...15,148,832
G
Mtg2
mitochondrial ribosome-associated GTPase 2
increases expression
ISO
Vincristine results in increased expression of MTG2 mRNA
CTD
PMID:23649840
NCBI chr 3:167,165,542...167,181,358
Ensembl chr 3:167,165,982...167,181,358
G
Mthfd2l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like
decreases expression
ISO
Vincristine results in decreased expression of MTHFD2L mRNA
CTD
PMID:23649840
NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112
G
Mtrf1l
mitochondrial translation release factor 1 like
decreases expression
ISO
Vincristine results in decreased expression of MTRF1L mRNA
CTD
PMID:23649840
NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836
G
Mvp
major vault protein
increases expression
ISO
Vincristine results in increased expression of MVP mRNA
CTD
PMID:23649840
NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
G
Mxd1
max dimerization protein 1
increases expression
ISO
Vincristine results in increased expression of MXD1 mRNA
CTD
PMID:23649840
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression increases expression
ISO EXP
Vincristine results in decreased expression of MYC mRNA Vincristine results in increased expression of MYC mRNA
CTD
PMID:16001973 PMID:20624997
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
decreases response to substance multiple interactions
ISO
MYCN protein results in decreased susceptibility to Vincristine [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine
CTD
PMID:10348353
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
G
Myh11
myosin heavy chain 11
increases expression
ISO
Vincristine results in increased expression of MYH11 mRNA
CTD
PMID:23649840
NCBI chr10:743,364...838,459
Ensembl chr10:743,685...838,459
G
Mysm1
myb-like, SWIRM and MPN domains 1
increases expression
ISO
Vincristine results in increased expression of MYSM1 mRNA
CTD
PMID:23649840
NCBI chr 5:109,761,345...109,826,652
Ensembl chr 5:109,776,286...109,819,967
G
Mzb1
marginal zone B and B1 cell-specific protein
decreases expression
ISO
Vincristine results in decreased expression of MZB1 mRNA
CTD
PMID:23649840
NCBI chr18:27,238,999...27,241,060
Ensembl chr18:27,239,001...27,241,094
G
N4bp2l2
NEDD4 binding protein 2-like 2
increases expression
ISO
Vincristine results in increased expression of N4BP2L2 mRNA
CTD
PMID:23649840
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
Naa25
N(alpha)-acetyltransferase 25, NatB auxiliary subunit
decreases expression
ISO
Vincristine results in decreased expression of NAA25 mRNA
CTD
PMID:23649840
NCBI chr12:35,098,256...35,150,498
Ensembl chr12:35,098,075...35,150,467
G
Naa50
N(alpha)-acetyltransferase 50, NatE catalytic subunit
decreases expression
ISO
Vincristine results in decreased expression of NAA50 mRNA
CTD
PMID:23649840
NCBI chr11:56,538,366...56,560,842
Ensembl chr11:56,538,366...56,560,842
G
Nabp1
nucleic acid binding protein 1
increases expression
ISO
Vincristine results in increased expression of NABP1 mRNA
CTD
PMID:23649840
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Naca
nascent polypeptide associated complex subunit alpha
decreases expression
ISO
Vincristine results in decreased expression of NACA mRNA
CTD
PMID:23649840
NCBI chr 7:468,862...481,992
Ensembl chr 7:469,723...481,992
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
Vincristine results in increased expression of NAMPT mRNA
CTD
PMID:23649840
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Napb
NSF attachment protein beta
increases expression
ISO
Vincristine results in increased expression of NAPB mRNA
CTD
PMID:23649840
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
Vincristine results in decreased expression of NASP mRNA
CTD
PMID:23649840
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
G
Nbn
nibrin
increases expression
EXP
Vincristine results in increased expression of NBN mRNA
CTD
PMID:20624997
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Ncbp1
nuclear cap binding protein subunit 1
decreases expression
ISO
Vincristine results in decreased expression of NCBP1 mRNA
CTD
PMID:23649840
NCBI chr 5:60,416,023...60,449,004
Ensembl chr 5:60,415,982...60,449,089
G
Nceh1
neutral cholesterol ester hydrolase 1
increases expression
ISO
Vincristine results in increased expression of NCEH1 mRNA
CTD
PMID:23649840
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
G
Ncf2
neutrophil cytosolic factor 2
increases expression
ISO
Vincristine results in increased expression of NCF2 mRNA
CTD
PMID:23649840
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Ncoa7
nuclear receptor coactivator 7
increases expression
ISO
Vincristine results in increased expression of NCOA7 mRNA
CTD
PMID:23649840
NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871
G
Nde1
nudE neurodevelopment protein 1
increases expression
ISO
Vincristine results in increased expression of NDE1 mRNA
CTD
PMID:23649840
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
G
Ndufb4
NADH:ubiquinone oxidoreductase subunit B4
decreases expression
ISO
Vincristine results in decreased expression of NDUFB4 mRNA
CTD
PMID:23649840
NCBI chr11:63,063,723...63,070,426
Ensembl chr11:63,063,795...63,070,425
G
Nefl
neurofilament light chain
increases expression multiple interactions
EXP
Vincristine results in increased expression of NEFL protein coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of NEFL protein]
CTD
PMID:34939713
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
increases expression
ISO
Vincristine results in increased expression of NEURL3 mRNA
CTD
PMID:23649840
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Nfat5
nuclear factor of activated T-cells 5
increases expression
ISO
Vincristine results in increased expression of NFAT5 mRNA
CTD
PMID:23649840
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Nfatc2
nuclear factor of activated T-cells 2
increases response to substance
ISO
NFATC2 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325
G
Nfe2l1
NFE2 like bZIP transcription factor 1
increases expression
ISO
Vincristine results in increased expression of NFE2L1 mRNA
CTD
PMID:23649840
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of NFE2L2 mRNA; Vincristine results in decreased expression of NFE2L2 protein coenzyme Q10 inhibits the reaction [Vincristine results in decreased expression of NFE2L2 mRNA]; Quercetin inhibits the reaction [Vincristine results in decreased expression of NFE2L2 protein]
CTD
PMID:33038355 PMID:34939713 PMID:36808657
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfe2l3
NFE2 like bZIP transcription factor 3
decreases expression
ISO
Vincristine results in decreased expression of NFE2L3 mRNA
CTD
PMID:23649840
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
G
Ngf
nerve growth factor
multiple interactions decreases response to substance
EXP
Bicuculline inhibits the reaction [Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]]; Bicuculline inhibits the reaction [Thiopental inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]]; Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]; Thiopental inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein] NGF protein results in decreased susceptibility to Vincristine; Vincristine results in decreased susceptibility to NGF protein
CTD
PMID:9524088 PMID:9622663 PMID:10553948 PMID:11991087
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nhsl1
NHS-like 1
increases expression
ISO
Vincristine results in increased expression of NHSL1 mRNA
CTD
PMID:23649840
NCBI chr 1:12,956,525...13,188,580
Ensembl chr 1:12,956,021...13,187,547
G
Ninj1
ninjurin 1
increases expression
ISO
Vincristine results in increased expression of NINJ1 mRNA
CTD
PMID:23649840
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nisch
nischarin
decreases expression
ISO
Vincristine results in decreased expression of NISCH mRNA
CTD
PMID:23649840
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to Vincristine
CTD
PMID:18463239
NCBI chr 8:98,892,168...99,003,912
Ensembl chr 8:98,873,398...99,020,645
G
Nmrk2
nicotinamide riboside kinase 2
decreases response to substance
ISO
ITGB1BP3 mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 7:8,514,855...8,517,916
Ensembl chr 7:8,514,927...8,517,922
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
Vincristine results in decreased expression of NNT mRNA
CTD
PMID:23649840
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Nol12
nucleolar protein 12
decreases expression
ISO
Vincristine results in decreased expression of NOL12 mRNA
CTD
PMID:23649840
NCBI chr 7:110,493,294...110,498,908
Ensembl chr 7:110,493,246...110,498,907
G
Nol4l
nucleolar protein 4-like
increases expression
ISO
Vincristine results in increased expression of NOL4L mRNA
CTD
PMID:23649840
NCBI chr 3:141,884,840...142,007,668
Ensembl chr 3:141,884,840...142,008,976
G
Nos1
nitric oxide synthase 1
decreases expression
ISO
Vincristine results in decreased expression of NOS1 protein
CTD
PMID:16098672
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Npl
N-acetylneuraminate pyruvate lyase
increases expression
ISO
Vincristine results in increased expression of NPL mRNA
CTD
PMID:23649840
NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372
G
Nqo1
NAD(P)H quinone dehydrogenase 1
decreases activity multiple interactions
EXP
Vincristine results in decreased activity of NQO1 protein Quercetin inhibits the reaction [Vincristine results in decreased activity of NQO1 protein]
CTD
PMID:33038355
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
Vincristine inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions increases activity
ISO
[Vincristine results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; NR1I2 protein promotes the reaction [Vincristine results in increased expression of ABCB1 protein]
CTD
PMID:20041327
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
decreases expression
ISO
Vincristine results in decreased expression of NR2F2 mRNA
CTD
PMID:23649840
NCBI chr 1:124,008,282...124,022,521
Ensembl chr 1:124,009,181...124,022,031
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
increases expression
ISO
Vincristine results in increased expression of NR5A2 mRNA
CTD
PMID:23649840
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
Vincristine results in decreased expression of NREP mRNA
CTD
PMID:23649840
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nrn1
neuritin 1
decreases expression
ISO
Vincristine results in decreased expression of NRN1 mRNA
CTD
PMID:23649840
NCBI chr17:28,129,969...28,138,898
Ensembl chr17:28,129,977...28,138,896
G
Nsmce4a
NSE4 homolog A, SMC5-SMC6 complex component
decreases expression
ISO
Vincristine results in decreased expression of NSMCE4A mRNA
CTD
PMID:23649840
NCBI chr 1:185,102,075...185,109,166
Ensembl chr 1:185,094,360...185,109,166
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
Vincristine results in increased expression of NT5E mRNA
CTD
PMID:23649840
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Nudt7
nudix hydrolase 7
decreases expression
ISO
Vincristine results in decreased expression of NUDT7 mRNA
CTD
PMID:23649840
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
G
Nuf2
NUF2 component of NDC80 kinetochore complex
increases expression
ISO
Vincristine results in increased expression of NUF2 mRNA
CTD
PMID:23649840
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Numb
NUMB, endocytic adaptor protein
increases expression
ISO
Vincristine results in increased expression of NUMB mRNA
CTD
PMID:23649840
NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354
G
Nup153
nucleoporin 153
increases expression
ISO
Vincristine results in increased expression of NUP153 mRNA
CTD
PMID:23649840
NCBI chr17:17,972,217...18,024,876
Ensembl chr17:17,972,217...18,024,876
G
Nxt1
nuclear transport factor 2-like export factor 1
decreases expression
ISO
Vincristine results in decreased expression of NXT1 mRNA
CTD
PMID:23649840
NCBI chr 3:136,108,975...136,111,897
Ensembl chr 3:136,108,862...136,111,907
G
Oga
O-GlcNAcase
increases expression
ISO
Vincristine results in increased expression of OGA mRNA
CTD
PMID:23649840
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
G
Ogg1
8-oxoguanine DNA glycosylase
decreases expression
ISO
Vincristine results in decreased expression of OGG1 mRNA
CTD
PMID:23649840
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
ISO
Vincristine results in decreased expression of OGT mRNA
CTD
PMID:23649840
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Olah
oleoyl-ACP hydrolase
increases expression
ISO
Vincristine results in increased expression of OLAH mRNA
CTD
PMID:23649840
NCBI chr17:74,877,651...74,902,517
Ensembl chr17:74,877,655...74,902,518
G
Orai1
ORAI calcium release-activated calcium modulator 1
decreases expression
ISO
Vincristine results in decreased expression of ORAI1 mRNA
CTD
PMID:23649840
NCBI chr12:33,533,151...33,548,361
Ensembl chr12:33,534,344...33,548,405
G
Otp
orthopedia homeobox
increases expression
ISO
Vincristine results in increased expression of OTP mRNA
CTD
PMID:23649840
NCBI chr 2:26,108,158...26,116,359
Ensembl chr 2:26,108,163...26,116,359
G
Oxtr
oxytocin receptor
affects response to substance
ISO
OXTR protein affects the susceptibility to Vincristine
CTD
PMID:33429010
NCBI chr 4:145,598,549...145,614,674
Ensembl chr 4:145,599,561...145,614,674
G
P2rx5
purinergic receptor P2X 5
decreases expression
ISO
Vincristine results in decreased expression of P2RX5 mRNA
CTD
PMID:23649840
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
G
P2rx7
purinergic receptor P2X 7
multiple interactions
EXP
[(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) binds to and results in decreased activity of P2RX7 protein] which results in decreased susceptibility to Vincristine
CTD
PMID:16982702
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
Vincristine results in decreased expression of P4HA1 mRNA
CTD
PMID:23649840
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Pabpc1l
poly(A) binding protein, cytoplasmic 1-like
decreases expression
ISO
Vincristine results in decreased expression of PABPC1L mRNA
CTD
PMID:23649840
NCBI chr 3:152,692,825...152,725,997
Ensembl chr 3:152,693,700...152,725,997
G
Pabpn1
poly(A) binding protein, nuclear 1
decreases expression
ISO
Vincristine results in decreased expression of PABPN1 mRNA
CTD
PMID:23649840
NCBI chr15:28,368,100...28,372,712
Ensembl chr15:28,368,100...28,372,703
G
Paip1
poly(A) binding protein interacting protein 1
decreases expression
ISO
Vincristine results in decreased expression of PAIP1 mRNA
CTD
PMID:23649840
NCBI chr 2:51,523,190...51,550,241
Ensembl chr 2:51,522,921...51,550,241
G
Pank2
pantothenate kinase 2
decreases expression
ISO
Vincristine results in decreased expression of PANK2 mRNA
CTD
PMID:23649840
NCBI chr 3:118,483,382...118,519,551
Ensembl chr 3:118,483,444...118,518,320
G
Paqr4
progestin and adipoQ receptor family member 4
decreases expression
ISO
Vincristine results in decreased expression of PAQR4 mRNA
CTD
PMID:23649840
NCBI chr10:12,758,970...12,762,649
Ensembl chr10:12,758,972...12,762,584
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[CEP 33779 results in increased susceptibility to Vincristine] which results in increased cleavage of PARP1 protein; [NVP-BSK805 results in increased susceptibility to Vincristine] which results in increased cleavage of PARP1 protein
CTD
PMID:28669723
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp2
poly (ADP-ribose) polymerase 2
decreases expression
ISO
Vincristine results in decreased expression of PARP2 mRNA
CTD
PMID:23649840
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
G
Parp9
poly (ADP-ribose) polymerase family, member 9
increases expression
ISO
Vincristine results in increased expression of PARP9 mRNA
CTD
PMID:23649840
NCBI chr11:64,780,977...64,814,995
Ensembl chr11:64,780,981...64,815,455
G
Patl1
PAT1 homolog 1, processing body mRNA decay factor
decreases expression
ISO
Vincristine results in decreased expression of PATL1 mRNA
CTD
PMID:23649840
NCBI chr 1:208,831,115...208,862,904
Ensembl chr 1:208,831,115...208,862,857
G
Pbxip1
PBX homeobox interacting protein 1
increases expression
ISO
Vincristine results in increased expression of PBXIP1 mRNA
CTD
PMID:23649840
NCBI chr 2:174,856,339...174,868,922
Ensembl chr 2:174,856,397...174,868,919
G
Pced1b
PC-esterase domain containing 1B
decreases expression
ISO
Vincristine results in decreased expression of PCED1B mRNA
CTD
PMID:23649840
NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:128,391,319...128,528,231
G
Pcf11
PCF11 cleavage and polyadenylation factor subunit
decreases expression
ISO
Vincristine results in decreased expression of PCF11 mRNA
CTD
PMID:23649840
NCBI chr 1:146,694,045...146,724,030
Ensembl chr 1:146,697,646...146,724,124
G
Pcgf2
polycomb group ring finger 2
decreases expression
ISO
Vincristine results in decreased expression of PCGF2 mRNA
CTD
PMID:23649840
NCBI chr10:82,682,563...82,694,563
Ensembl chr10:82,683,553...82,693,406
G
Pcnx1
pecanex 1
increases expression
ISO
Vincristine results in increased expression of PCNX1 mRNA
CTD
PMID:23649840
NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271
G
Pcnx2
pecanex 2
increases expression
ISO
Vincristine results in increased expression of PCNX2 mRNA
CTD
PMID:23649840
NCBI chr19:53,718,920...53,869,559
Ensembl chr19:53,718,655...53,871,364
G
Pcsk7
proprotein convertase subtilisin/kexin type 7
increases expression
ISO
Vincristine results in increased expression of PCSK7 mRNA
CTD
PMID:23649840
NCBI chr 8:46,202,079...46,224,699
Ensembl chr 8:46,202,131...46,224,705
G
Pdcd5
programmed cell death 5
decreases expression
ISO
Vincristine results in decreased expression of PDCD5 mRNA
CTD
PMID:23649840
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
G
Pde4b
phosphodiesterase 4B
increases expression
ISO
Vincristine results in increased expression of PDE4B mRNA
CTD
PMID:23649840
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pdk1
pyruvate dehydrogenase kinase 1
decreases expression
ISO
Vincristine results in decreased expression of PDK1 mRNA
CTD
PMID:23649840
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pdk3
pyruvate dehydrogenase kinase 3
decreases expression
ISO
Vincristine results in decreased expression of PDK3 mRNA
CTD
PMID:23649840
NCBI chr X:58,486,699...58,553,533
Ensembl chr X:58,486,554...58,553,557
G
Pds5b
PDS5 cohesin associated factor B
increases expression
ISO
Vincristine results in increased expression of PDS5B mRNA
CTD
PMID:23649840
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
ISO
Vincristine results in increased expression of PEA15 mRNA
CTD
PMID:23649840
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Peli1
pellino E3 ubiquitin protein ligase 1
decreases expression
ISO
Vincristine results in decreased expression of PELI1 mRNA
CTD
PMID:23649840
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
G
Pex11b
peroxisomal biogenesis factor 11 beta
decreases expression
ISO
Vincristine results in decreased expression of PEX11B mRNA
CTD
PMID:23649840
NCBI chr 2:184,172,041...184,180,972
Ensembl chr 2:184,172,004...184,181,495
G
Pex13
peroxisomal biogenesis factor 13
decreases expression
ISO
Vincristine results in decreased expression of PEX13 mRNA
CTD
PMID:23649840
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
G
Pfas
phosphoribosylformylglycinamidine synthase
decreases expression
ISO
Vincristine results in decreased expression of PFAS mRNA
CTD
PMID:23649840
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:53,691,626...53,708,420
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
decreases expression
ISO
Vincristine results in decreased expression of PFKFB4 mRNA
CTD
PMID:23649840
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pgm1
phosphoglucomutase 1
decreases expression
ISO
Vincristine results in decreased expression of PGM1 mRNA
CTD
PMID:23649840
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pgp
phosphoglycolate phosphatase
decreases expression
ISO
Vincristine results in decreased expression of PGP mRNA
CTD
PMID:23649840
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Phf11
PHD finger protein 11
increases expression
ISO
Vincristine results in increased expression of PHF11 mRNA
CTD
PMID:23649840
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
G
Phf6
PHD finger protein 6
decreases expression
ISO
Vincristine results in decreased expression of PHF6 mRNA
CTD
PMID:23649840
NCBI chr X:132,656,658...132,699,720
Ensembl chr X:132,656,672...132,699,127
G
Phtf2
putative homeodomain transcription factor 2
decreases expression
ISO
Vincristine results in decreased expression of PHTF2 mRNA
CTD
PMID:23649840
NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
increases expression
ISO
Vincristine results in increased expression of PIK3C2A mRNA
CTD
PMID:23649840
NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases phosphorylation multiple interactions
ISO
Vincristine results in decreased phosphorylation of PIK3R1 protein 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Vincristine results in decreased phosphorylation of PIK3R1 protein]; bisphenol A inhibits the reaction [Vincristine results in decreased phosphorylation of PIK3R1 protein]; perfluorooctanoic acid inhibits the reaction [Vincristine results in decreased phosphorylation of PIK3R1 protein]
CTD
PMID:36181250
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
ISO
Vincristine results in decreased expression of PIK3R2 mRNA
CTD
PMID:23649840
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pilra
paired immunoglobin-like type 2 receptor alpha
increases expression
ISO
Vincristine results in increased expression of PILRA mRNA
CTD
PMID:23649840
NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094
G
Pim2
Pim-2 proto-oncogene, serine/threonine kinase
increases expression
ISO
Vincristine results in increased expression of PIM2 mRNA
CTD
PMID:23649840
NCBI chr X:14,617,582...14,622,851
Ensembl chr X:14,617,582...14,622,851
G
Pitpnb
phosphatidylinositol transfer protein, beta
decreases expression
ISO
Vincristine results in decreased expression of PITPNB mRNA
CTD
PMID:23649840
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
G
Pkig
cAMP-dependent protein kinase inhibitor gamma
increases expression
ISO
Vincristine results in increased expression of PKIG mRNA
CTD
PMID:23649840
NCBI chr 3:152,330,477...152,398,085
Ensembl chr 3:152,366,041...152,398,082
G
Pla1a
phospholipase A1 member A
increases expression
ISO
Vincristine results in increased expression of PLA1A mRNA
CTD
PMID:23649840
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
G
Pla2g4c
phospholipase A2 group IVC
increases expression
ISO
Vincristine results in increased expression of PLA2G4C mRNA
CTD
PMID:23649840
NCBI chr 1:74,237,714...74,275,757
Ensembl chr 1:74,236,211...74,274,656
G
Plat
plasminogen activator, tissue type
increases expression
EXP
Vincristine results in increased expression of PLAT mRNA
CTD
PMID:20624997
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
Vincristine results in increased expression of PLAUR mRNA
CTD
PMID:20624997
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plcxd1
phosphatidylinositol-specific phospholipase C, X domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of PLCXD1 mRNA
CTD
PMID:23649840
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
G
Plek
pleckstrin
increases expression
ISO
Vincristine results in increased expression of PLEK mRNA
CTD
PMID:23649840
NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131
G
Plekha2
pleckstrin homology domain containing A2
decreases expression
ISO
Vincristine results in decreased expression of PLEKHA2 mRNA
CTD
PMID:23649840
NCBI chr16:66,938,684...67,000,661
Ensembl chr16:66,939,109...66,999,395
G
Plekhg1
pleckstrin homology and RhoGEF domain containing G1
increases expression
ISO
Vincristine results in increased expression of PLEKHG1 mRNA
CTD
PMID:23649840
NCBI chr 1:40,348,684...40,434,063
Ensembl chr 1:40,311,221...40,434,063
G
Plpp3
phospholipid phosphatase 3
increases expression
ISO
Vincristine results in increased expression of PLPP3 mRNA
CTD
PMID:23649840
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Pm20d2
peptidase M20 domain containing 2
decreases expression
ISO
Vincristine results in decreased expression of PM20D2 mRNA
CTD
PMID:23649840
NCBI chr 5:47,566,059...47,586,334
Ensembl chr 5:47,566,072...47,586,212
G
Pmp22
peripheral myelin protein 22
increases response to substance
ISO
PMP22 gene mutant form results in increased susceptibility to Vincristine
CTD
PMID:12427913
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
Vincristine results in decreased expression of PMS1 mRNA
CTD
PMID:23649840
NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237
G
Pnisr
PNN interacting serine and arginine rich protein
decreases expression
ISO
Vincristine results in decreased expression of PNISR mRNA
CTD
PMID:23649840
NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:35,395,965...35,422,844
G
Pnoc
prepronociceptin
decreases expression
ISO
Vincristine results in decreased expression of PNOC mRNA
CTD
PMID:23649840
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
Poglut1
protein O-glucosyltransferase 1
increases expression
ISO
Vincristine results in increased expression of POGLUT1 mRNA
CTD
PMID:23649840
NCBI chr11:62,198,600...62,226,446
Ensembl chr11:62,198,513...62,226,434
G
Pogz
pogo transposable element derived with ZNF domain
increases expression
ISO
Vincristine results in increased expression of POGZ mRNA
CTD
PMID:23649840
NCBI chr 2:182,394,269...182,440,711
Ensembl chr 2:182,380,768...182,440,707
G
Pola1
DNA polymerase alpha 1, catalytic subunit
decreases expression
ISO
Vincristine results in decreased expression of POLA1 mRNA
CTD
PMID:23649840
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Pold3
DNA polymerase delta 3, accessory subunit
decreases expression
ISO
Vincristine results in decreased expression of POLD3 mRNA
CTD
PMID:23649840
NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665
G
Polq
DNA polymerase theta
increases expression
ISO
Vincristine results in increased expression of POLQ mRNA
CTD
PMID:23649840
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
G
Polr1b
RNA polymerase I subunit B
decreases expression
ISO
Vincristine results in decreased expression of POLR1B mRNA
CTD
PMID:23649840
NCBI chr 3:116,333,910...116,358,385
Ensembl chr 3:116,333,889...116,358,379
G
Polr1h
RNA polymerase I subunit H
decreases response to substance multiple interactions
ISO
POLR1H protein results in decreased susceptibility to Vincristine Verapamil inhibits the reaction [POLR1H protein results in decreased susceptibility to Vincristine]
CTD
PMID:14726695
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
G
Postn
periostin
decreases response to substance
ISO
POSTN mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Pou2af1
POU class 2 homeobox associating factor 1
decreases expression
ISO
Vincristine results in decreased expression of POU2AF1 mRNA
CTD
PMID:23649840
NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:51,474,015...51,548,819
G
Pou2f1
POU class 2 homeobox 1
decreases expression
ISO
Vincristine results in decreased expression of POU2F1 mRNA
CTD
PMID:23649840
NCBI chr13:78,120,617...78,263,306
Ensembl chr13:78,130,685...78,263,363
G
Ppargc1a
PPARG coactivator 1 alpha
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of PPARGC1A protein Quercetin inhibits the reaction [Vincristine results in decreased expression of PPARGC1A protein]
CTD
PMID:36808657
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppm1a
protein phosphatase, Mg2+/Mn2+ dependent, 1A
increases expression
ISO
Vincristine results in increased expression of PPM1A mRNA
CTD
PMID:23649840
NCBI chr 6:91,439,094...91,486,139
Ensembl chr 6:91,438,834...91,480,697
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression
ISO
Vincristine results in increased expression of PPP1R10 mRNA
CTD
PMID:23649840
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
EXP ISO
Vincristine results in increased expression of PPP1R15A mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
increases response to substance
ISO
PPP1R1B protein results in increased susceptibility to Vincristine
CTD
PMID:17470401
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Ppp1r3e
protein phosphatase 1, regulatory subunit 3E
decreases expression
ISO
Vincristine results in decreased expression of PPP1R3E mRNA
CTD
PMID:23649840
NCBI chr15:28,348,443...28,349,603
Ensembl chr15:28,347,854...28,349,603
G
Ppp4r3b
protein phosphatase 4, regulatory subunit 3B
decreases expression
ISO
Vincristine results in decreased expression of PPP4R3B mRNA
CTD
PMID:23649840
NCBI chr14:102,917,043...102,965,210
Ensembl chr14:102,917,443...103,068,192
G
Prc1
protein regulator of cytokinesis 1
increases expression
ISO
Vincristine results in increased expression of PRC1 mRNA
CTD
PMID:17374387
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prim1
DNA primase subunit 1
decreases expression
ISO
Vincristine results in decreased expression of PRIM1 mRNA
CTD
PMID:23649840
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prkcd
protein kinase C, delta
affects localization
ISO
Vincristine affects the localization of PRKCD protein
CTD
PMID:9852137
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkce
protein kinase C, epsilon
increases response to substance
EXP
PRKCE protein results in increased susceptibility to Vincristine
CTD
PMID:12809704
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
increases expression
ISO
Vincristine results in increased expression of PRKDC mRNA
CTD
PMID:23649840
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Prlr
prolactin receptor
increases expression
ISO
Vincristine results in increased expression of PRLR mRNA
CTD
PMID:23649840
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prnp
prion protein
decreases response to substance
ISO
PRNP protein results in decreased susceptibility to Vincristine
CTD
PMID:15386405
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Prpf4b
pre-mRNA processing factor 4B
decreases expression
ISO
Vincristine results in decreased expression of PRP4K mRNA
CTD
PMID:23649840
NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625
G
Prr12
proline rich 12
decreases expression
ISO
Vincristine results in decreased expression of PRR12 mRNA
CTD
PMID:23649840
NCBI chr 1:95,510,015...95,534,002
Ensembl chr 1:95,509,931...95,533,652
G
Prr3
proline rich 3
decreases expression
ISO
Vincristine results in decreased expression of PRR3 mRNA
CTD
PMID:23649840
NCBI chr20:2,792,868...2,799,865
Ensembl chr20:2,792,860...2,799,865
G
Prrg4
proline rich and Gla domain 4
increases expression
ISO
Vincristine results in increased expression of PRRG4 mRNA
CTD
PMID:23649840
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
Vincristine results in increased expression of PSD3 mRNA
CTD
PMID:23649840
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psme4
proteasome activator subunit 4
increases expression
ISO
Vincristine results in increased expression of PSME4 mRNA
CTD
PMID:23649840
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
G
Psmg4
proteasome assembly chaperone 4
increases expression
ISO
Vincristine results in increased expression of PSMG4 mRNA
CTD
PMID:23649840
NCBI chr17:30,710,682...30,718,035
Ensembl chr17:30,710,682...30,718,082
G
Pspc1
paraspeckle component 1
decreases expression
ISO
Vincristine results in decreased expression of PSPC1 mRNA
CTD
PMID:23649840
NCBI chr15:30,828,617...30,911,315
Ensembl chr15:30,828,626...30,911,202
G
Ptafr
platelet-activating factor receptor
increases expression
ISO
Vincristine results in increased expression of PTAFR mRNA
CTD
PMID:23649840
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Ptger4
prostaglandin E receptor 4
increases expression
ISO
Vincristine results in increased expression of PTGER4 mRNA
CTD
PMID:23649840
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgr2
prostaglandin reductase 2
decreases expression
ISO
Vincristine results in decreased expression of PTGR2 mRNA
CTD
PMID:23649840
NCBI chr 6:103,931,367...103,963,113
Ensembl chr 6:103,931,409...103,963,111
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
ISO
Vincristine results in increased expression of PTGS2 mRNA; Vincristine results in increased expression of PTGS2 protein KN 93 inhibits the reaction [Vincristine results in increased expression of PTGS2 mRNA]; KN 93 inhibits the reaction [Vincristine results in increased expression of PTGS2 protein]
CTD
PMID:34286406
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2b
protein tyrosine kinase 2 beta
increases phosphorylation
ISO
Vincristine results in increased phosphorylation of PTK2B protein
CTD
PMID:11478917
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
decreases expression
ISO
Vincristine results in decreased expression of PTPN11 mRNA
CTD
PMID:23649840
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
increases expression
ISO
Vincristine results in increased expression of PTPN13 mRNA
CTD
PMID:23649840
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Ptpn3
protein tyrosine phosphatase, non-receptor type 3
increases expression
ISO
Vincristine results in increased expression of PTPN3 mRNA
CTD
PMID:23649840
NCBI chr 5:71,908,520...72,027,323
Ensembl chr 5:71,911,135...72,065,443
G
Ptprk
protein tyrosine phosphatase, receptor type, K
increases expression
ISO
Vincristine results in increased expression of PTPRK mRNA
CTD
PMID:23649840
NCBI chr 1:16,738,896...17,236,687
Ensembl chr 1:16,850,576...17,103,605
G
Ptpro
protein tyrosine phosphatase, receptor type, O
increases expression
ISO
Vincristine results in increased expression of PTPRO mRNA
CTD
PMID:23649840
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
G
Ptprr
protein tyrosine phosphatase, receptor type, R
increases expression
ISO
Vincristine results in increased expression of PTPRR mRNA
CTD
PMID:23649840
NCBI chr 7:51,662,595...51,929,605
Ensembl chr 7:51,662,595...51,929,603
G
Pvrig
PVR related immunoglobulin domain containing
decreases expression
ISO
Vincristine results in decreased expression of PVRIG mRNA
CTD
PMID:23649840
NCBI chr12:17,363,721...17,365,577
Ensembl chr12:17,364,080...17,365,280
G
Pxt1
peroxisomal testis enriched protein 1
increases expression
ISO
Vincristine results in increased expression of PXT1 mRNA
CTD
PMID:23649840
NCBI chr20:7,002,270...7,005,296
Ensembl chr20:7,002,271...7,006,780
G
Qrich1
glutamine-rich 1
increases phosphorylation
ISO
Vincristine results in increased phosphorylation of QRICH1 protein
CTD
PMID:17510977
NCBI chr 8:109,216,900...109,256,472
Ensembl chr 8:109,217,376...109,261,359
G
Rab11fip1
RAB11 family interacting protein 1
increases expression
ISO
Vincristine results in increased expression of RAB11FIP1 mRNA
CTD
PMID:23649840
NCBI chr16:64,886,902...64,917,491
Ensembl chr16:64,884,676...64,917,491
G
Rab11fip3
RAB11 family interacting protein 3
increases expression
ISO
Vincristine results in increased expression of RAB11FIP3 mRNA
CTD
PMID:23649840
NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479
G
Rab12
RAB12, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB12 mRNA
CTD
PMID:23649840
NCBI chr 9:106,480,301...106,506,895
Ensembl chr 9:106,480,301...106,506,910
G
Rab20
RAB20, member RAS oncogene family
decreases expression
ISO
Vincristine results in decreased expression of RAB20 mRNA
CTD
PMID:23649840
NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529
G
Rab21
RAB21, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB21 mRNA
CTD
PMID:23649840
NCBI chr 7:50,904,050...50,928,890
Ensembl chr 7:50,904,057...50,928,839
G
Rab29
RAB29, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB29 mRNA
CTD
PMID:23649840
NCBI chr13:43,307,757...43,313,420
Ensembl chr13:43,307,775...43,313,417
G
Rab8b
RAB8B, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB8B mRNA
CTD
PMID:23649840
NCBI chr 8:67,458,921...67,536,466
Ensembl chr 8:67,458,923...67,536,384
G
Rab9a
RAB9A, member RAS oncogene family
increases expression
ISO
Vincristine results in increased expression of RAB9A mRNA
CTD
PMID:23649840
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
G
Rabggtb
Rab geranylgeranyltransferase subunit beta
decreases expression
ISO
Vincristine results in decreased expression of RABGGTB mRNA
CTD
PMID:23649840
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
G
Rabif
RAB interacting factor
decreases expression
ISO
Vincristine results in decreased expression of RABIF mRNA
CTD
PMID:23649840
NCBI chr13:45,936,371...45,948,929
Ensembl chr13:45,936,369...45,949,775
G
Rac2
Rac family small GTPase 2
affects response to substance
ISO
RAC2 protein affects the susceptibility to Vincristine
CTD
PMID:19783987
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rack1
receptor for activated C kinase 1
decreases expression
ISO
Vincristine results in decreased expression of RACK1 mRNA
CTD
PMID:23649840
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Rad54l
RAD54 like
decreases expression
ISO
Vincristine results in decreased expression of RAD54L mRNA
CTD
PMID:23649840
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Ralgdsl1
ral guanine nucleotide dissociation stimulator like 1
increases expression
ISO
Vincristine results in increased expression of RGL1 mRNA
CTD
PMID:23649840
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
G
Rasef
RAS and EF hand domain containing
increases expression
ISO
Vincristine results in increased expression of RASEF mRNA
CTD
PMID:23649840
NCBI chr 5:87,548,908...87,619,286
Ensembl chr 5:87,548,908...87,619,031
G
Rassf1
Ras association domain family member 1
increases expression
EXP
Vincristine results in increased expression of RASSF1 mRNA
CTD
PMID:20624997
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rassf4
Ras association domain family member 4
increases expression
ISO
Vincristine results in increased expression of RASSF4 mRNA
CTD
PMID:23649840
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
[CEP 33779 results in increased susceptibility to Vincristine] which results in increased phosphorylation of RB1 protein; [NVP-BSK805 results in increased susceptibility to Vincristine] which results in increased phosphorylation of RB1 protein; [XL019 compound co-treated with Vincristine] results in increased expression of and results in increased phosphorylation of RB1 protein modified form
CTD
PMID:28669723 PMID:29187454
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
increases expression
ISO
Vincristine results in increased expression of RBBP4 mRNA
CTD
PMID:23649840
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
Vincristine results in decreased expression of RBBP8 mRNA
CTD
PMID:23649840
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
Vincristine results in decreased expression of RBL1 mRNA
CTD
PMID:23649840
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbm12
RNA binding motif protein 12
decreases expression
ISO
Vincristine results in decreased expression of RBM12 mRNA
CTD
PMID:23649840
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915 Ensembl chr 3:144,611,623...144,629,915
G
Rbm15
RNA binding motif protein 15
decreases expression
ISO
Vincristine results in decreased expression of RBM15 mRNA
CTD
PMID:23649840
NCBI chr 2:194,945,974...194,954,498
Ensembl chr 2:194,945,974...194,954,703
G
Rbm17
RNA binding motif protein 17
decreases response to substance
ISO
RBM17 protein results in decreased susceptibility to Vincristine
CTD
PMID:16061639
NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014
G
Rbm18
RNA binding motif protein 18
increases expression
ISO
Vincristine results in increased expression of RBM18 mRNA
CTD
PMID:23649840
NCBI chr 3:19,467,333...19,487,171
Ensembl chr 3:19,467,335...19,487,178
G
Rbm25
RNA binding motif protein 25
decreases expression
ISO
Vincristine results in decreased expression of RBM25 mRNA
CTD
PMID:23649840
NCBI chr 6:103,271,775...103,319,090
Ensembl chr 6:103,271,801...103,317,854
G
Rbm4b
RNA binding motif protein 4B
decreases expression
ISO
Vincristine results in decreased expression of RBM4B mRNA
CTD
PMID:23649840
NCBI chr 1:202,047,934...202,058,025
Ensembl chr 1:202,047,927...202,058,020
G
Rbm5
RNA binding motif protein 5
decreases expression
ISO
Vincristine results in decreased expression of RBM5 mRNA
CTD
PMID:23649840
NCBI chr 8:108,420,220...108,449,481
Ensembl chr 8:108,420,222...108,449,430
G
Rbm6
RNA binding motif protein 6
decreases expression
ISO
Vincristine results in decreased expression of RBM6 mRNA
CTD
PMID:23649840
NCBI chr 8:108,452,687...108,552,783
Ensembl chr 8:108,452,687...108,552,771
G
Rbm8a
RNA binding motif protein 8A
decreases expression
ISO
Vincristine results in decreased expression of RBM8A mRNA
CTD
PMID:23649840
NCBI chr 2:184,165,189...184,167,959
Ensembl chr 2:184,165,193...184,167,959
G
Rcc1l
RCC1 like
increases expression
ISO
Vincristine results in increased expression of RCC1L mRNA
CTD
PMID:23649840
NCBI chr12:22,543,125...22,574,042
Ensembl chr12:22,543,734...22,574,036
G
Recql4
RecQ like helicase 4
decreases expression
ISO
Vincristine results in decreased expression of RECQL4 mRNA
CTD
PMID:23649840
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
G
Rel
REL proto-oncogene, NF-kB subunit
increases expression
ISO
Vincristine results in increased expression of REL mRNA
CTD
PMID:23649840
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression increases phosphorylation
EXP ISO
coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of RELA protein]; Sumatriptan inhibits the reaction [Vincristine results in increased phosphorylation of RELA protein] KN 93 inhibits the reaction [Vincristine results in increased phosphorylation of RELA protein]
CTD
PMID:29958920 PMID:34286406 PMID:34939713
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Reps1
RALBP1 associated Eps domain containing 1
increases expression
ISO
Vincristine results in increased expression of REPS1 mRNA
CTD
PMID:23649840
NCBI chr 1:12,697,742...12,775,562
Ensembl chr 1:12,697,747...12,775,561
G
Rev1
REV1, DNA directed polymerase
decreases expression
ISO
Vincristine results in decreased expression of REV1 mRNA
CTD
PMID:23649840
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
G
Rffl
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
increases expression
ISO
Vincristine results in increased expression of RFFL mRNA
CTD
PMID:23649840
NCBI chr10:67,740,711...67,803,669
Ensembl chr10:67,740,712...67,824,434
G
Rftn1
raftlin lipid raft linker 1
increases expression
ISO
Vincristine results in increased expression of RFTN1 mRNA
CTD
PMID:23649840
NCBI chr 9:10,804,611...11,002,084
Ensembl chr 9:10,804,611...11,002,084
G
Rgs1
regulator of G-protein signaling 1
increases expression
ISO
Vincristine results in increased expression of RGS1 mRNA
CTD
PMID:23649840
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rgs10
regulator of G-protein signaling 10
increases response to substance
ISO
RGS10 protein results in increased susceptibility to Vincristine
CTD
PMID:21044322
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
Vincristine results in increased expression of RGS16 mRNA
CTD
PMID:23649840
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs17
regulator of G-protein signaling 17
increases response to substance
ISO
RGS17 protein results in increased susceptibility to Vincristine
CTD
PMID:21044322
NCBI chr 1:42,222,248...42,324,625
Ensembl chr 1:42,227,070...42,324,609
G
Rhof
ras homolog family member F, filopodia associated
increases expression
ISO
Vincristine results in increased expression of RHOF mRNA
CTD
PMID:23649840
NCBI chr12:33,422,375...33,446,689
Ensembl chr12:33,431,280...33,446,703
G
Rhoq
ras homolog family member Q
increases expression
ISO
Vincristine results in increased expression of RHOQ mRNA
CTD
PMID:23649840
NCBI chr 6:7,613,632...7,652,047
G
Rif1
replication timing regulatory factor 1
decreases expression
ISO
Vincristine results in decreased expression of RIF1 mRNA
CTD
PMID:23649840
NCBI chr 3:36,554,689...36,607,961
Ensembl chr 3:36,554,697...36,603,617
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
Vincristine results in increased expression of RIPK2 mRNA
CTD
PMID:23649840
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rnase6
ribonuclease A family member k6
decreases expression
ISO
Vincristine results in decreased expression of RNASE6 mRNA
CTD
PMID:23649840
NCBI chr15:24,354,305...24,357,289
Ensembl chr15:24,354,303...24,357,328
G
Rnf144a
ring finger protein 144A
decreases expression
ISO
Vincristine results in decreased expression of RNF144A mRNA
CTD
PMID:23649840
NCBI chr 6:42,899,767...43,019,769
Ensembl chr 6:42,903,174...43,020,012
G
Rnf19b
ring finger protein 19B
increases expression
ISO
Vincristine results in increased expression of RNF19B mRNA
CTD
PMID:23649840
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Rnf213
ring finger protein 213
decreases expression
ISO
Vincristine results in decreased expression of RNF213 mRNA
CTD
PMID:23649840
NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918
G
Rnf34
ring finger protein 34
increases expression
ISO
Vincristine results in increased expression of RNF34 mRNA
CTD
PMID:23649840
NCBI chr12:33,703,655...33,724,606
Ensembl chr12:33,703,673...33,724,586
G
Rora
RAR-related orphan receptor A
increases expression
ISO
Vincristine results in increased expression of RORA mRNA
CTD
PMID:23649840
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpain
RPA interacting protein
decreases expression
ISO
Vincristine results in decreased expression of RPAIN mRNA
CTD
PMID:23649840
NCBI chr10:55,692,410...55,699,910
Ensembl chr10:55,692,417...55,699,933
G
Rpl10
ribosomal protein L10
decreases expression
ISO
Vincristine results in decreased expression of RPL10 mRNA
CTD
PMID:23649840
NCBI chr X:152,054,562...152,056,769
Ensembl chr X:152,054,452...152,056,761
G
Rpl13
ribosomal protein L13
decreases expression
ISO
Vincristine results in decreased expression of RPL13 mRNA
CTD
PMID:23649840
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
G
Rpl17
ribosomal protein L17
decreases expression
ISO
Vincristine results in decreased expression of RPL17 mRNA
CTD
PMID:23649840
NCBI chr18:68,581,141...68,584,253
Ensembl chr18:68,581,098...68,584,253
G
Rpl31
ribosomal protein L31
decreases expression
ISO
Vincristine results in decreased expression of RPL31 mRNA
CTD
PMID:23649840
NCBI chr 9:41,647,397...41,651,441
Ensembl chr 9:41,647,426...41,662,129
G
Rpl37a
ribosomal protein L37A
decreases expression
ISO
Vincristine results in decreased expression of RPL37A mRNA
CTD
PMID:23649840
NCBI chr 9:74,298,843...74,300,926
G
Rpl5
ribosomal protein L5
decreases expression
ISO
Vincristine results in decreased expression of RPL5 mRNA
CTD
PMID:23649840
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rpl6
ribosomal protein L6
decreases response to substance
ISO
RPL6 protein results in decreased susceptibility to Vincristine
CTD
PMID:15846068
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
G
Rpl7
ribosomal protein L7
decreases expression
ISO
Vincristine results in decreased expression of RPL7 mRNA
CTD
PMID:23649840
NCBI chr 5:3,217,184...3,220,192
G
Rprd1a
regulation of nuclear pre-mRNA domain containing 1A
decreases expression
ISO
Vincristine results in decreased expression of RPRD1A mRNA
CTD
PMID:23649840
NCBI chr18:15,791,418...15,839,338
Ensembl chr18:15,791,418...15,839,338
G
Rps24
ribosomal protein S24
decreases expression
ISO
Vincristine results in decreased expression of RPS24 mRNA
CTD
PMID:23649840
NCBI chr16:89,538...94,267
Ensembl chr16:89,604...94,279
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
Vincristine results in increased expression of RPS27L mRNA
CTD
PMID:23649840
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rragc
Ras-related GTP binding C
increases expression
ISO
Vincristine results in increased expression of RRAGC mRNA
CTD
PMID:23649840
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
Vincristine results in decreased expression of RRM2 mRNA
CTD
PMID:23649840
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rrp7a
ribosomal RNA processing 7 homolog A
decreases expression
ISO
Vincristine results in decreased expression of RRP7A mRNA
CTD
PMID:23649840
NCBI chr 7:114,262,929...114,272,817
Ensembl chr 7:114,256,472...114,272,817
G
Rskr
ribosomal protein S6 kinase related
decreases expression
ISO
Vincristine results in decreased expression of RSKR mRNA
CTD
PMID:23649840
NCBI chr10:63,185,286...63,191,963
Ensembl chr10:63,156,044...63,191,141
G
Rsrp1
arginine and serine rich protein 1
decreases expression
ISO
Vincristine results in decreased expression of RSRP1 mRNA
CTD
PMID:23649840
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
Runx3
RUNX family transcription factor 3
increases response to substance
ISO
RUNX3 protein results in increased susceptibility to Vincristine
CTD
PMID:15756676
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
G
S100a4
S100 calcium-binding protein A4
increases expression
ISO
Vincristine results in increased expression of S100A4 mRNA
CTD
PMID:23649840
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100a8
S100 calcium binding protein A8
increases expression
ISO EXP
Vincristine results in increased expression of S100A8 mRNA
CTD
PMID:20624997 PMID:21971985
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
Vincristine results in increased expression of S100A9 mRNA
CTD
PMID:20624997
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Samhd1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
decreases expression
ISO
Vincristine results in decreased expression of SAMHD1 mRNA
CTD
PMID:23649840
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
increases expression
ISO
Vincristine results in increased expression of SAMSN1 mRNA
CTD
PMID:23649840
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
G
Sarm1
sterile alpha and TIR motif containing 1
increases expression multiple interactions
EXP
Vincristine results in increased expression of SARM1 mRNA coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of SARM1 mRNA]
CTD
PMID:34939713
NCBI chr10:63,369,456...63,393,016
Ensembl chr10:63,369,456...63,392,822
G
Sash3
SAM and SH3 domain containing 3
increases expression
ISO
Vincristine results in increased expression of SASH3 mRNA
CTD
PMID:23649840
NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
Vincristine results in increased expression of SAT1 mRNA
CTD
PMID:23649840
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sbf2
SET binding factor 2
increases expression
ISO
Vincristine results in increased expression of SBF2 mRNA
CTD
PMID:23649840
NCBI chr 1:164,352,892...164,719,883
Ensembl chr 1:164,353,444...164,719,807
G
Sbno1
strawberry notch homolog 1
increases expression
ISO
Vincristine results in increased expression of SBNO1 mRNA
CTD
PMID:23649840
NCBI chr12:32,175,176...32,234,200
Ensembl chr12:32,185,485...32,230,158
G
Scaf11
SR-related CTD-associated factor 11
increases expression
ISO
Vincristine results in increased expression of SCAF11 mRNA
CTD
PMID:23649840
NCBI chr 7:127,571,678...127,624,089
Ensembl chr 7:127,574,463...127,624,101
G
Scamp2
secretory carrier membrane protein 2
decreases expression
ISO
Vincristine results in decreased expression of SCAMP2 mRNA
CTD
PMID:23649840
NCBI chr 8:57,965,612...57,992,248
Ensembl chr 8:57,965,631...57,992,646
G
Sclt1
sodium channel and clathrin linker 1
increases expression
ISO
Vincristine results in increased expression of SCLT1 mRNA
CTD
PMID:23649840
NCBI chr 2:124,605,445...124,763,964
Ensembl chr 2:124,605,658...124,764,065
G
Scly
selenocysteine lyase
decreases expression
ISO
Vincristine results in decreased expression of SCLY mRNA
CTD
PMID:23649840
NCBI chr 9:91,890,269...91,910,947
Ensembl chr 9:91,890,306...91,910,941
G
Sdcbp
syndecan binding protein
increases expression
ISO
Vincristine results in increased expression of SDCBP mRNA
CTD
PMID:23649840
NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:19,489,961...19,527,572
G
Sec31b
SEC31 homolog B, COPII coat complex component
decreases expression
ISO
Vincristine results in decreased expression of SEC31B mRNA
CTD
PMID:23649840
NCBI chr 1:243,376,283...243,404,557
Ensembl chr 1:243,378,456...243,404,557
G
Sec62
SEC62 homolog, preprotein translocation factor
decreases expression
ISO
Vincristine results in decreased expression of SEC62 mRNA
CTD
PMID:23649840
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
G
Sele
selectin E
increases expression
EXP
Vincristine results in increased expression of SELE mRNA
CTD
PMID:20624997
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selenoh
selenoprotein H
decreases expression
ISO
Vincristine results in decreased expression of SELENOH mRNA
CTD
PMID:23649840
NCBI chr 3:69,751,850...69,753,417
Ensembl chr 3:69,752,757...69,753,417
G
Senp1
SUMO specific peptidase 1
decreases expression
ISO
Vincristine results in decreased expression of SENP1 mRNA
CTD
PMID:23649840
NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
G
Septin6
septin 6
decreases expression
ISO
Vincristine results in decreased expression of SEPTIN6 mRNA
CTD
PMID:23649840
NCBI chr X:116,153,255...116,230,334
Ensembl chr X:116,153,255...116,230,115
G
Serinc5
serine incorporator 5
increases expression
ISO
Vincristine results in increased expression of SERINC5 mRNA
CTD
PMID:23649840
NCBI chr 2:23,846,899...23,950,346
Ensembl chr 2:23,846,900...23,950,346
G
Serpinb10
serpin family B member 10
increases expression
ISO
Vincristine results in increased expression of SERPINB10 mRNA
CTD
PMID:23649840
NCBI chr13:23,553,348...23,571,182
Ensembl chr13:23,553,430...23,571,182
G
Serpinb2
serpin family B member 2
increases expression
ISO
Vincristine results in increased expression of SERPINB2 mRNA
CTD
PMID:23649840
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Serpinb8
serpin family B member 8
increases expression
ISO
Vincristine results in increased expression of SERPINB8 mRNA
CTD
PMID:23649840
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpine1
serpin family E member 1
increases expression increases response to substance
EXP ISO
Vincristine results in increased expression of SERPINE1 mRNA SERPINE1 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:20624997 PMID:21245421
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sertad3
SERTA domain containing 3
decreases expression
ISO
Vincristine results in decreased expression of SERTAD3 mRNA
CTD
PMID:23649840
NCBI chr 1:82,763,535...82,767,271
Ensembl chr 1:82,763,149...82,769,001
G
Sesn1
sestrin 1
increases expression
EXP
Vincristine results in increased expression of SESN1 mRNA
CTD
PMID:20624997
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sesn2
sestrin 2
increases expression
ISO
Vincristine results in increased expression of SESN2 mRNA
CTD
PMID:23649840
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Setbp1
SET binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of SETBP1 mRNA
CTD
PMID:23649840
NCBI chr18:72,190,542...72,551,272
Ensembl chr18:72,191,035...72,552,556
G
Setd1b
SET domain containing 1B, histone lysine methyltransferase
decreases expression
ISO
Vincristine results in decreased expression of SETD1B mRNA
CTD
PMID:23649840
NCBI chr12:33,395,963...33,421,671
Ensembl chr12:33,396,120...33,426,934
G
Setd6
SET domain containing 6, protein lysine methyltransferase
decreases expression
ISO
Vincristine results in decreased expression of SETD6 mRNA
CTD
PMID:23649840
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
G
Sfxn3
sideroflexin 3
increases expression
ISO
Vincristine results in increased expression of SFXN3 mRNA
CTD
PMID:23649840
NCBI chr 1:243,907,958...243,917,065
Ensembl chr 1:243,907,751...243,917,073
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
Vincristine results in increased expression of SGK1 mRNA
CTD
PMID:23649840
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sh3yl1
SH3 and SYLF domain containing 1
increases expression
ISO
Vincristine results in increased expression of SH3YL1 mRNA
CTD
PMID:23649840
NCBI chr 6:47,522,098...47,565,858
Ensembl chr 6:47,522,091...47,565,858
G
Shisa8
shisa family member 8
decreases expression
ISO
Vincristine results in decreased expression of SHISA8 mRNA
CTD
PMID:23649840
NCBI chr 7:113,722,408...113,727,858
Ensembl chr 7:113,722,408...113,727,858
G
Siah1
siah E3 ubiquitin protein ligase 1
decreases expression
ISO
Vincristine results in decreased expression of SIAH1 mRNA
CTD
PMID:23649840
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Siah2
siah E3 ubiquitin protein ligase 2
increases expression
ISO
Vincristine results in increased expression of SIAH2 mRNA
CTD
PMID:23649840
NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950
G
Sidt2
SID1 transmembrane family, member 2
increases expression
ISO
Vincristine results in increased expression of SIDT2 mRNA
CTD
PMID:23649840
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
G
Sirt1
sirtuin 1
decreases expression multiple interactions
EXP
Vincristine results in decreased expression of SIRT1 protein Quercetin inhibits the reaction [Vincristine results in decreased expression of SIRT1 protein]
CTD
PMID:36808657
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Siva1
SIVA1, apoptosis-inducing factor
decreases expression
ISO
Vincristine results in decreased expression of SIVA1 mRNA
CTD
PMID:23649840
NCBI chr 6:131,705,323...131,709,697
Ensembl chr 6:131,705,323...131,709,690
G
Six1
SIX homeobox 1
decreases expression
ISO
Vincristine results in decreased expression of SIX1 mRNA
CTD
PMID:23649840
NCBI chr 6:91,746,739...91,751,975
Ensembl chr 6:91,746,739...91,751,975
G
Skil
SKI-like proto-oncogene
increases expression
ISO
Vincristine results in increased expression of SKIL mRNA
CTD
PMID:23649840
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Skp2
S-phase kinase associated protein 2
decreases expression
ISO
Vincristine results in decreased expression of SKP2 mRNA
CTD
PMID:23649840
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression
ISO
Vincristine results in increased expression of SLAMF1 mRNA
CTD
PMID:23649840
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
G
Slamf7
SLAM family member 7
increases expression
ISO
Vincristine results in increased expression of SLAMF7 mRNA
CTD
PMID:23649840
NCBI chr13:84,135,656...84,154,528
Ensembl chr13:84,136,899...84,154,105
G
Slc10a2
solute carrier family 10 member 2
increases response to substance
ISO
SLC10A2 gene SNP results in increased susceptibility to Vincristine
CTD
PMID:21245421
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Slc15a4
solute carrier family 15 member 4
decreases expression
ISO
Vincristine results in decreased expression of SLC15A4 mRNA
CTD
PMID:23649840
NCBI chr12:29,048,634...29,082,480
Ensembl chr12:29,063,015...29,082,480
G
Slc16a14
solute carrier family 16, member 14
decreases expression
ISO
Vincristine results in decreased expression of SLC16A14 mRNA
CTD
PMID:23649840
NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318
G
Slc20a1
solute carrier family 20 member 1
decreases expression
ISO
Vincristine results in decreased expression of SLC20A1 mRNA
CTD
PMID:23649840
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a23
solute carrier family 22, member 23
increases expression
ISO
Vincristine results in increased expression of SLC22A23 mRNA
CTD
PMID:23649840
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc25a1
solute carrier family 25 member 1
decreases expression
ISO
Vincristine results in decreased expression of SLC25A1 mRNA
CTD
PMID:23649840
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a11
solute carrier family 25 member 11
decreases expression
ISO
Vincristine results in decreased expression of SLC25A11 mRNA
CTD
PMID:23649840
NCBI chr10:55,357,590...55,360,441
Ensembl chr10:55,357,597...55,360,410
G
Slc25a37
solute carrier family 25 member 37
decreases expression
ISO
Vincristine results in decreased expression of SLC25A37 mRNA
CTD
PMID:23649840
NCBI chr15:44,534,280...44,576,697
Ensembl chr15:44,536,727...44,577,199
G
Slc29a1
solute carrier family 29 member 1
decreases expression
ISO
Vincristine results in decreased expression of SLC29A1 mRNA
CTD
PMID:23649840
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc29a2
solute carrier family 29 member 2
decreases expression
ISO
Vincristine results in decreased expression of SLC29A2 mRNA
CTD
PMID:23649840
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Slc2a1
solute carrier family 2 member 1
decreases response to substance
ISO
SLC2A1 protein results in decreased susceptibility to Vincristine
CTD
PMID:17520257
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc44a5
solute carrier family 44, member 5
increases expression
ISO
Vincristine results in increased expression of SLC44A5 mRNA
CTD
PMID:23649840
NCBI chr 2:242,911,050...243,208,018
Ensembl chr 2:242,911,325...243,206,404
G
Slc4a7
solute carrier family 4 member 7
decreases expression
ISO
Vincristine results in decreased expression of SLC4A7 mRNA
CTD
PMID:23649840
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Vincristine results in increased expression of SLC7A11 mRNA
CTD
PMID:23649840
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc9a9
solute carrier family 9 member A9
increases expression
ISO
Vincristine results in increased expression of SLC9A9 mRNA
CTD
PMID:23649840
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
G
Slco4c1
solute carrier organic anion transporter family, member 4C1
decreases expression
ISO
Vincristine results in decreased expression of SLCO4C1 mRNA
CTD
PMID:23649840
NCBI chr 9:97,177,497...97,229,161
Ensembl chr 9:97,178,861...97,229,715
G
Smad1
SMAD family member 1
increases expression
ISO
Vincristine results in increased expression of SMAD1 mRNA
CTD
PMID:23649840
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smad2
SMAD family member 2
decreases expression
ISO
Vincristine results in decreased expression of SMAD2 mRNA
CTD
PMID:23649840
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smad4
SMAD family member 4
increases expression
ISO
Vincristine results in increased expression of SMAD4 mRNA
CTD
PMID:23649840
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Smc6
structural maintenance of chromosomes 6
decreases expression
ISO
Vincristine results in decreased expression of SMC6 mRNA
CTD
PMID:23649840
NCBI chr 6:33,978,730...34,033,201
Ensembl chr 6:33,978,716...34,031,746
G
Snapc3
small nuclear RNA activating complex, polypeptide 3
decreases expression
ISO
Vincristine results in decreased expression of SNAPC3 mRNA
CTD
PMID:23649840
NCBI chr 5:97,817,827...97,868,494
Ensembl chr 5:97,817,947...97,844,650
G
Snn
stannin
increases expression
ISO
Vincristine results in increased expression of SNN mRNA
CTD
PMID:23649840
NCBI chr10:4,572,933...4,581,606
Ensembl chr10:4,572,376...4,584,021
G
Snord104
small nucleolar RNA, C/D box 104
decreases expression
ISO
Vincristine results in decreased expression of SNORD104 mRNA
CTD
PMID:23649840
NCBI chr10:91,435,313...91,435,382
Ensembl chr10:91,435,313...91,435,382
G
Snrnp200
small nuclear ribonucleoprotein U5 subunit 200
increases expression
ISO
Vincristine results in increased expression of SNRNP200 mRNA
CTD
PMID:23649840
NCBI chr 3:114,428,854...114,458,194
Ensembl chr 3:114,428,854...114,458,182
G
Snrpa1
small nuclear ribonucleoprotein polypeptide A'
increases expression
ISO
Vincristine results in increased expression of SNRPA1 mRNA
CTD
PMID:23649840
NCBI chr 1:119,641,402...119,654,653
Ensembl chr 1:119,638,481...119,654,653
G
Snrpn
small nuclear ribonucleoprotein polypeptide N
decreases expression
ISO
Vincristine results in decreased expression of SNRPN mRNA
CTD
PMID:23649840
NCBI chr 1:111,101,327...111,123,400
Ensembl chr 1:111,101,329...111,123,634
G
Snu13
small nuclear ribonucleoprotein 13
decreases expression
ISO
Vincristine results in decreased expression of SNU13 mRNA
CTD
PMID:23649840
NCBI chr 7:113,565,293...113,570,887
Ensembl chr 7:113,565,295...113,570,872 Ensembl chr 1:113,565,295...113,570,872
G
Snx11
sorting nexin 11
increases expression
ISO
Vincristine results in increased expression of SNX11 mRNA
CTD
PMID:23649840
NCBI chr10:81,742,020...81,752,778
Ensembl chr10:81,742,024...81,752,712
G
Snx25
sorting nexin 25
decreases expression
ISO
Vincristine results in decreased expression of SNX25 mRNA
CTD
PMID:23649840
NCBI chr16:46,134,552...46,238,471
Ensembl chr16:46,125,804...46,238,440
G
Snx4
sorting nexin 4
decreases expression
ISO
Vincristine results in decreased expression of SNX4 mRNA
CTD
PMID:23649840
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Snx5
sorting nexin 5
decreases expression
ISO
Vincristine results in decreased expression of SNX5 mRNA
CTD
PMID:23649840
NCBI chr 3:131,621,875...131,641,127
Ensembl chr 3:131,621,880...131,641,192
G
Sobp
sine oculis binding protein homolog
decreases expression
ISO
Vincristine results in decreased expression of SOBP mRNA
CTD
PMID:23649840
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
Vincristine results in increased expression of SOCS3 mRNA
CTD
PMID:23649840
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
bisindolylmaleimide I inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; calphostin C inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; Cycloheximide promotes the reaction [Vincristine results in increased expression of SOD2 mRNA]; Dactinomycin inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Vincristine results in increased expression of SOD2 mRNA]
CTD
PMID:9852137
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Son
SON DNA and RNA binding protein
decreases expression
ISO
Vincristine results in decreased expression of SON mRNA
CTD
PMID:23649840
NCBI chr11:30,850,890...30,923,167
Ensembl chr11:30,892,005...30,923,167
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
increases expression
ISO
Vincristine results in increased expression of SOS1 mRNA
CTD
PMID:16001973
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
G
Sp1
Sp1 transcription factor
decreases expression
ISO
Vincristine results in decreased expression of SP1 mRNA
CTD
PMID:23649840
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Sp100
SP100 nuclear antigen
increases expression
ISO
Vincristine results in increased expression of SP100 mRNA
CTD
PMID:23649840
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
G
Sp4
Sp4 transcription factor
decreases expression
ISO
Vincristine results in decreased expression of SP4 mRNA
CTD
PMID:23649840
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Spart
spartin
decreases expression
ISO
Vincristine results in decreased expression of SPART mRNA
CTD
PMID:23649840
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
G
Spic
Spi-C transcription factor
increases expression
ISO
Vincristine results in increased expression of SPIC mRNA
CTD
PMID:23649840
NCBI chr 7:23,069,815...23,077,517
Ensembl chr 7:23,069,821...23,077,548
G
Spin4
spindlin family, member 4
decreases expression
ISO
Vincristine results in decreased expression of SPIN4 mRNA
CTD
PMID:23649840
NCBI chr X:59,888,728...59,892,817
Ensembl chr X:59,891,581...59,892,330
G
Spon1
spondin 1
increases expression
EXP
Vincristine results in increased expression of SPON1 mRNA
CTD
PMID:20624997
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spred1
sprouty-related, EVH1 domain containing 1
increases expression
ISO
Vincristine results in increased expression of SPRED1 mRNA
CTD
PMID:23649840
NCBI chr 3:103,983,120...104,050,321
Ensembl chr 3:103,983,072...104,049,718
G
Spry1
sprouty RTK signaling antagonist 1
decreases expression
ISO
Vincristine results in decreased expression of SPRY1 mRNA
CTD
PMID:23649840
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
G
Sqstm1
sequestosome 1
multiple interactions increases expression
ISO
[cotylenin A co-treated with Vincristine] results in increased degradation of SQSTM1 protein Vincristine results in increased expression of SQSTM1 mRNA
CTD
PMID:23649840 PMID:25672400
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
Vincristine results in decreased expression of SREBF1 mRNA
CTD
PMID:23649840
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srek1
splicing regulatory glutamic acid and lysine rich protein 1
decreases expression
ISO
Vincristine results in decreased expression of SREK1 mRNA
CTD
PMID:23649840
NCBI chr 2:34,849,548...34,885,120
Ensembl chr 2:34,852,458...34,884,972
G
Srgn
serglycin
increases expression
ISO
Vincristine results in increased expression of SRGN mRNA
CTD
PMID:23649840
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Sri
sorcin
decreases response to substance
ISO
SRI protein results in decreased susceptibility to Vincristine
CTD
PMID:18423116
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
G
Srm
spermidine synthase
decreases expression
ISO
Vincristine results in decreased expression of SRM mRNA
CTD
PMID:23649840
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
Vincristine results in decreased expression of SRSF3 mRNA
CTD
PMID:23649840
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srsf7
serine and arginine rich splicing factor 7
decreases expression
ISO
Vincristine results in decreased expression of SRSF7 mRNA
CTD
PMID:23649840
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Ssbp1
single stranded DNA binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of SSBP1 mRNA
CTD
PMID:23649840
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
G
Sstr2
somatostatin receptor 2
increases expression
ISO
Vincristine results in increased expression of SSTR2 mRNA
CTD
PMID:23649840
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
G
Stag1
STAG1 cohesin complex component
increases expression
ISO
Vincristine results in increased expression of STAG1 mRNA
CTD
PMID:23649840
NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677
G
Stambpl1
STAM binding protein-like 1
decreases expression
ISO
Vincristine results in decreased expression of STAMBPL1 mRNA
CTD
PMID:23649840
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
G
Stat1
signal transducer and activator of transcription 1
increases expression
ISO
Vincristine results in increased expression of STAT1 mRNA
CTD
PMID:16001973
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions increases expression
EXP
Quercetin inhibits the reaction [Vincristine results in increased expression of STAT3 protein]
CTD
PMID:36808657
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stip1
stress-induced phosphoprotein 1
decreases expression
ISO
Vincristine results in decreased expression of STIP1 mRNA
CTD
PMID:23649840
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Stk4
serine/threonine kinase 4
increases expression
ISO
Vincristine results in increased expression of STK4 mRNA
CTD
PMID:23649840
NCBI chr 3:152,745,958...152,827,747
Ensembl chr 3:152,745,681...152,827,744
G
Strip2
striatin interacting protein 2
decreases expression
ISO
Vincristine results in decreased expression of STRIP2 mRNA
CTD
PMID:23649840
NCBI chr 4:58,536,034...58,578,279
Ensembl chr 4:58,536,055...58,578,291
G
Sts
steroid sulfatase
decreases expression
ISO
Vincristine results in decreased expression of STS mRNA
CTD
PMID:23649840
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Stx12
syntaxin 12
increases expression
ISO
Vincristine results in increased expression of STX12 mRNA
CTD
PMID:23649840
NCBI chr 5:145,062,978...145,092,423
Ensembl chr 5:145,063,587...145,092,377
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
ISO
Vincristine results in increased expression of SUN2 mRNA
CTD
PMID:23649840
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Supt20h
SPT20 homolog, SAGA complex component
increases expression
ISO
Vincristine results in increased expression of SUPT20H mRNA
CTD
PMID:23649840
NCBI chr 2:138,897,316...138,930,493
Ensembl chr 2:138,897,416...138,930,495
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
increases expression
ISO
Vincristine results in increased expression of SUZ12 mRNA
CTD
PMID:23649840
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
G
Syf2
SYF2 pre-mRNA-splicing factor
increases expression
ISO
Vincristine results in increased expression of SYF2 mRNA
CTD
PMID:23649840
NCBI chr 5:147,156,492...147,164,416
Ensembl chr 5:147,156,480...147,164,414
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Vincristine results in decreased expression of SYNCRIP mRNA
CTD
PMID:23649840
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
Vincristine results in decreased expression of SYNE2 mRNA
CTD
PMID:23649840
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Sypl2
synaptophysin-like 2
increases expression
ISO
Vincristine results in increased expression of SYPL2 mRNA
CTD
PMID:23649840
NCBI chr 2:195,849,062...195,863,794
Ensembl chr 2:195,849,062...195,863,794
G
Sytl3
synaptotagmin-like 3
increases expression
ISO
Vincristine results in increased expression of SYTL3 mRNA
CTD
PMID:23649840
NCBI chr 1:46,896,308...46,967,461
Ensembl chr 1:46,911,217...46,967,460
G
Taf15
TATA-box binding protein associated factor 15
increases expression
ISO
Vincristine results in increased expression of TAF15 mRNA
CTD
PMID:23649840
NCBI chr10:68,272,921...68,304,951
Ensembl chr10:68,272,969...68,304,949
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
decreases expression
ISO
Vincristine results in decreased expression of TAF1D mRNA
CTD
PMID:23649840
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Taf5l1
TATA-box binding protein associated factor 5 like 1
decreases expression
ISO
Vincristine results in decreased expression of TAF5L mRNA
CTD
PMID:23649840
NCBI chr19:51,991,704...52,011,001
Ensembl chr19:51,991,708...52,011,295
G
Tank
TRAF family member-associated NFKB activator
decreases expression increases expression
ISO
Vincristine results in decreased expression of TANK mRNA Vincristine results in increased expression of TANK mRNA
CTD
PMID:23649840
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
Vincristine results in increased expression of TAP1 mRNA
CTD
PMID:23649840
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tasor2
transcription activation suppressor family member 2
increases expression
ISO
Vincristine results in increased expression of TASOR2 mRNA
CTD
PMID:23649840
NCBI chr17:66,583,554...66,650,127
Ensembl chr17:66,594,908...66,649,135
G
Tbc1d12
TBC1 domain family, member 12
decreases expression
ISO
Vincristine results in decreased expression of TBC1D12 mRNA
CTD
PMID:23649840
NCBI chr 1:236,603,597...236,685,859
Ensembl chr 1:236,603,607...236,685,859
G
Tbc1d4
TBC1 domain family, member 4
increases expression
ISO
Vincristine results in increased expression of TBC1D4 mRNA
CTD
PMID:23649840
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tbc1d8b
TBC1 domain family member 8B
decreases expression
ISO
Vincristine results in decreased expression of TBC1D8B mRNA
CTD
PMID:23649840
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbx22
T-box transcription factor 22
increases expression
ISO
Vincristine results in increased expression of TBX22 mRNA
CTD
PMID:23649840
NCBI chr X:72,723,619...72,774,647
Ensembl chr X:72,723,617...72,774,647
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
Vincristine results in decreased expression of TCAF1 mRNA
CTD
PMID:23649840
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tcea2
transcription elongation factor A2
increases expression
ISO
Vincristine results in increased expression of TCEA2 mRNA
CTD
PMID:23649840
NCBI chr 3:168,796,244...168,804,125
Ensembl chr 3:168,796,331...168,804,116
G
Tcf19
transcription factor 19
decreases expression
ISO
Vincristine results in decreased expression of TCF19 mRNA
CTD
PMID:23649840
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
ISO
Vincristine results in decreased expression of TCIRG1 mRNA
CTD
PMID:23649840
NCBI chr 1:201,127,034...201,138,787
Ensembl chr 1:201,127,034...201,138,742
G
Tdrd9
tudor domain containing 9
increases expression
ISO
Vincristine results in increased expression of TDRD9 mRNA
CTD
PMID:23649840
NCBI chr 6:131,029,644...131,145,076
Ensembl chr 6:131,029,652...131,144,651
G
Tenm2
teneurin transmembrane protein 2
increases expression
ISO
Vincristine results in increased expression of TENM2 mRNA
CTD
PMID:23649840
NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597
G
Tent2
terminal nucleotidyltransferase 2
increases expression
ISO
Vincristine results in increased expression of TENT2 mRNA
CTD
PMID:23649840
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Tent5c
terminal nucleotidyltransferase 5C
decreases expression
ISO
Vincristine results in decreased expression of TENT5C mRNA
CTD
PMID:23649840
NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744
G
Tfap2a
transcription factor AP-2 alpha
decreases expression
ISO
Vincristine results in decreased expression of TFAP2A mRNA
CTD
PMID:23649840
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tfpi
tissue factor pathway inhibitor
increases expression
ISO
Vincristine results in increased expression of TFPI mRNA
CTD
PMID:23649840
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tgds
TDP-glucose 4,6-dehydratase
increases expression
ISO
Vincristine results in increased expression of TGDS mRNA
CTD
PMID:23649840
NCBI chr15:95,175,064...95,195,555
Ensembl chr15:95,174,608...95,195,554
G
Tgfbi
transforming growth factor, beta induced
decreases response to substance
ISO
TGFBI mRNA results in decreased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
G
Tgfbr3
transforming growth factor beta receptor 3
decreases expression
ISO
Vincristine results in decreased expression of TGFBR3 mRNA
CTD
PMID:23649840
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
G
Thada
THADA, armadillo repeat containing
increases expression
ISO
Vincristine results in increased expression of THADA mRNA
CTD
PMID:23649840
NCBI chr 6:10,183,942...10,488,007
Ensembl chr 6:10,183,982...10,487,159
G
Thbd
thrombomodulin
decreases response to substance
ISO
THBD protein results in decreased susceptibility to Vincristine
CTD
PMID:27474498
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression
EXP
Vincristine results in increased expression of THBS1 mRNA
CTD
PMID:20624997
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Them6
thioesterase superfamily member 6
decreases expression
ISO
Vincristine results in decreased expression of THEM6 mRNA
CTD
PMID:23649840
NCBI chr 7:106,606,570...106,609,747
Ensembl chr 7:106,606,570...106,609,746
G
Themis2
thymocyte selection associated family member 2
increases expression
ISO
Vincristine results in increased expression of THEMIS2 mRNA
CTD
PMID:23649840
NCBI chr 5:144,991,110...145,006,362
Ensembl chr 5:144,991,112...145,006,400
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Vincristine binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tigar
TP53 induced glycolysis regulatory phosphatase
increases expression
ISO
Vincristine results in increased expression of TIGAR mRNA
CTD
PMID:23649840
NCBI chr 4:159,927,136...159,946,077
Ensembl chr 4:159,927,139...159,946,029
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP ISO
Vincristine results in increased expression of TIMP1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tinag
tubulointerstitial nephritis antigen
decreases expression
ISO
Vincristine results in decreased expression of TINAG mRNA
CTD
PMID:23649840
NCBI chr 8:77,800,031...77,885,077
Ensembl chr 8:77,800,032...77,885,077
G
Tirap
TIR domain containing adaptor protein
decreases expression
ISO
Vincristine results in decreased expression of TIRAP mRNA
CTD
PMID:23649840
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
G
Tlcd1
TLC domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of TLCD1 mRNA
CTD
PMID:23649840
NCBI chr10:63,074,469...63,076,502
Ensembl chr10:63,074,469...63,076,501
G
Tlr10
toll-like receptor 10
decreases expression
ISO
Vincristine results in decreased expression of TLR10 mRNA
CTD
PMID:23649840
NCBI chr14:43,400,843...43,414,056
Ensembl chr14:43,406,217...43,413,917
G
Tm2d1
TM2 domain containing 1
decreases expression
ISO
Vincristine results in decreased expression of TM2D1 mRNA
CTD
PMID:23649840
NCBI chr 5:113,020,793...113,062,134
Ensembl chr 5:113,020,760...113,050,933
G
Tmcc3
transmembrane and coiled-coil domain family 3
increases expression
ISO
Vincristine results in increased expression of TMCC3 mRNA
CTD
PMID:23649840
NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926
G
Tmco6
transmembrane and coiled-coil domains 6
decreases expression
ISO
Vincristine results in decreased expression of TMCO6 mRNA
CTD
PMID:23649840
NCBI chr18:28,349,248...28,355,843
Ensembl chr18:28,349,248...28,355,843
G
Tmem106c
transmembrane protein 106C
decreases expression
ISO
Vincristine results in decreased expression of TMEM106C mRNA
CTD
PMID:23649840
NCBI chr 7:129,088,468...129,094,128
Ensembl chr 7:129,088,498...129,094,130
G
Tmem107
transmembrane protein 107
decreases expression
ISO
Vincristine results in decreased expression of TMEM107 mRNA
CTD
PMID:23649840
NCBI chr10:53,772,153...53,774,685
Ensembl chr10:53,771,784...53,774,676
G
Tmem163
transmembrane protein 163
increases expression
ISO
Vincristine results in increased expression of TMEM163 mRNA
CTD
PMID:23649840
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
G
Tmem177
transmembrane protein 177
decreases expression
ISO
Vincristine results in decreased expression of TMEM177 mRNA
CTD
PMID:23649840
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem200a
transmembrane protein 200A
decreases expression
ISO
Vincristine results in decreased expression of TMEM200A mRNA
CTD
PMID:23649840
NCBI chr 1:19,323,646...19,408,324
Ensembl chr 1:19,323,829...19,406,453
G
Tmem223
transmembrane protein 223
decreases expression
ISO
Vincristine results in decreased expression of TMEM223 mRNA
CTD
PMID:23649840
NCBI chr 1:205,668,716...205,670,077
Ensembl chr 1:205,662,063...205,670,056
G
Tmem267
transmembrane protein 267
increases expression
ISO
Vincristine results in increased expression of TMEM267 mRNA
CTD
PMID:23649840
NCBI chr 2:51,580,210...51,588,937
Ensembl chr 2:51,581,252...51,587,636
G
Tmem38a
transmembrane protein 38a
decreases expression
ISO
Vincristine results in decreased expression of TMEM38A mRNA
CTD
PMID:23649840
NCBI chr16:17,258,160...17,274,204
Ensembl chr16:17,258,164...17,273,415
G
Tmem43
transmembrane protein 43
increases expression
ISO
Vincristine results in increased expression of TMEM43 mRNA
CTD
PMID:23649840
NCBI chr 4:123,977,680...123,992,823
Ensembl chr 4:123,977,625...123,992,825
G
Tmem80
transmembrane protein 80
decreases expression
ISO
Vincristine results in decreased expression of TMEM80 mRNA
CTD
PMID:23649840
NCBI chr 1:196,435,999...196,444,368
Ensembl chr 1:196,436,003...196,444,367 Ensembl chr 1:196,436,003...196,444,367
G
Tmf1
TATA element modulatory factor 1
increases expression
ISO
Vincristine results in increased expression of TMF1 mRNA
CTD
PMID:23649840
NCBI chr 4:129,759,952...129,785,705
Ensembl chr 4:129,763,114...129,785,629
G
Tmx4
thioredoxin-related transmembrane protein 4
decreases expression
ISO
Vincristine results in decreased expression of TMX4 mRNA
CTD
PMID:23649840
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP ISO
coenzyme Q10 inhibits the reaction [Vincristine results in increased expression of TNF protein]; Pregabalin inhibits the reaction [Vincristine results in increased expression of TNF protein]; Sumatriptan inhibits the reaction [Vincristine results in increased expression of TNF mRNA]; tetrahydrocurcumin inhibits the reaction [Vincristine results in increased expression of TNF protein]; Tropisetron inhibits the reaction [Vincristine results in increased expression of TNF protein] KN 93 inhibits the reaction [Vincristine results in increased expression of TNF mRNA] Vincristine results in increased expression of TNF mRNA; Vincristine results in increased expression of TNF protein
CTD
PMID:23649840 PMID:24374478 PMID:26102012 PMID:29958920 PMID:34286406 PMID:34939713 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
Vincristine results in increased expression of TNFAIP3 mRNA
CTD
PMID:23649840
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Vincristine results in increased expression of TNFAIP6 mRNA
CTD
PMID:23649840
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfaip8l1
TNF alpha induced protein 8 like 1
increases expression
ISO
Vincristine results in increased expression of TNFAIP8L1 mRNA
CTD
PMID:23649840
NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254
G
Tnfrsf17
TNF receptor superfamily member 17
decreases expression
ISO
Vincristine results in decreased expression of TNFRSF17 mRNA
CTD
PMID:23649840
NCBI chr10:4,301,023...4,306,889
Ensembl chr10:4,301,038...4,306,788
G
Tnfrsf19
TNF receptor superfamily member 19
decreases expression
ISO
Vincristine results in decreased expression of TNFRSF19 mRNA
CTD
PMID:23649840
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
Vincristine results in increased expression of TNFRSF9 mRNA
CTD
PMID:23649840
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
increases expression
ISO
Vincristine results in increased expression of TNFSF10 mRNA
CTD
PMID:23649840
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf4
TNF superfamily member 4
increases expression
ISO
Vincristine results in increased expression of TNFSF4 mRNA
CTD
PMID:23649840
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
G
Tnfsf9
TNF superfamily member 9
increases expression
ISO
Vincristine results in increased expression of TNFSF9 mRNA
CTD
PMID:23649840
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tnip2
TNFAIP3 interacting protein 2
increases expression
ISO
Vincristine results in increased expression of TNIP2 mRNA
CTD
PMID:23649840
NCBI chr14:76,228,350...76,245,553
Ensembl chr14:76,228,371...76,275,265
G
Tnni3
troponin I3, cardiac type
increases expression
EXP
Vincristine results in increased expression of TNNI3 protein
CTD
PMID:20624997
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Tnnt2
troponin T2, cardiac type
multiple interactions
EXP
Vincristine inhibits the reaction [Isoproterenol results in increased secretion of TNNT2 protein]
CTD
PMID:25537132
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tomm70
translocase of outer mitochondrial membrane 70
decreases expression
ISO
Vincristine results in decreased expression of TOMM70 mRNA
CTD
PMID:23649840
NCBI chr11:43,378,719...43,417,166
Ensembl chr11:43,377,216...43,417,202
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
Vincristine results in decreased expression of TOP2A mRNA
CTD
PMID:23649840
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Topbp1
DNA topoisomerase II binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of TOPBP1 mRNA
CTD
PMID:23649840
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
G
Tp53
tumor protein p53
increases response to substance increases glutathionylation increases expression multiple interactions increases activity
ISO
TP53 protein results in increased susceptibility to Vincristine Vincristine results in increased glutathionylation of TP53 protein Vincristine results in increased expression of TP53 protein [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of TP53 protein Vincristine results in increased activity of TP53 protein
CTD
PMID:9815696 PMID:12082016 PMID:14704126 PMID:15131059 PMID:17555331 PMID:22010212 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
Vincristine results in increased expression of TP53I3 mRNA
CTD
PMID:23649840
NCBI chr 6:27,818,327...27,825,753
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
Vincristine results in increased expression of TP53INP1 mRNA
CTD
PMID:23649840
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpcn2
two pore segment channel 2
increases expression
ISO
Vincristine results in increased expression of TPCN2 mRNA
CTD
PMID:23649840
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Tpd52
tumor protein D52
decreases expression
ISO
Vincristine results in decreased expression of TPD52 mRNA
CTD
PMID:23649840
NCBI chr 2:92,735,365...92,816,079
Ensembl chr 2:92,735,620...92,816,622
G
Tpd52l1
TPD52 like 1
increases expression
EXP
Vincristine results in increased expression of TPD52L1 mRNA
CTD
PMID:20624997
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Tpi1
triosephosphate isomerase 1
affects response to substance
ISO
TPI1 protein affects the susceptibility to Vincristine
CTD
PMID:18309519
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Tpm4
tropomyosin 4
increases expression
ISO
Vincristine results in increased expression of TPM4 mRNA
CTD
PMID:23649840
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tprg1l
tumor protein p63 regulated 1-like
increases expression
ISO
Vincristine results in increased expression of TPRG1L mRNA
CTD
PMID:23649840
NCBI chr 5:164,722,151...164,725,358
Ensembl chr 5:164,710,285...164,725,425
G
Tra2a
transformer 2 alpha
increases expression
ISO
Vincristine results in increased expression of TRA2A mRNA
CTD
PMID:23649840
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
Vincristine results in increased expression of TRAF1 mRNA
CTD
PMID:23649840
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf3ip3
TRAF3 interacting protein 3
decreases expression
ISO
Vincristine results in decreased expression of TRAF3IP3 mRNA
CTD
PMID:23649840
NCBI chr13:104,694,802...104,719,655
Ensembl chr13:104,694,805...104,719,673
G
Trappc10
trafficking protein particle complex subunit 10
increases expression
ISO
Vincristine results in increased expression of TRAPPC10 mRNA
CTD
PMID:23649840
NCBI chr20:10,438,737...10,499,074
Ensembl chr20:10,438,737...10,499,074
G
Trex1
three prime repair exonuclease 1
decreases expression
ISO
Vincristine results in decreased expression of TREX1 mRNA
CTD
PMID:23649840
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
G
Trib1
tribbles pseudokinase 1
decreases expression
ISO
Vincristine results in decreased expression of TRIB1 mRNA
CTD
PMID:23649840
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trim13
tripartite motif-containing 13
decreases expression
ISO
Vincristine results in decreased expression of TRIM13 mRNA
CTD
PMID:23649840
NCBI chr15:35,733,548...35,772,676
Ensembl chr15:35,734,107...35,772,677
G
Trim29
tripartite motif-containing 29
increases expression
ISO
Vincristine results in increased expression of TRIM29 mRNA
CTD
PMID:23649840
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
G
Trim45
tripartite motif-containing 45
decreases expression
ISO
Vincristine results in decreased expression of TRIM45 mRNA
CTD
PMID:23649840
NCBI chr 2:188,349,979...188,359,205
Ensembl chr 2:188,349,744...188,359,204
G
Trio
trio Rho guanine nucleotide exchange factor
increases expression
ISO
Vincristine results in increased expression of TRIO mRNA
CTD
PMID:23649840
NCBI chr 2:78,505,069...78,801,384
Ensembl chr 2:78,505,070...78,803,135
G
Trir
telomerase RNA component interacting RNase
decreases expression
ISO
Vincristine results in decreased expression of TRIR mRNA
CTD
PMID:23649840
NCBI chr19:23,125,083...23,128,502
Ensembl chr19:23,125,083...23,128,510
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
increases expression
ISO
Vincristine results in increased expression of TRPV2 mRNA
CTD
PMID:23649840
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
increases response to substance
EXP
TRPV4 protein results in increased susceptibility to Vincristine
CTD
PMID:18234883
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
G
Tsc22d1
TSC22 domain family, member 1
decreases expression
ISO
Vincristine results in decreased expression of TSC22D1 mRNA
CTD
PMID:23649840
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tsen15
tRNA splicing endonuclease subunit 15
decreases expression
ISO
Vincristine results in decreased expression of TSEN15 mRNA
CTD
PMID:23649840
NCBI chr13:64,490,216...64,505,591
Ensembl chr13:64,490,218...64,505,617
G
Tsg101
tumor susceptibility 101
affects response to substance
ISO
TSG101 affects the susceptibility to Vincristine
CTD
PMID:15044860
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
ISO
Vincristine results in decreased expression of TSHZ1 mRNA
CTD
PMID:23649840
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
Vincristine results in decreased expression of TTC3 mRNA
CTD
PMID:23649840
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Ttc9c
tetratricopeptide repeat domain 9C
increases expression decreases expression
ISO
Vincristine results in increased expression of TTC9C mRNA Vincristine results in decreased expression of TTC9C mRNA
CTD
PMID:23649840
NCBI chr 1:205,701,768...205,712,782
Ensembl chr 1:205,701,768...205,712,773
G
Ttyh2
tweety family member 2
increases expression
ISO
Vincristine results in increased expression of TTYH2 mRNA
CTD
PMID:23649840
NCBI chr10:99,709,063...99,753,449
Ensembl chr10:99,709,007...99,753,444
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBA1B mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1c
tubulin, alpha 1C
decreases expression
ISO
Vincristine results in decreased expression of TUBA1C mRNA
CTD
PMID:23649840
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba3b
tubulin, alpha 3B
decreases expression
ISO
Vincristine results in decreased expression of TUBA3D mRNA
CTD
PMID:23649840
NCBI chr 4:178,588,779...178,594,328
Ensembl chr 4:178,588,779...178,594,326
G
Tuba4a
tubulin, alpha 4A
decreases expression
EXP ISO
Vincristine results in decreased expression of TUBA4A mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
Vincristine results in decreased expression of TUBB3 mRNA
CTD
PMID:23649840
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBB4B mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBB mRNA Vincristine results in decreased expression of TUBB5 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubg1
tubulin, gamma 1
decreases expression
ISO EXP
Vincristine results in decreased expression of TUBG1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr10:86,052,845...86,059,436
Ensembl chr10:86,052,743...86,059,433
G
Tubgcp5
tubulin gamma complex component 5
decreases expression
ISO
Vincristine results in decreased expression of TUBGCP5 mRNA
CTD
PMID:23649840
NCBI chr 1:106,636,526...106,672,175
Ensembl chr 1:106,636,526...106,672,175
G
Tulp4
TUB like protein 4
increases expression
ISO
Vincristine results in increased expression of TULP4 mRNA
CTD
PMID:23649840
NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688
G
Twf1
twinfilin actin-binding protein 1
affects response to substance
ISO
TWF1 protein affects the susceptibility to Vincristine
CTD
PMID:19783987
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
G
Txnip
thioredoxin interacting protein
increases expression
ISO
Vincristine results in increased expression of TXNIP mRNA
CTD
PMID:23649840
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Tymp
thymidine phosphorylase
multiple interactions
ISO
TYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]
CTD
PMID:15907805
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Tyms
thymidylate synthetase
affects response to substance
ISO
TYMS gene polymorphism affects the susceptibility to Vincristine
CTD
PMID:15713801
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
U2surp
U2 snRNP-associated SURP domain containing
increases expression
ISO
Vincristine results in increased expression of U2SURP mRNA
CTD
PMID:23649840
NCBI chr 8:96,018,932...96,075,795
Ensembl chr 8:96,022,957...96,075,691
G
Ubald2
UBA-like domain containing 2
increases expression
ISO
Vincristine results in increased expression of UBALD2 mRNA
CTD
PMID:23649840
NCBI chr10:101,662,507...101,667,089
Ensembl chr10:101,658,127...101,667,061
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
Vincristine results in decreased expression of UBAP2 mRNA
CTD
PMID:23649840
NCBI chr 5:56,348,243...56,437,403
Ensembl chr 5:56,348,246...56,437,049
G
Ubc
ubiquitin C
decreases expression
ISO
Vincristine results in decreased expression of UBC mRNA
CTD
PMID:23649840
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
Vincristine results in decreased expression of UBE2C mRNA
CTD
PMID:23649840
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2g1
ubiquitin-conjugating enzyme E2G 1
decreases expression
ISO
Vincristine results in decreased expression of UBE2G1 mRNA
CTD
PMID:23649840
NCBI chr10:57,225,963...57,306,748
Ensembl chr10:57,225,952...57,308,568
G
Ube2i
ubiquitin-conjugating enzyme E2I
decreases expression
ISO
Vincristine results in decreased expression of UBE2I mRNA
CTD
PMID:23649840
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ube2j1
ubiquitin-conjugating enzyme E2, J1
decreases expression
ISO
Vincristine results in decreased expression of UBE2J1 mRNA
CTD
PMID:23649840
NCBI chr 5:47,422,476...47,441,476
Ensembl chr 5:47,422,587...47,441,461
G
Ubr2
ubiquitin protein ligase E3 component n-recognin 2
increases expression
ISO
Vincristine results in increased expression of UBR2 mRNA
CTD
PMID:23649840
NCBI chr 9:13,982,427...14,062,315
Ensembl chr 9:13,982,329...14,062,139
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
increases expression
ISO
Vincristine results in increased expression of UBR4 mRNA
CTD
PMID:23649840
NCBI chr 5:151,635,825...151,743,931
Ensembl chr 5:151,635,868...151,743,784
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
EXP
Vincristine results in increased expression of UCHL1 protein
CTD
PMID:16797537
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ucp2
uncoupling protein 2
decreases expression
ISO
Vincristine results in decreased expression of UCP2 mRNA
CTD
PMID:23649840
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ugcg
UDP-glucose ceramide glucosyltransferase
increases expression
ISO
Vincristine results in increased expression of UGCG mRNA
CTD
PMID:23649840
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Uggt2
UDP-glucose glycoprotein glucosyltransferase 2
increases expression
ISO
Vincristine results in increased expression of UGGT2 mRNA
CTD
PMID:23649840
NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806
G
Unc119
unc-119 lipid binding chaperone
increases expression
ISO
Vincristine results in increased expression of UNC119 mRNA
CTD
PMID:23649840
NCBI chr10:63,237,862...63,243,339
Ensembl chr10:63,237,903...63,243,339
G
Upb1
beta-ureidopropionase 1
increases expression
ISO
Vincristine results in increased expression of UPB1 mRNA
CTD
PMID:23649840
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Urod
uroporphyrinogen decarboxylase
decreases expression
ISO
Vincristine results in decreased expression of UROD mRNA
CTD
PMID:23649840
NCBI chr 5:130,464,695...130,468,783
Ensembl chr 5:130,455,217...130,468,808
G
Usp12
ubiquitin specific peptidase 12
increases expression
ISO
Vincristine results in increased expression of USP12 mRNA
CTD
PMID:23649840
NCBI chr12:8,309,845...8,363,686
Ensembl chr12:8,309,750...8,363,656
G
Usp25
ubiquitin specific peptidase 25
decreases expression
ISO
Vincristine results in decreased expression of USP25 mRNA
CTD
PMID:23649840
NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348
G
Usp34
ubiquitin specific peptidase 34
increases expression
ISO
Vincristine results in increased expression of USP34 mRNA
CTD
PMID:23649840
NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376
G
Usp37
ubiquitin specific peptidase 37
decreases expression
ISO
Vincristine results in decreased expression of USP37 mRNA
CTD
PMID:23649840
NCBI chr 9:76,018,863...76,118,732
Ensembl chr 9:76,018,991...76,084,044
G
Vamp2
vesicle-associated membrane protein 2
decreases expression
ISO
Vincristine results in decreased expression of VAMP2 mRNA
CTD
PMID:23649840
NCBI chr10:53,793,581...53,797,815
Ensembl chr10:53,793,923...53,797,809
G
Vasp
vasodilator-stimulated phosphoprotein
increases expression
ISO
Vincristine results in increased expression of VASP mRNA
CTD
PMID:23649840
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO EXP
Vincristine results in increased expression of VCAM1 mRNA
CTD
PMID:20624997 PMID:23649840
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vdr
vitamin D receptor
affects response to substance
ISO
VDR gene polymorphism affects the susceptibility to Vincristine
CTD
PMID:15713801
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
decreases expression
EXP
Vincristine results in decreased expression of VEGFA mRNA
CTD
PMID:20624997
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vezf1
vascular endothelial zinc finger 1
decreases expression
ISO
Vincristine results in decreased expression of VEZF1 mRNA
CTD
PMID:23649840
NCBI chr10:72,859,669...72,876,111
Ensembl chr10:72,859,877...72,876,111
G
Vit
vitrin
increases response to substance
ISO
VIT mRNA results in increased susceptibility to Vincristine
CTD
PMID:25199881
NCBI chr 6:16,445,966...16,565,644
Ensembl chr 6:16,445,955...16,565,665
G
Vps13a
vacuolar protein sorting 13 homolog A
decreases expression
ISO
Vincristine results in decreased expression of VPS13A mRNA
CTD
PMID:23649840
NCBI chr 1:213,901,999...214,128,638
Ensembl chr 1:213,901,999...214,128,555
G
Vps13d
vacuolar protein sorting 13 homolog D
increases expression
ISO
Vincristine results in increased expression of VPS13D mRNA
CTD
PMID:23649840
NCBI chr 5:156,830,509...157,055,895
Ensembl chr 5:156,830,512...157,055,891
G
Vps25
vacuolar protein sorting 25 homolog
decreases expression
ISO
Vincristine results in decreased expression of VPS25 mRNA
CTD
PMID:23649840
NCBI chr10:86,196,062...86,201,606
Ensembl chr10:86,188,812...86,231,829
G
Vps53
VPS53 subunit of GARP complex
increases expression
ISO
Vincristine results in increased expression of VPS53 mRNA
CTD
PMID:23649840
NCBI chr10:60,919,820...61,038,674
Ensembl chr10:60,919,820...61,038,676
G
Vps72
vacuolar protein sorting 72 homolog
decreases expression
ISO
Vincristine results in decreased expression of VPS72 mRNA
CTD
PMID:23649840
NCBI chr 2:182,678,594...182,690,185
Ensembl chr 2:182,678,609...182,690,182
G
Vti1a
vesicle transport through interaction with t-SNAREs 1A
decreases expression
ISO
Vincristine results in decreased expression of VTI1A mRNA
CTD
PMID:23649840
NCBI chr 1:254,356,343...254,661,854
Ensembl chr 1:254,356,429...254,661,852
G
Vwf
von Willebrand factor
increases expression
EXP
Vincristine results in increased expression of VWF mRNA
CTD
PMID:20624997
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
decreases expression
ISO
Vincristine results in decreased expression of WDHD1 mRNA
CTD
PMID:23649840
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Wdr17
WD repeat domain 17
decreases expression
ISO
Vincristine results in decreased expression of WDR17 mRNA
CTD
PMID:23649840
NCBI chr16:37,059,923...37,191,125
Ensembl chr16:37,059,895...37,191,122
G
Wdr33
WD repeat domain 33
decreases expression
ISO
Vincristine results in decreased expression of WDR33 mRNA
CTD
PMID:23649840
NCBI chr18:23,432,233...23,535,460
Ensembl chr18:23,432,191...23,468,597
G
Wdr72
WD repeat domain 72
decreases expression
ISO
Vincristine results in decreased expression of WDR72 mRNA
CTD
PMID:23649840
NCBI chr 8:74,838,338...75,020,938
Ensembl chr 8:74,838,318...75,018,229
G
Wdr76
WD repeat domain 76
decreases expression
ISO
Vincristine results in decreased expression of WDR76 mRNA
CTD
PMID:23649840
NCBI chr 3:108,456,784...108,491,528
Ensembl chr 3:108,456,815...108,490,840
G
Wdr90
WD repeat domain 90
decreases expression
ISO
Vincristine results in decreased expression of WDR90 mRNA
CTD
PMID:23649840
NCBI chr10:14,864,672...14,881,285
Ensembl chr10:14,864,670...14,881,292
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
Vincristine results in decreased expression of WEE1 mRNA
CTD
PMID:23649840
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wnk1
WNK lysine deficient protein kinase 1
increases expression
ISO
Vincristine results in increased expression of WNK1 mRNA
CTD
PMID:23649840
NCBI chr 4:153,128,334...153,253,905
Ensembl chr 4:153,128,334...153,253,905
G
Wsb1
WD repeat and SOCS box-containing 1
decreases expression
ISO
Vincristine results in decreased expression of WSB1 mRNA
CTD
PMID:23649840
NCBI chr10:64,202,761...64,219,039
Ensembl chr10:64,202,763...64,219,019
G
Xirp2
xin actin-binding repeat containing 2
decreases expression
ISO
Vincristine results in decreased expression of XIRP2 mRNA
CTD
PMID:23649840
NCBI chr 3:52,126,213...52,213,094
Ensembl chr 3:51,870,092...52,213,091
G
Xpnpep3
X-prolyl aminopeptidase 3
increases expression
ISO
Vincristine results in increased expression of XPNPEP3 mRNA
CTD
PMID:23649840
NCBI chr 7:112,926,154...112,978,793
Ensembl chr 7:112,926,248...112,974,878
G
Ypel5
yippee-like 5
increases expression
ISO
Vincristine results in increased expression of YPEL5 mRNA
CTD
PMID:23649840
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Ythdc2
YTH N6-methyladenosine RNA binding protein C2
decreases expression
ISO
Vincristine results in decreased expression of YTHDC2 mRNA
CTD
PMID:23649840
NCBI chr18:37,266,559...37,331,681
Ensembl chr18:37,265,836...37,331,023
G
Ythdf3
YTH N6-methyladenosine RNA binding protein F3
increases expression
ISO
Vincristine results in increased expression of YTHDF3 mRNA
CTD
PMID:23649840
NCBI chr 2:98,350,304...98,384,608
Ensembl chr 2:98,350,588...98,384,606
G
Zbtb10
zinc finger and BTB domain containing 10
increases expression
ISO
Vincristine results in increased expression of ZBTB10 mRNA
CTD
PMID:23649840
NCBI chr 2:92,475,254...92,509,892
Ensembl chr 2:92,479,014...92,512,515
G
Zbtb14
zinc finger and BTB domain containing 14
decreases expression
ISO
Vincristine results in decreased expression of ZBTB14 mRNA
CTD
PMID:23649840
NCBI chr 9:109,333,440...109,338,646
Ensembl chr 9:109,331,028...109,338,632
G
Zbtb24
zinc finger and BTB domain containing 24
decreases expression
ISO
Vincristine results in decreased expression of ZBTB24 mRNA
CTD
PMID:23649840
NCBI chr20:44,943,302...44,965,329
Ensembl chr20:44,947,297...44,963,963
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
Vincristine results in increased expression of ZC3H12A mRNA
CTD
PMID:23649840
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zcchc2
zinc finger CCHC-type containing 2
decreases expression
ISO
Vincristine results in decreased expression of ZCCHC2 mRNA
CTD
PMID:23649840
NCBI chr13:22,118,677...22,193,626
Ensembl chr13:22,119,568...22,166,373
G
Zfp207
zinc finger protein 207
decreases expression increases expression
ISO
Vincristine results in decreased expression of ZNF207 mRNA Vincristine results in increased expression of ZNF207 mRNA
CTD
PMID:23649840
NCBI chr10:65,385,807...65,398,086
Ensembl chr10:65,385,740...65,397,386
G
Zfp395
zinc finger protein 395
decreases expression
ISO
Vincristine results in decreased expression of ZNF395 mRNA
CTD
PMID:23649840
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
G
Zfp503
zinc finger protein 503
decreases expression
ISO
Vincristine results in decreased expression of ZNF503 mRNA
CTD
PMID:23649840
NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848
G
Zfp638
zinc finger protein 638
increases expression
ISO
Vincristine results in increased expression of ZNF638 mRNA
CTD
PMID:23649840
NCBI chr 4:116,355,934...116,475,051
Ensembl chr 4:116,402,428...116,479,845
G
Zfp652
zinc finger protein 652
decreases expression
ISO
Vincristine results in decreased expression of ZNF652 mRNA
CTD
PMID:23649840
NCBI chr10:80,626,555...80,706,397
Ensembl chr10:80,649,400...80,698,674
G
Zfp672
zinc finger protein 672
decreases expression
ISO
Vincristine results in decreased expression of ZNF672 mRNA
CTD
PMID:23649840
NCBI chr10:42,496,558...42,512,134
Ensembl chr10:42,495,476...42,504,852
G
Zfp691
zinc finger protein 691
decreases expression
ISO
Vincristine results in decreased expression of ZNF691 mRNA
CTD
PMID:23649840
NCBI chr 5:132,780,259...132,784,954
Ensembl chr 5:132,780,181...132,785,000
G
Zfp692
zinc finger protein 692
decreases expression
ISO
Vincristine results in decreased expression of ZNF692 mRNA
CTD
PMID:23649840
NCBI chr10:42,484,576...42,496,573
Ensembl chr10:42,488,588...42,496,018
G
Zfp709
zinc finger protein 709
decreases expression
ISO
Vincristine results in decreased expression of ZNF443 mRNA
CTD
PMID:23649840
NCBI chr16:17,907,599...17,920,047
Ensembl chr16:17,909,641...17,919,700
G
Zfp830
zinc finger protein 830
decreases expression
ISO
Vincristine results in decreased expression of ZNF830 mRNA
CTD
PMID:23649840
NCBI chr10:67,701,340...67,702,804
Ensembl chr10:67,701,073...67,704,523
G
Zfyve16
zinc finger FYVE-type containing 16
increases expression
ISO
Vincristine results in increased expression of ZFYVE16 mRNA
CTD
PMID:23649840
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
Vincristine results in increased expression of ZMAT3 mRNA
CTD
PMID:23649840
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Zmiz2
zinc finger, MIZ-type containing 2
increases expression
ISO
Vincristine results in increased expression of ZMIZ2 mRNA
CTD
PMID:23649840
NCBI chr14:81,251,391...81,267,936
Ensembl chr14:81,251,417...81,267,936
G
Zmynd8
zinc finger, MYND-type containing 8
increases expression
ISO
Vincristine results in increased expression of ZMYND8 mRNA
CTD
PMID:23649840
NCBI chr 3:154,528,917...154,629,532
Ensembl chr 3:154,529,043...154,628,463
G
Znfx1
zinc finger, NFX1-type containing 1
increases expression
ISO
Vincristine results in increased expression of ZNFX1 mRNA
CTD
PMID:23649840
NCBI chr 3:155,764,073...155,791,777
Ensembl chr 3:155,764,980...155,821,242
G
Znrf2
zinc and ring finger 2
decreases expression
ISO
Vincristine results in decreased expression of ZNRF2 mRNA
CTD
PMID:23649840
NCBI chr 4:83,950,406...84,032,676
Ensembl chr 4:83,949,309...84,027,818
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19918
chemical entity
19916
atom
19916
nonmetal atom
19852
nitrogen atom
19013
nitrogen molecular entity
19013
organonitrogen compound
18856
carboxamide
17575
formamides
1812
(1S,3S,4R,7S,8S,11S,12S,13S,15R,20R)-7-formamido-20-isocyanoisocycloamphilectane
0
(nitroamino)methylformamide
0
2-amino-5-formylamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5'-phosphate(2-)
0
4-(dichloroacetyl)piperazine-1-carbaldehyde
0
4-amino-5-formamidomethyl-2-methylpyrimidine
0
4-formylaminoantipyrine
0
5-formamidopyrimidine
0
Formylisoglutamine
0
Istamycin A1
0
Istamycin B1
0
Istamycin C1
0
N(6)-formyl-L-lysine +
0
N(alpha)-formyl-N(epsilon)-fructosyllysine
0
N,N-dimethylformamide +
37
N,N-dimethylformamide-d7
0
N,N-dipropylformamide
0
N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-[5-hydroxy-3-(2-oxolanylmethyldisulfanyl)pent-2-en-2-yl]formamide
0
N-[2-hydroxy-5-(1-hydroxy-2-\{[1-(4-methoxyphenyl)propan-2-yl]amino\}ethyl)phenyl]formamide +
0
N-benzylformamide +
0
N-butylformamide
0
N-cyclohexylformamide
0
N-formyl-D-kynurenine
0
N-formyl-L-methionyl-L-methionine
0
N-formylisoglutamic acid
0
N-furfurylformamide
0
N-methylformamide
100
Thiamine disulfide
0
antimycin A
631
antimycin A9
0
benfotiamine
15
coelichelin
0
cyclodepsipeptide 2
0
dysoxyhainanin A
0
formamide +
135
formamidopyrimidine +
3
formanilide
0
hookerianamide H
0
lejimalide A
0
lejimalide B
0
myrothenone A
0
orlistat
104
oxonitine
0
respirantin
0
triforine
1
vincristine
1161
Path 2
CHEBI ontology
19918
subatomic particle
19916
composite particle
19916
hadron
19916
baryon
19916
nucleon
19916
atomic nucleus
19916
atom
19916
main group element atom
19866
p-block element atom
19866
carbon group element atom
19811
carbon atom
19806
organic molecular entity
19806
organic group
18995
organic divalent group
18969
organodiyl group
18969
carbonyl group
18922
carbonyl compound
18922
carboxylic acid
18646
carboacyl group
17727
univalent carboacyl group
17727
carbamoyl group
17575
carboxamide
17575
formamides
1812
(1S,3S,4R,7S,8S,11S,12S,13S,15R,20R)-7-formamido-20-isocyanoisocycloamphilectane
0
(nitroamino)methylformamide
0
2-amino-5-formylamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5'-phosphate(2-)
0
4-(dichloroacetyl)piperazine-1-carbaldehyde
0
4-amino-5-formamidomethyl-2-methylpyrimidine
0
4-formylaminoantipyrine
0
5-formamidopyrimidine
0
Formylisoglutamine
0
Istamycin A1
0
Istamycin B1
0
Istamycin C1
0
N(6)-formyl-L-lysine +
0
N(alpha)-formyl-N(epsilon)-fructosyllysine
0
N,N-dimethylformamide +
37
N,N-dimethylformamide-d7
0
N,N-dipropylformamide
0
N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-[5-hydroxy-3-(2-oxolanylmethyldisulfanyl)pent-2-en-2-yl]formamide
0
N-[2-hydroxy-5-(1-hydroxy-2-\{[1-(4-methoxyphenyl)propan-2-yl]amino\}ethyl)phenyl]formamide +
0
N-benzylformamide +
0
N-butylformamide
0
N-cyclohexylformamide
0
N-formyl-D-kynurenine
0
N-formyl-L-methionyl-L-methionine
0
N-formylisoglutamic acid
0
N-furfurylformamide
0
N-methylformamide
100
Thiamine disulfide
0
antimycin A
631
antimycin A9
0
benfotiamine
15
coelichelin
0
cyclodepsipeptide 2
0
dysoxyhainanin A
0
formamide +
135
formamidopyrimidine +
3
formanilide
0
hookerianamide H
0
lejimalide A
0
lejimalide B
0
myrothenone A
0
orlistat
104
oxonitine
0
respirantin
0
triforine
1
vincristine
1161